Patent Grant
12251333
A person or animal may have limited or impaired mobility so typical urination processes are challenging or impossible. For example, a person may experience or have a disability that impairs mobility. A person may have restricted travel conditions such as those experienced by pilots, drivers, and workers in hazardous areas. Additionally, sometimes bodily fluids collection is needed for monitoring purposes or clinical testing.
Urinary catheters, such as a Foley catheter, can address some of these circumstances, such as incontinence. Unfortunately, urinary catheters can be uncomfortable, painful, and can lead to complications, such as infections. Additionally, bed pans, which are receptacles used for the toileting of bedridden individuals are sometimes used. However, bedpans can be prone to discomfort, spills, and other hygiene issues.
Embodiments disclosed herein are directed to fluid collection assemblies that include at least one inflation device, methods for using the same, and systems including the same. In an embodiment, a fluid collection assembly is disclosed. The fluid collection assembly includes a fluid impermeable barrier defining a chamber, at least one opening, and at least one fluid outlet. The fluid collection assembly also includes at least one porous material disposed in the chamber. The fluid collection assembly also includes at least one inflation device including a bladder and at least one valve. The bladder includes one or more walls defining at least one interior region. The at least one valve is configured to selectively permit at least one inflation fluid to flow into and out of the at least one interior region to switch the bladder between a first state and at least a second state. An amount of the at least one inflation fluid present in the at least one interior region is greater when the bladder is in the second state than when the bladder is in the first state. The fluid impermeable barrier exhibits a first length when the bladder exhibits the first state and a second length measure when the bladder exhibits the second state, wherein the first length is less than the second length. The first length and second length measured parallel to a longitudinal axis of the fluid collection assembly.
In an embodiment, a fluid collection assembly is disclosed. The fluid collection assembly includes a fluid impermeable barrier. The fluid impermeable barrier defines a chamber, at least one opening, and at least one fluid outlet. The fluid collection assembly also includes at least one porous material disposed in the chamber. The fluid collection assembly further includes at least one inflation device including a bladder and at least one valve. The bladder includes one or more walls defining at least one interior region. The at least one valve is configured to selectively permit at least one inflation fluid to flow into and out of the at least one interior region to switch the bladder between a first state and at least a second state. An amount of the at least one inflation fluid present in the at least one interior region is greater when the bladder is in the second state than when the bladder is in the first state. The fluid impermeable barrier exhibits a first width measured when the bladder exhibits the first state and a second width when the bladder exhibits the second state. The first width is less than the second width by about 1 cm or less. The first width and the second width measured perpendicular to a longitudinal axis of the fluid collection assembly.
In an embodiment, a fluid collection system is disclosed. The fluid collection system includes a fluid collection assembly. The fluid collection assembly includes a fluid impermeable barrier defining a chamber, at least one opening, and at least one fluid outlet. The fluid collection assembly also includes at least one porous material disposed in the chamber. The fluid collection assembly also includes at least one inflation device including a bladder and at least one valve. The bladder includes one or more walls defining at least one interior region. The at least one valve is configured to selectively permit at least one inflation fluid to flow into and out of the at least one interior region to switch the bladder between a first state and at least a second state. An amount of the at least one inflation fluid present in the at least one interior region is greater when the bladder is in the second state than when the bladder is in the first state. The fluid impermeable barrier exhibits at least one of a first length when the bladder exhibits the first state and a second length measure when the bladder exhibits the second state or a first width measured when the bladder exhibits the first state and a second width when the bladder exhibits the second state. The first length is less than the second length and the first width is less than the second width by about 1 cm or less. The first length and second length measured parallel to a longitudinal axis of the fluid collection assembly and first width and the second width measured perpendicular to a longitudinal axis of the fluid collection assembly. The fluid collection assembly also includes a fluid storage container and a vacuum source. The at least one fluid outlet of the fluid collection assembly, the fluid storage container, and the vacuum source are in fluid communication with each other.
In an embodiment, a method of using a fluid collection assembly is disclosed. The method includes positioning at least one opening of the fluid collection assembly adjacent to a female urethral opening. The fluid collection assembly includes a fluid impermeable barrier including a proximal end region, a distal end region opposite the proximal end region, and two lateral sides extending between the proximal end region and the distal end region. The fluid impermeable barrier defines a chamber, at least one opening between the two lateral sides, and at least one fluid outlet at the proximal end region. The fluid collection assembly also includes at least one porous material disposed in the chamber. The fluid collection assembly further includes at least one inflation device including a bladder and at least one valve. The bladder includes one or more walls defining at least one interior region. The method also includes flowing at least one inflation fluid through the at least one valve and into the at least one interior region of the at least one inflation element to increase at least one of a length of the fluid collection assembly or increase a width of the fluid collection assembly by at most about 1 cm.
Features from any of the disclosed embodiments may be used in combination with one another, without limitation. In addition, other features and advantages of the present disclosure will become apparent to those of ordinary skill in the art through consideration of the following detailed description and the accompanying drawings.
The drawings illustrate several embodiments of the present disclosure, wherein identical reference numerals refer to identical or similar elements or features in different views or embodiments shown in the drawings.
Embodiments disclosed herein are directed to fluid collection assemblies that include at least one inflation device, methods for using the same, and systems including the same. An example fluid collection assembly includes a fluid impermeable barrier defining at least one opening, a chamber, and at least one fluid outlet. The fluid collection assembly also includes at least one porous material disposed in the chamber. As previously discussed, the fluid collection assembly further includes at least one inflation device. The inflation device includes bladder having one or more walls defining an interior region. The inflation device also includes at least one valve configured to selectively permit fluid flow into and out of the interior region to switch the bladder between a first state (e.g., a deflated and/or initial state) and a second state (e.g., an at least partially inflated state). The inflation device may at least one of controllably change the length of the fluid collection assembly to accommodate different sized vulvas or controllably change the width (e.g., maximum width) of at least a portion of the fluid collection assembly to more comfortably fit the fluid collection assembly within the labia folds of an individual using the fluid collection assembly.
The fluid collection assembly is configured to be positioned about, around, or at least partially within the vulva (e.g., labia majora, labia minora, clitoris, urethral opening, vaginal opening, etc.) of an individual. For example, the fluid collection assembly may be at least partially positioned within or between the labia folds. The fluid collection assembly may also be positioned adjacent to the mons pubis, the perineum, buttocks, and the inner thighs of the individual.
The inflation devices of the fluid collection assemblies disclosed herein allows the fluid collection assemblies to change a size thereof. The ability of the fluid collection assemblies to change a size thereof allows such fluid collection assemblies to be used with a variety of individuals exhibiting different sized anatomy. In particular, the fluid collection assemblies including the at least one inflation device may be used with individuals exhibiting different lengths of vulvas and/or different sizes of labia folds. As used herein, the sizes of the labia folds may refer to the length of one or all of the labia folds, the width of one or all of the labia folds, the thickness of one or all of the labia folds, or, more preferably, the space between two or more of the labia folds in which the fluid collection assembly may be disposed.
Some conventional fluid collection assemblies are unable to change a size thereof which restricts the ability of such conventional fluid collection assemblies to be used effectively with individuals exhibiting different sized anatomies. For example, such conventional fluid collection assemblies may only be used with individuals exhibiting certain sized anatomy. Using such conventional fluid collection assemblies with anatomy that is bigger or smaller than the conventional fluid collection assembly is configured to be used with may result in gaps between the conventional fluid collection assemblies and the vulva. The gaps may allow bodily fluids to leak from the conventional fluid collection assemblies and allow air to enter the chamber of such conventional fluid collection assemblies thereby decreasing the ability of a vacuum pressure to remove bodily fluids from the chamber. Further, such conventional fluid collection assemblies may be uncomfortable to use.
As previously discussed, the inflation devices of the fluid collection assemblies disclosed herein allow the fluid collection assemblies to change a size thereof such that the fluid collection assemblies may be used with different sized anatomy. In an example, the inflation device of the fluid collection assembly may be configured to change a length of the fluid collection assembly. In such an example, the inflation device may be inflated (e.g., at least one inflation fluid may be provided to the inflation device) or deflated (e.g., the inflation fluid may be removed from the inflation device) when the length of the vulva of an individual is greater or less than, respectively, than the length of vulva that the fluid collection assembly is configured to be used with. The ability of the inflation device to increase or decrease the overall length of the fluid collection assembly depending on the length of the vulva of the individual prevents the formation of gaps between the fluid collection assembly and the vulva through which bodily fluids and air may flow. The ability of the inflation device to increase or decrease the overall length of the fluid collection assembly depending on the length of the vulva of the individual may also make the fluid collection assembly more comfortable to use. In an example, the inflation device of the fluid collection assembly may be configured to change a maximum width of the fluid collection assembly. In such an example, the inflation device may be inflated or deflated when the size of the labia folds in which the fluid collection assembly is positioned is greater than or less than the size the labia folds in which the fluid collection assembly is configured to be used with. As such, changing the maximum width of the fluid collection assembly may decrease gaps between the fluid collection assembly and the labia folds and may allow the fluid collection assembly to be positioned closer to the urethral opening of the individual. Further, changing the maximum width of the fluid collection assembly depending on the size of the labia folds allows the fluid collection assembly to be at least partially positioned between the labia folds while maximizing comfort.
It is noted that some conventional fluid collection assemblies may include inflation devices that are configured to be increase the overall width of such conventional fluid collection assemblies such that the conventional fluid collection assemblies contact the thighs of the individual. However, unlike the fluid collection assemblies disclosed herein, such inflation device are not configured to predominately contact and be positioned between the labia folds of the individual since the increase in the width of the fluid collection assemblies required to contact the thighs would make it impossible or uncomfortable to position such a fluid collection assembly between the labia folds.
The inflation device 112 includes a bladder 114. The bladder 114 includes one or more walls 116 defining an interior region 118. The inflation device 112 also includes at least one valve 120 in fluid communication with the interior region 118. The valve 120 is configured to selectively permit flow of at least one inflation fluid into and/or out the interior region 118. For example, the valve 120 may allow the inflation fluid to enter the interior region 118 when it is desirable to at least one of increase the length of the bladder 114 which, in turn, increases the length of the fluid collection assembly 100. The valve 120 may also enable removing the inflation fluid from the interior region 118 when it is desirable to decrease the length (e.g., return to the initial length) of the of the fluid collection assembly 100.
Disposing or removing the inflation fluid into and from the interior region 118 changes the state of the bladder 114. The bladder 114 may exhibit at least a first state and a second state. The amount (volume or weight) of inflation fluid present in the interior region 118 is greater when the bladder 114 is in the second state than when the bladder 114 is in the first state. In an example, as shown in
The bladder 114 may exhibit one or more additional states (e.g., third state, fourth state, and so forth) besides the first and second states discussed above. In an embodiment, the one or more additional states may include less of the inflation fluid in the interior region 118 (e.g., is more deflated) than the first state (e.g., the first state is a partially inflated state). In such an embodiment, the one or more additional states may include a deflated or partially deflated state and may be formed by removing the inflation fluid from the interior region 118 when the bladder 114 is in the first or second state. In an embodiment, the one or more additional states may include more of the inflation fluid in the interior region 118 (e.g., is more inflated) than the first state (e.g., the first state is a deflated or partially inflated state) and include less of the inflation fluid in the interior region 118 than the second state. In such an embodiment, the one or more additional states include a partially inflated state and may be formed by adding the inflation fluid to or removing the inflation fluid from the interior region 118 when the bladder 114 is in the first state or second state, respectively. In an embodiment, the one or more additional states may include more of the inflation fluid in the interior region 118 than the second state (e.g., the second state is a partially inflated state). In such an embodiment, the one or more additional states may be an at least partially inflated state and may be formed by adding the inflation fluid to the interior region 118 when the bladder 114 is in the first state or second state. It is noted that, in some embodiments, the bladder 114 may only include the first and second states.
As shown in
The walls 116 are formed from a material is substantially impermeable to the inflation fluid (e.g., substantially impermeable to a gas and/or a liquid) which allows the bladder 114 to retain the inflation fluid without embarrassing leaks. The walls 116 may also be formed from a flexible material. The flexible material of the walls 116 allows the bladder 114 and, by extension, the fluid collection assembly 100 to at least one of increase in size or change a shape thereof. For example, the flexible material of the walls 116 allow the interior region 118 to increase a volume thereof when the interior region 118 receives an inflation fluid and decrease a volume thereof when the inflation fluid is removed from the interior region 118. Examples of materials that may form the walls 116 of the bladder 114 include silicone, rubber, latex, polychloroprene, nylon fabric, polypropylene, polyvinyl chloride, nitrile rubber, other suitable polymers, a metal foil, a composite, or combinations thereof. In an embodiment, the walls 116 are configured to stretch (e.g., elastically or plastically stretch) so the walls 116 remain taut when the bladder 114 is at least partially inflated. In an embodiment, the wall 116 forms a plurality of wrinkles when the bladder 114 is at least partially deflated and adding inflation fluid into the interior region 118 decreases the wrinkles, similar to an accordion.
The bladder 114 of the inflation device 112 and, in particular, the walls 116 of the bladder 114 may exhibit any suitable shape. In an embodiment, as previously discussed, the bladder 114 may exhibit a shape that generally corresponds to the shape of the region of the fluid impermeable barrier 102 that the bladder 114 is adjacent to when the bladder 114 is in the deflated state. In such an embodiment, the bladder 114 may exhibit a shape that is different than the region of the fluid impermeable barrier 102 that the bladder 114 is adjacent to when the bladder 114 is in at least partially inflated state. In an embodiment, the fluid collection assembly 100 may include a bladder 114 adjacent to the proximal region end 103 of the fluid impermeable barrier 102. In such an embodiment, the bladder 114 may exhibit a generally annular shape, a generally C-shape, or another suitable shape (e.g., a shape defining a hole) which allows the bladder 114 to not obstruct the fluid outlet 108.
The valve 120 may include any suitable valve configured to allow for the controllable addition and remove of the inflation fluid from the interior region 118. In an embodiment, the valve 120 is a luer valve and includes a male-tapper fitting or a female-taper fitting. In an embodiment, the valve 120 includes a fluid impermeable membrane with a slit or opening formed. The slit or opening of the fluid impermeable membrane remains substantially closed when no external load is applied thereto but opens when an external load is applied thereto (e.g., an external load caused by pressing a syringe against the fluid impermeable membrane). In an embodiment, the valve 120 may include a mechanical valve, such as a ball valve, a butterfly valve, or any other suitable mechanical valve. The mechanical valve may be manually operated or controlled using a computer. In an embodiment, the valve 120 may include a check valve to limit leaks from the bladder 114 and to make the fluid collection assembly 100 easier to use. In such an embodiment, the valve 120 may only add or remove (but not both) inflation fluid from the interior region 118 and, as such, the fluid collection assembly 100 is configured for single use.
In an embodiment, the valve 120 extends from or near the proximal region end 103, the distal end region 105, or a back side 122 of the fluid impermeable barrier 102. The back side 122 of the fluid impermeable barrier 102 is the side of the fluid impermeable barrier 102 that is generally opposite the opening 104. The valve 120 at or near the proximal region end 103, the distal end region 105, or a back side 122 may allow a user of the fluid collection assembly 100 (e.g., medical practitioner, nurse, or the individual using the fluid collection assembly 100) to access the valve 120 when the fluid collection assembly 100 is adjacent to the vulva since, generally, the inner thighs of the individual may contact or obstruct the surfaces of the fluid impermeable barrier 102 except the proximal region end 103, the distal end region 105, or a back side 122. Further, the valve 120 at or near the proximal region end 103, the distal end region 105, or a back side 122 prevents the valve 120 from pressing against the inner thighs during use which may cause discomfort.
In an embodiment, the fluid collection assembly 100 may only include a single inflation device 112 (e.g., a single bladder 114 and/or a single valve 120). For example, the fluid collection assembly 100 may only include the inflation device 112 at the proximal region end 103 or distal end region 105. In an embodiment, the fluid collection assembly 100 may include a plurality of inflation device 112 (e.g., a plurality of bladders 114) and/or a plurality of valves 120. For example, as illustrated, the fluid collection assembly 100 may include two inflation devices 112. One of the inflation device 112 may be attached to or otherwise proximate to the proximal region end 103 of the fluid impermeable barrier 102 and the other inflation device 112 may be attached to or otherwise proximate to the distal end region 105 of the fluid impermeable barrier 102. The two inflation devices 112 attached to the proximal and distal end regions 103, 105 allow the length of the fluid collection assembly 100 to increase from either or both of the proximal or distal end regions 103, 105 thereof. Increasing the length of the fluid collection assembly 100 from one or both of the proximal or distal end regions 103, 105 allows better control over the position of the fluid collection assembly 100 such that the opening 104 is adjacent to the urethral opening of the individual and allows for the fluid collection assembly to better fit the vulva. Each inflation device 112 (e.g. each bladder 114) may include one or more valves 120 to allow for independent inflation of the bladders 114 which allows for better control of the shape and size of the fluid collection assembly 100. However, the fluid collection assembly 100 may only include a single valve 120 for two or more bladders 114 when the two or more bladders 114 are fluidly coupled together using one or more tubes extending therebetween. In some examples, a single bladder 114 may include a plurality of valves 120, for instance, to increase the likelihood that one valve 120 is easily accessible.
The inflation device 112 may include additional components other than the components discussed above. For example, the inflation device 112 may include less flexible material (e.g., rigid material or material that is less flexible than the walls 116) that are used to control the shape of the bladder 114 when the bladder 114 is inflated (e.g., switched from the first state to the second state). The less flexible material may form parts of the walls 116, wrap around the walls 116, or extend in the interior region 118 between opposing portions of the walls 116 which limits expansion of the walls 116 at and near the less flexible material.
The at least one inflation fluid added or removed from the interior region 118 may include any suitable fluid, such as any suitable liquid or any suitable gas. In an embodiment, the inflation fluid is formed from at least one generally regarded as safe (“GRAS”) material. Forming the inflation fluid from a GRAS material may decrease health risks caused by inadvertently exposing the individual to the inflation fluid. Examples of GRAS materials that may form the inflation fluid includes water, saline solution, alcohol solution, atmospheric air, nitrogen, or combinations thereof.
As previously discussed, the fluid collection assembly 100 includes a fluid impermeable barrier 102. In an embodiment, as shown, the fluid impermeable barrier 102 forms at least a portion of the inflation device 112 since the fluid impermeable barrier 102 defines a portion of the interior region 118. In such an embodiment, the walls 116 of the bladder 114 are attached to the fluid impermeable barrier 102 in a substantially fluid tight manner to prevent the inflation fluid leaking from the interior region 118. In an embodiment, the bladder 114 is distinct from the fluid impermeable barrier 102 (e.g., the fluid impermeable barrier 102 does not partially define the interior region 118). In such an embodiment, the wall 116 of the bladder 114 may be attached to the fluid impermeable barrier 102. In an embodiment, the bladder 114 is spaced from the fluid impermeable barrier 102, such as when the bladder 114 is disposed within the chamber 106. Examples of other locations of the bladder 114 relative to the fluid impermeable barrier 102 are disclosed in U.S. Provisional Patent Application No. 63/030,685 filed on May 27, 2020, the disclosure of which is incorporated herein, in its entirety, by this reference.
The fluid impermeable barrier 102 may be formed of any suitable fluid imporous material(s), such as a fluid impermeable polymer (e.g., silicone, polypropylene, polyethylene, polyethylene terephthalate, a polycarbonate, etc.), a metal film, natural rubber, another suitable material, or combinations thereof. The fluid impermeable barrier 102 substantially prevents the bodily fluids from passing through the fluid impermeable barrier 102. In an example, the fluid impermeable barrier 102 may be air permeable and fluid impermeable. In such an example, the fluid impermeable barrier 102 may be formed of a hydrophobic material that defines a plurality of pores. At least a surface of the fluid impermeable barrier 102 that may contact the individual may be formed from a soft and/or smooth material (e.g., silicone), thereby reducing chaffing. In an embodiment, the fluid impermeable barrier 102 may be formed from a flexible material, such as silicone, which allows the fluid impermeable barrier 102 to be bent into a shape that conforms the anatomy of the individual. Further, as shown in
In some examples, the fluid impermeable barrier 102 may be tubular (ignoring the opening), such as substantially cylindrical (as shown), oblong, prismatic, or flattened tubes when the bladder 114 is in the first state and/or the second state. During use, the outer surface 124 of the fluid impermeable barrier 102 may contact the individual. The fluid impermeable barrier 102 may be sized and shaped to fit in the gluteal cleft between the legs of a female user when the bladder 114 are in at least the second state.
The opening 104 provides an ingress route for fluids to enter the chamber 106. The opening 104 may be defined by the fluid impermeable barrier 102 such as by an inner edge of the fluid impermeable barrier 102. For example, the opening 104 is formed in and extends through the fluid impermeable barrier 102, from the outer surface 124 to the inner surface 126, thereby enabling fluid(s) to enter the chamber 106 from outside of the fluid collection assembly 100. The opening 104 may be an elongated hole in the fluid impermeable barrier 102. For example, the opening 104 may be defined as a cut-out in the fluid impermeable barrier 102. The opening 104 may be located and shaped to be positioned adjacent to a female urethra.
The fluid collection assembly 100 may be positioned proximate to the female urethral opening and urine may enter the chamber of the fluid collection assembly 100 via the opening 104. The fluid collection assembly 100 is configured to receive the bodily fluids into the chamber 106 via the opening 104. When in use, the opening 104 may have an elongated shape that extends from a first location below the urethral opening (e.g., at or near the anus or the vaginal opening) to a second location above the urethral opening (e.g., at or near the top of the vaginal opening or the pubic hair).
The opening 104 may have an elongated shape because the space between the legs of a female is relatively small when the legs of the female are closed, thereby only permitting the flow of the fluid(s) along a path that corresponds to the elongated shape of the opening 104 (e.g., longitudinally extending opening). The opening 104 in the fluid impermeable barrier 102 may exhibit a length measured along the longitudinal axis 111 of the fluid collection assembly 100 that may be at least about 10% of the length of the fluid collection assembly 100, such as about 25% to about 50%, about 40% to about 60%, about 50% to about 75%, about 65% to about 85%, or about 75% to about 95% of the length of the fluid collection assembly 100.
The opening 104 in the fluid impermeable barrier 102 may exhibit a width measured transverse to the longitudinal axis 111 of the fluid collection assembly 100 that may be, when the fluid collection assembly 100 and the bladder 114 are in the first state, at least about 10% of the circumference of the fluid collection assembly 100, such as about 25% to about 50%, about 40% to about 60%, about 50% to about 75%, about 65% to about 85%, or about 75% to about 100% of the circumference of the fluid collection assembly 100. The opening 104 may exhibit a width that is greater than 50% of the circumference of the fluid collection assembly 100 since the vacuum (e.g., suction) through the conduit 128 pulls the fluid through the porous material 110 and into the conduit 128. As shown in
In some examples, the opening 104 may be vertically oriented (e.g., having a major axis parallel to the longitudinal axis 111 of the fluid collection assembly 100). In some examples (not shown), the opening 104 may be horizontally oriented (e.g., having a major axis perpendicular to the longitudinal axis 111 of the fluid collection assembly 100). In an example, the fluid impermeable barrier 102 may be configured to be attached to the individual, such as adhesively attached (e.g., with a hydrogel adhesive) to the individual. According to an example, a suitable adhesive is a hydrogel layer.
As previously discussed, the fluid impermeable barrier 102 may define fluid outlet 108 configured to remove bodily fluids from the chamber 106. The fluid outlet 108 is distinct from the opening 104 and the valve 120. In some examples, the fluid outlet 108 is sized to receive the conduit 128. The conduit 128 may be disposed in the chamber 106 via the fluid outlet 108. The fluid outlet 108 may be sized and shaped to form an at least substantially fluid tight seal against the conduit 128 or the at least one tube substantially preventing the bodily fluids from escaping the chamber 106.
The fluid impermeable barrier 102 may include markings thereon, such as one or more markings to aid a user in aligning the fluid collection assembly 100 on the individual. For example, a line on the fluid impermeable barrier 102 (e.g., opposite the opening 104) may allow a healthcare professional to align the opening 104 over the urethral opening of the individual. In examples, the markings may include one or more of alignment guide or an orientation indicator, such as a stripe or hashes. Such markings may be positioned to align the fluid collection assembly 100 to one or more anatomical features such as a pubic bone, etc.
As previously discussed, the fluid collection assembly 100 includes porous material 110 disposed in the chamber 106. The porous material 110 may cover at least a portion (e.g., all) of the opening 104. The porous material 110 is exposed to the environment outside of the chamber 106 through the opening 104. The permeable properties referred to herein may be wicking, capillary action, absorption, diffusion, or other similar properties or processes, and are referred to herein as “permeable” and/or “porous.” The porous material 110 may also wick the bodily fluids generally towards an interior of the chamber 106, as discussed in more detail below. The porous material 110 may include one or more of a fluid permeable membrane 130 or a fluid permeable support 132.
In an embodiment, at least a portion of the porous material 110 may be a wicking material configured to wick and/or allow flow of the bodily fluids away from the opening 104, thereby preventing bodily fluids from escaping the chamber 106. The wicking material may not include absorption of the bodily fluids into the wicking material. Put another way, substantially no absorption of the bodily fluids into the wicking material may take place after the wicking material is exposed to the bodily fluids. While no absorption is desired, the term “substantially no absorption” may allow for nominal amounts of absorption of the bodily fluids into the wicking material (e.g., absorbency), such as about 10 wt % of the dry weight of the wicking material, about 7 wt %, about 5 wt %, about 3 wt %, about 2 wt %, about 1 wt %, or about 0.5 wt % of the dry weight of the wicking material.
The fluid collection assembly 100 may include the fluid permeable membrane 130 disposed in the chamber 106. The fluid permeable membrane 130 may cover at least a portion (e.g., all) of the opening 104. The fluid permeable membrane 130 may be composed to pull/push the bodily fluids away from the opening 104, thereby promoting fluid flow into the chamber 106, prevent fluid remaining on the vulva of the individual, and preventing the bodily fluids from escaping the chamber 106.
The fluid permeable membrane 130 may include any material that may be permeable to the bodily fluids. For example, the fluid permeable membrane 130 may include fabric, such as a gauze (e.g., a silk, linen, or cotton gauze), another soft fabric, or another smooth fabric. Forming the fluid permeable membrane 130 from gauze, soft fabric, and/or smooth fabric may reduce chaffing caused by the fluid collection assembly 100 and makes wearing the fluid collection assembly more comfortable. In an embodiment, the fluid permeable membrane 130 is formed from a flexible material, such as gauze, since the shape and/or size of the fluid permeable membrane 130 may change when the fluid collection assembly 100 and the bladder 114 switch between states, as shown in
The fluid collection assembly 100 may include the fluid permeable support 132 disposed in the chamber 106. The fluid permeable support 132 is configured to support the fluid permeable membrane 130 and maintain the shape of the chamber 106 since the fluid impermeable barrier 102 and the fluid permeable membrane 130 may be formed from a relatively foldable, flimsy, or otherwise easily deformable material. For example, the fluid permeable support 132 may be positioned so the fluid permeable membrane 130 is disposed between the fluid permeable support 132 and the fluid impermeable barrier 102. The fluid permeable support 132 may support and maintain the position of the fluid permeable membrane 130 and the shape of the chamber 106. The fluid permeable support 132 may include any material that may be permeable to the bodily fluids, such as any of the fluid permeable membrane 130 materials disclosed above. For example, the fluid permeable membrane 130 material(s) may be utilized in a more dense or rigid form than in the fluid permeable membrane 130 when used as the fluid permeable support 132. The fluid permeable support 132 may be formed from any fluid porous material that is less deformable than the fluid permeable membrane 130. For example, the fluid permeable support 132 may include a porous polymer (e.g., nylon, polyester, polyurethane, polyethylene, polypropylene, etc.) structure (e.g., spun fibers such as spun nylon fibers) or a foam (e.g., an open cell foam). In some examples, the fluid permeable support 132 may be formed from a natural material, such as cotton, wool, silk, or combinations thereof. In such examples, the material may have a coating to prevent or limit absorption of the bodily fluids into the material, such as a water repellent coating. In some examples, the fluid permeable support 132 may be formed from fabric, felt, gauze, or combinations thereof.
In some examples, the fluid permeable membrane 130 may be optional. For example, the porous material 110 may include only the fluid permeable support 132. In such examples, the bladder 114 may be positioned within the fluid permeable support 132 since, for instance, at least some materials of the support 132 disclosed herein are flexible enough to accommodate the shape and/or size changes discussed herein. In some examples, the fluid permeable support 132 may be optionally omitted from the fluid collection assembly 100 and the porous material 110 may only include the fluid permeable membrane 130. In such examples, the bladder 114 may be positioned within the fluid permeable membrane 130.
In an embodiment, the fluid permeable membrane 130 and/or the fluid permeable support 132 are wicking materials. In such an embodiment, the fluid permeable support 132 may have a greater ability to wick the bodily fluids than the fluid permeable membrane 130, such as to move the bodily fluids inwardly from the 116 of the fluid collection assembly 100. In some examples, the wicking ability of the fluid permeable support 132 and the fluid permeable membrane 130 may be substantially the same. In an embodiment, the fluid permeable membrane 130 and/or the fluid permeable support 132 are non-wicking materials (e.g., absorbent materials).
In an embodiment, not shown, the fluid permeable membrane 130 and the fluid permeable support 132 may at least substantially completely fill the portions of the chamber 106 not occupied by the inflation device 112 and the conduit 128. In an embodiment, as shown in
The fluid reservoir 134 is a substantially unoccupied portion of the chamber 106. The fluid reservoir 134 may be defined between the fluid impermeable barrier 102 and at least one of the inflation device 112, the fluid permeable membrane 130, or the fluid permeable support 132. The bodily fluids in the chamber 106 may flow through the fluid permeable membrane 130 and/or fluid permeable support 132 to the fluid reservoir 134. The fluid reservoir 134 may retain of the bodily fluids. The bodily fluids in the chamber 106 may flow through the fluid permeable membrane 130 and/or fluid permeable support 132 and, optionally, to the fluid reservoir 134. The fluid impermeable barrier 102 may retain the bodily fluids in the fluid reservoir 134. The fluid reservoir 134 may be in a portion of the chamber 106 designed to be in a gravimetrically low point of the fluid collection assembly 100 when the fluid collection assembly 100 is worn.
The inflation devices and, in particular, the bladders disclosed herein may be located adjacent to regions of the fluid collection assemblies other than or in addition to the proximal end region and the distal end region of the fluid impermeable barrier. For example,
The fluid collection assembly 200 is configured to be at least partially positioned between the labia folds of an individual. Positioning the fluid collection assembly 200 at least partially between the labia folds may decrease the number and/or size of gaps formed between the fluid collection assembly 200 and the vulva thereby minimizing leakage of the bodily fluids and the suction pressure between the fluid collection assembly 200 and the vulva. Also, positioning the fluid collection assembly 200 at least a portion between the labia folds may decrease the distance between the urethral opening of the individual and the fluid collection assembly 200 which increases the quantity of bodily fluids that are discharged from the urethral opening that are received by the fluid collection assembly 200 (e.g., received through the opening 204 and into the porous material 210). As previously discussed, the size of the labia folds may vary from individual to individual. Fluid collection assemblies exhibiting a maximum width that is too large for the particular size of the labia folds may make positioning such a fluid collection assembly between the labia folds difficult, uncomfortable, and may limit the ability to position such a wide fluid collection assembly proximate to the urethral opening of the individual. Fluid collection assembly exhibiting a maximum width that is too small for the particular size of the labia folds may form gaps between the narrow fluid collection assembly and the labia folds through which the bodily fluids and the suction pressure may leak.
The fluid collection assembly 200 is configured to change a width of at least a portion thereof thereby allowing the fluid collection assembly 200 to be used effectively with individuals with differently sized labia folds. In particular, the inflation device 212 allows the width of the fluid collection assembly 200 to be selectively and controllably changed thereby allowing the width of at least a portion of the fluid collection assembly 200 to be controllably and selectively changed. As previously discussed, the inflation device 212 may be disposed adjacent to the at least one lateral side 236 of the fluid impermeable barrier 202 which allows the inflation device 212 to control the width of at least a portion of the fluid collection assembly 200. The lateral side 236 of the fluid impermeable barrier 202 may include a side of the fluid impermeable barrier 202 that is between the opening 204 and the back side 222 of the fluid impermeable barrier 202 and between the proximal and distal end regions 203, 205 of the fluid impermeable barrier 202. As shown in
At least some convention fluid collection assemblies exhibit a maximum width that is greater than 3 cm. Such widths of the conventional fluid collection assemblies allows the conventional fluid collection assemblies to be used with a significant number (but not all) individuals. In an embodiment, the fluid collection assembly 200 may exhibit a maximum width that is about 3 cm or greater when the bladder 214 exhibits the deflated state. In an embodiment, the fluid collection assembly 200 may exhibit a maximum width when the bladder 214 exhibits the deflated state that is about 3 cm or less, such as about 2.75 cm or less, about 2.5 cm or less, about 2.25 cm or less, about 2 cm or less, about 1.75 cm or less, about 1.5 cm or less, or in ranges of about 1.5 cm to about 2 cm, about 1.75 cm to about 2.25 cm, about 2 cm to about 2.5 cm, about 2.25 cm to about 2.75 cm, or about 2.5 cm to about 3 cm. Selecting the maximum width of the fluid collection assembly 200 to be about 3 cm or less may decrease the volume of the chamber 206 which limits the quantity of bodily fluids that may be stored in the chamber 206 but also allows the fluid collection assembly 200 to be used with individuals having relatively small sized labia folds. Further, the inflation device 212 allows the fluid collection assembly 200 to be used with individuals having relatively large sized labia folds by switching the bladder 214 from the first state to the second state even when the fluid collection assembly 200 exhibits a maximum width that is less than 3 cm.
In an embodiment, the at least one inflation device 212 may be configured such that the maximum difference between the second width W2 is greater than the first width W1 by about 2 cm or less, about 1.75 cm or less, about 1.5 cm or less, about 1.25 cm or less, about 1 cm or less, about 7.5 mm or less, about 6 mm or less, about 5 mm or less, about 4 mm or less, about 3 mm or less, about 2 mm or less, about 1 mm or less, or in ranges of about 1 mm to about 3 mm, about 2 mm to about 4 mm, about 3 mm to about 5 mm, about 4 mm to about 6 mm, about 5 mm to about 7.5 mm, about 6 mm to about 1 cm, about 7.5 mm to about 1.25 cm, about 1 cm to about 1.5 cm, about 1.25 cm to about 1.75 cm, or about 1.5 cm to about 2 cm. For example, the difference in sizes of the labia folds from a relatively small sized labia folds to a relatively large sized labia folds may only vary by at most 2 cm and, more commonly, less than 1.5 cm and less than 1 cm. Restricting the maximum change in the width that the portion of the fluid collection assembly 200 may exhibit may prevent overinflation of the bladder 214 when the fluid collection assembly 200 is positioned between the labia folds since overinflation may injure the labia folds. In an embodiment, the fluid collection assembly 200 may include a rigid band extending around at least a portion of or integrally formed with the inflation device 212 that prevents overinflation of the bladder 214.
In an embodiment, the inflation device 212 (e.g., the bladder 214) is positioned adjacent to a portion of the lateral side 236 of the fluid impermeable barrier 202 that is closer to the opening 204 than the back side 222 of the fluid impermeable barrier 202. The inflation device 212 may exhibit such a location since the portion of the lateral sides 236 that is closer to the opening 204 than the back side 222 is more likely to be positioned between the labia folds of the individual than a portion of the lateral side 236 that is closer to the back side 222 than the opening 204. As such, positioning the inflation device 212 to be closer to the opening 204 than the back side 222 better ensures that the inflation device 212 (e.g., the bladder 214) is positioned between the labia folds and that the bladder 214 is more likely to contact the labia folds than the thighs of the individual. In an embodiment, the inflation device 212 may be positioned adjacent to a portion of the lateral side 236 that is equally spaced from the opening 204 and the back side 222 or closer to the back side 222 than the opening 204.
In an embodiment, positioning the inflation device 212 to be closer to the opening 204 than the back side 222 allows the fluid collection assembly 200 to include one or more additional inflation devices (not shown) that are distinct and separate from the inflation devices 212. The additional inflation devices may be positioned adjacent to a portion of the lateral sides 236 that is closer to the back side 222 than the opening 204. The additional inflation devices may be configured to contact the thighs of the patient instead of the labia folds of the individual since the additional inflation devices are positioned closer to the back side 222 which decreases the likelihood that the addition inflation devices contact the labia folds. The additional inflation devices may be configured to increase the width of the fluid collection assembly 200 more than the inflation devices 212.
In an embodiment, the fluid collection assembly 200 includes a plurality of inflation devices 212 (e.g., plurality of bladders 214). In such an embodiment, at least one of the inflation devices 212 may be positioned on one side of the opening 204 and at least one other inflation device 212 may be positioned on the other side of the opening 204. Positioning the inflation devices 212 on both sides of the opening 204 allows for better control of the position of the opening 204 relatively to the urethral opening. For example, positioning the inflation devices 212 on both sides of the opening 204 may allow the central portion of the opening 204 to be positioned adjacent to the urethral opening of the individual by controllably inflating and/or deflating the bladders 214 on one or both sides of the opening 204. Positioning the central portion of the opening 204 adjacent to the urethral opening may maximize the quantity of bodily fluids that are received into the fluid collection assembly 200.
The fluid collection assemblies illustrated in
The fluid collection assembly 300 includes a fluid impermeable barrier 302 that includes a proximal end region 303, a distal end region 305 opposite the proximal end region 303, and at least one lateral side 336. The fluid collection assembly 300 includes at least one first inflation device 312a (e.g., at least one first inflation device 312a adjacent to the proximal end region 303 and at least one other inflation device 312a adjacent to the distal end region 305) that is configured to controllably change the length of the fluid collection assembly 300. For example, the first inflation device 312a may be the same or substantially similar to the inflation device(s) 112 illustrated in
The at least one first inflation device 312a and the at least one second inflation device 312b are distinct and separate from each other. Further, the first inflation device 312a and the second inflation devices 312b are not in fluid communication with each other. This allows the first and second inflation devices 312a, 312b to be independently switched from the first state to second state and vice versa (e.g., independently inflated and deflated). Independently switching the first and second inflation devices 312a, 312b allows for better control of the size of the fluid collection assembly 300. For example, the first inflation device 312a may be inflated when the vulva of the individual is relatively long but the second inflation device 312b may remain deflated when the labia folds of the individual are relatively small.
The first and second inflation devices 312a, 312b may be in fluid communication with each other. For example,
The fluid collection assembly 400 includes a fluid impermeable barrier 402 that includes a proximal end region 403, a distal end region 405 opposite the proximal end region 403, and at least one lateral side 436. The fluid collection assembly 400 includes at least one first inflation device 412a that is configured to controllably change the length of the fluid collection assembly 400. The first inflation device 412a may include, for example, at least one first inflation device 412a adjacent to the proximal end region 403 and/or at least one other first inflation device 412a adjacent to the distal end region 405. The fluid collection assembly also includes at least one second inflation device 412b configured to control the width of at least a portion of the fluid collection assembly 400. The second inflation device 412b may include at least one second inflation device 412b on one side of the opening (not shown) and/or at least one other second inflation device 412b on the other side of the opening.
At least two of the inflation devices of the fluid collection assembly 400 may be in fluid communication with each other. The inflation devices of the fluid collection assembly 400 may be in fluid communication with each other when the inflation fluid in one inflation device may flow to another inflation device through at least one tube 438. The tube 438 may include any structure that defines a passageway that allows the inflation fluid to flow therein and substantially prevents the inflation fluid from leaving the passageway. The tube 438 allows inflating one inflation device to also inflate at least one other inflation device and deflating one inflation to also deflate at least one other inflation device. Configuring at least two of the inflation devices to be in fluid communication with each other may help improve the comfort of using the fluid collection assembly 400 and prevent rupturing the bladders thereof when the individual using the fluid collection assembly 400 moves. For example, when the individual using the fluid collection assembly 400 moves, the individual may compress a portion of the bladder of one of the plurality of inflation devices. When the inflation device is not in fluid communication with another inflation device, the inflation fluid present in the bladder may cause another portion of the bladder to bulge with may cause discomfort or rupture the bladder. However, when the inflation devices are in fluid communication with each other, the inflation fluid displaced by the compression may be distributed over a larger area thereby preventing or at least minimizing the formation of bulges.
In an embodiment, as illustrated, the tube 438 may extending within the chamber 406. However, extending the tube 438 within the chamber 406 may decrease the quantity of bodily fluids that may be stored in the chamber 406 and may make disposing the porous material 410 in the chamber 406 more difficult. In an embodiment, the tube 438 may extend within the fluid impermeable barrier 402 (e.g., the fluid impermeable barrier 402 forms the tube 438) or extends outside of the chamber 406 and the fluid impermeable barrier 402. In an embodiment, the at least one tube 438 includes a plurality of tubes 438. In such an embodiment, at least one (e.g., all) of the plurality of tubes 438 may be disposed in the chamber 406, within the fluid impermeable barrier 402, outside of the chamber 406 and the fluid impermeable barrier 402, or combinations thereof.
In an embodiment, as illustrated, each of the first and second inflation devices 412a, 412b are in fluid communication with each other. In such an embodiment, the fluid collection assembly 400 may only include a single valve 420 which is used to inflate and deflate each of the first and second inflation devices 412a, 412b. It is noted that the fluid collection assembly 400 may include a plurality of valves 420 even when each of the first and second inflation devices 412a, 412b are in fluid communication with each other. In an embodiment, at least some of the plurality of inflation devices are not in fluid communication with each other. For example, when the first and second inflation devices 412a, 412b each include two or more inflation devices, the first inflation devices 412a may be in fluid communication with each other and the second inflation devices 412b may be in fluid communication with each other. As such, the length and width of the fluid collection assembly 400 may be control independently from each other.
In an embodiment, the fluid collection assemblies disclosed herein may include a single inflation device that is configured to controllably change the length and width of the fluid collection assembly.
The inflation device 512 may include a single bladder 514 and at least one valve 520. The bladder 514 includes one or more walls 516 defining a single interior region 518 and the valve 520 is in fluid communication with the interior region such that the valve 520 may add the inflation fluid to or remove inflation fluid from the interior region 518. The inflation device 512 is positioned adjacent to at least one of the proximal end region 503 or the distal end region 505 of the fluid impermeable barrier 502. The inflation device 512 is also positioned adjacent to at least a portion of the lateral side 536 of the fluid impermeable barrier 502 on either one or both sides of the opening (not shown). As such, the inflation device 512 is able to control the length and the width of the fluid collection assembly 500. Further, the inflation device 512 may exhibit a relatively large size compared to an inflation device that was only adjacent to one of the proximal end region 503, the distal end region 505, or a portion of the lateral side 536. The greater size of the inflation device 512 allows the inflation fluid to be distributed therein without or minimizing bulging when movement of the individual using the fluid collection assembly 500 compresses a portion of the inflation device.
The suction force may be applied to the outlet of the conduit 628 by the vacuum source 609 either directly or indirectly. The suction force may be applied indirectly via the fluid storage container 607. For example, the outlet of the conduit 628 may be disposed within the fluid storage container 607 and an additional conduit 628 may extend from the fluid storage container 607 to the vacuum source 609. The vacuum source 609 may apply suction to the fluid collection assembly 600 via the fluid storage container 607. The suction force may be applied directly via the vacuum source 609. For example, the outlet of the conduit 628 may be disposed within the vacuum source 609. An additional conduit 628 may extend from the vacuum source 609 to a point outside of the fluid collection assembly 600, such as to the fluid storage container 607. In such examples, the vacuum source 609 may be disposed between the fluid collection assembly 600 and the fluid storage container 607.
The fluid collection assembly 600 may be similar or identical to any of the fluid collection assemblies disclosed herein in one or more aspects. For example, the fluid collection assembly 600 may include a fluid impermeable barrier including a proximal end region, a distal end region, and at least one lateral side. The fluid impermeable barrier defines at least one opening, a chamber, and a fluid outlet at the proximal end region. The fluid collection assembly may at least one include at least one porous material and at least one inflation device. The inflation device is configured to controllably change a length and/or width of the fluid collection assembly.
The fluid storage container 607 is sized and shaped to retain a fluid. The fluid storage container 607 may include a bag (e.g., drainage bag), a bottle or cup (e.g., collection jar), or any other enclosed container for storing bodily fluid(s) such as urine. In some examples, the conduit 628 may extend from the fluid collection assembly 600 and attach to the fluid storage container 607 at a first point. An additional conduit 628 may attach to the fluid storage container 607 at a second point thereon and may extend and attach to the vacuum source 609. A vacuum (e.g., suction) may be drawn through fluid collection assembly 600 via the fluid storage container 607. Fluid, such as urine, may be drained from the fluid collection assembly 600 using the vacuum source 609.
The vacuum source 609 may include one or more of a manual vacuum pump, and electric vacuum pump, a diaphragm pump, a centrifugal pump, a displacement pump, a magnetically driven pump, a peristaltic pump, or any pump configured to produce a vacuum. The vacuum source 609 may provide a vacuum or suction to remove fluid from the fluid collection assembly 600. In some examples, the vacuum source 609 may be powered by one or more of a power cord (e.g., connected to a power socket), one or more batteries, or even manual power (e.g., a hand operated vacuum pump). In some examples, the vacuum source 609 may be sized and shaped to fit outside of, on, or within the fluid collection assembly 600. For example, the vacuum source 609 may include one or more miniaturized pumps or one or more micro pumps. The vacuum sources 609 disclosed herein may include one or more of a switch, a button, a plug, a remote, or any other device suitable to activate the vacuum source 609.
While various aspects and embodiments have been disclosed herein, other aspects and embodiments are contemplated. The various aspects and embodiments disclosed herein are for purposes of illustration and are not intended to be limiting.
Terms of degree (e.g., “about,” “substantially,” “generally,” etc.) indicate structurally or functionally insignificant variations. In an example, when the term of degree is included with a term indicating quantity, the term of degree is interpreted to mean±10%, ±5%, or +2% of the term indicating quantity. In an example, when the term of degree is used to modify a shape, the term of degree indicates that the shape being modified by the term of degree has the appearance of the disclosed shape. For instance, the term of degree may be used to indicate that the shape may have rounded corners instead of sharp corners, curved edges instead of straight edges, one or more protrusions extending therefrom, is oblong, is the same as the disclosed shape, etc.
| Number | Name | Date | Kind |
|---|---|---|---|
| 737443 | Mooers | Aug 1903 | A |
| 1015905 | Northrop | Jan 1912 | A |
| 1032841 | Koenig | Jul 1912 | A |
| 1178644 | Johnson | Apr 1916 | A |
| 1387726 | Karge | Aug 1921 | A |
| 1742080 | Jones | Dec 1929 | A |
| 1979899 | Obrien et al. | Nov 1934 | A |
| 2241010 | Chipley | May 1941 | A |
| 2262772 | Peder | Nov 1941 | A |
| 2326881 | Packer | Aug 1943 | A |
| 2379346 | Farrell | Jun 1945 | A |
| 2485555 | Bester | Oct 1949 | A |
| 2571357 | Charles | Oct 1951 | A |
| 2613670 | Edward | Oct 1952 | A |
| 2616426 | Adele | Nov 1952 | A |
| 2644234 | Earl | Jul 1953 | A |
| 2648335 | Chambers | Aug 1953 | A |
| 2859786 | Tupper | Nov 1958 | A |
| 2944551 | Carl | Jul 1960 | A |
| 2968046 | Duke | Jan 1961 | A |
| 2971512 | Reinhardt | Feb 1961 | A |
| 3032038 | Swinn | May 1962 | A |
| 3077883 | Hill | Feb 1963 | A |
| 3087938 | Hans et al. | Apr 1963 | A |
| 3169528 | Knox et al. | Feb 1965 | A |
| 3171506 | Therkel | Mar 1965 | A |
| 3194238 | Breece | Jul 1965 | A |
| 3198994 | Hildebrandt et al. | Aug 1965 | A |
| 3221742 | Egon | Dec 1965 | A |
| 3312221 | Overment | Apr 1967 | A |
| 3312981 | Mcguire et al. | Apr 1967 | A |
| 3349768 | Keane | Oct 1967 | A |
| 3362590 | Gene | Jan 1968 | A |
| 3366116 | Huck | Jan 1968 | A |
| 3398848 | Donovan | Aug 1968 | A |
| 3400717 | Bruce et al. | Sep 1968 | A |
| 3406688 | Bruce | Oct 1968 | A |
| 3424163 | Gravdahl | Jan 1969 | A |
| 3425471 | Yates | Feb 1969 | A |
| 3511241 | Lee | May 1970 | A |
| 3512185 | Ellis | May 1970 | A |
| 3520300 | Flower | Jul 1970 | A |
| 3528423 | Lee | Sep 1970 | A |
| 3613123 | Langstrom | Oct 1971 | A |
| 3648700 | Warner | Mar 1972 | A |
| 3651810 | Ormerod | Mar 1972 | A |
| 3661155 | Lindan | May 1972 | A |
| 3683918 | Pizzella | Aug 1972 | A |
| 3699815 | Holbrook | Oct 1972 | A |
| 3726277 | Hirschman | Apr 1973 | A |
| 3742952 | Magers et al. | Jul 1973 | A |
| 3757355 | Allen et al. | Sep 1973 | A |
| 3788324 | Lim | Jan 1974 | A |
| 3843016 | Bornhorst et al. | Oct 1974 | A |
| 3863638 | Rogers et al. | Feb 1975 | A |
| 3863798 | Kurihara et al. | Feb 1975 | A |
| 3864759 | Horiuchi | Feb 1975 | A |
| 3865109 | Elmore et al. | Feb 1975 | A |
| 3881486 | Fenton | May 1975 | A |
| 3881489 | Hartwell | May 1975 | A |
| 3915189 | Holbrook et al. | Oct 1975 | A |
| 3998228 | Poidomani | Dec 1976 | A |
| 3999550 | Martin | Dec 1976 | A |
| 4015604 | Csillag | Apr 1977 | A |
| 4020843 | Kanall | May 1977 | A |
| 4022213 | Stein | May 1977 | A |
| 4027776 | Douglas | Jun 1977 | A |
| 4064962 | Hunt | Dec 1977 | A |
| 4096897 | Cammarata | Jun 1978 | A |
| 4116197 | Bermingham | Sep 1978 | A |
| 4180178 | Turner | Dec 1979 | A |
| 4187953 | Turner | Feb 1980 | A |
| 4194508 | Anderson | Mar 1980 | A |
| 4200102 | Duhamel et al. | Apr 1980 | A |
| 4202058 | Anderson | May 1980 | A |
| 4203503 | Bertotti et al. | May 1980 | A |
| 4209076 | Bertotti et al. | Jun 1980 | A |
| 4223677 | Anderson | Sep 1980 | A |
| 4233025 | Larson et al. | Nov 1980 | A |
| 4233978 | Hickey | Nov 1980 | A |
| 4246901 | Frosch et al. | Jan 1981 | A |
| 4253542 | Ruspa et al. | Mar 1981 | A |
| 4257418 | Hessner | Mar 1981 | A |
| 4270539 | Frosch et al. | Jun 1981 | A |
| 4281655 | Terauchi | Aug 1981 | A |
| 4292916 | Bradley et al. | Oct 1981 | A |
| 4330239 | Gannaway | May 1982 | A |
| 4352356 | Tong | Oct 1982 | A |
| 4360933 | Kimura et al. | Nov 1982 | A |
| 4365363 | Windauer | Dec 1982 | A |
| 4375841 | Vielbig | Mar 1983 | A |
| 4387726 | Denard | Jun 1983 | A |
| 4403991 | Hill | Sep 1983 | A |
| 4425130 | Desmarais | Jan 1984 | A |
| 4446986 | Bowen et al. | May 1984 | A |
| 4453938 | Brendling | Jun 1984 | A |
| 4457314 | Knowles | Jul 1984 | A |
| 4476879 | Jackson | Oct 1984 | A |
| 4526688 | Schmidt et al. | Jul 1985 | A |
| 4528703 | Kraus | Jul 1985 | A |
| D280438 | Wendt | Sep 1985 | S |
| 4551141 | Mcneil | Nov 1985 | A |
| 4553968 | Komis | Nov 1985 | A |
| 4581026 | Schneider | Apr 1986 | A |
| 4589516 | Inoue et al. | May 1986 | A |
| 4601716 | Smith | Jul 1986 | A |
| 4610675 | Triunfol | Sep 1986 | A |
| 4620333 | Ritter | Nov 1986 | A |
| 4626250 | Schneider | Dec 1986 | A |
| 4627846 | Ternstroem | Dec 1986 | A |
| 4631061 | Martin | Dec 1986 | A |
| 4650477 | Johnson | Mar 1987 | A |
| 4655754 | Richmond et al. | Apr 1987 | A |
| 4656675 | Fajnsztajn | Apr 1987 | A |
| 4681570 | Dalton | Jul 1987 | A |
| 4681577 | Stern et al. | Jul 1987 | A |
| 4692160 | Nussbaumer | Sep 1987 | A |
| 4707864 | Ikematsu et al. | Nov 1987 | A |
| 4713065 | Koot | Dec 1987 | A |
| 4713066 | Komis | Dec 1987 | A |
| 4723953 | Pratt et al. | Feb 1988 | A |
| 4735841 | Sourdet | Apr 1988 | A |
| 4743236 | Manschot | May 1988 | A |
| 4747166 | Kuntz | May 1988 | A |
| 4752944 | Conrads et al. | Jun 1988 | A |
| 4769215 | Ehrenkranz | Sep 1988 | A |
| 4771484 | Mozell | Sep 1988 | A |
| 4772280 | Rooyakkers | Sep 1988 | A |
| 4784654 | Beecher | Nov 1988 | A |
| 4790830 | Hamacher | Dec 1988 | A |
| 4790835 | Elias | Dec 1988 | A |
| 4791686 | Taniguchi et al. | Dec 1988 | A |
| 4795449 | Schneider et al. | Jan 1989 | A |
| 4798603 | Meyer et al. | Jan 1989 | A |
| 4799928 | Crowley | Jan 1989 | A |
| 4804377 | Hanifl et al. | Feb 1989 | A |
| 4812053 | Bhattacharjee | Mar 1989 | A |
| 4813943 | Smith | Mar 1989 | A |
| 4820297 | Kaufman et al. | Apr 1989 | A |
| 4846818 | Keldahl et al. | Jul 1989 | A |
| 4846909 | Klug et al. | Jul 1989 | A |
| 4865595 | Heyden | Sep 1989 | A |
| 4880417 | Yabrov et al. | Nov 1989 | A |
| 4882794 | Stewart | Nov 1989 | A |
| 4883465 | Brennan | Nov 1989 | A |
| 4886498 | Newton | Dec 1989 | A |
| 4886508 | Washington | Dec 1989 | A |
| 4886509 | Mattsson | Dec 1989 | A |
| 4889532 | Metz et al. | Dec 1989 | A |
| 4889533 | Beecher | Dec 1989 | A |
| 4890691 | Ching-Ho | Jan 1990 | A |
| 4903254 | Haas | Feb 1990 | A |
| 4904248 | Vaillancourt | Feb 1990 | A |
| 4905692 | More | Mar 1990 | A |
| 4936838 | Cross et al. | Jun 1990 | A |
| 4950262 | Takagi | Aug 1990 | A |
| 4955922 | Terauchi | Sep 1990 | A |
| 4957487 | Gerow | Sep 1990 | A |
| 4965460 | Tanaka et al. | Oct 1990 | A |
| 4986823 | Anderson et al. | Jan 1991 | A |
| 4987849 | Sherman | Jan 1991 | A |
| 5002541 | Conkling et al. | Mar 1991 | A |
| 5004463 | Nigay | Apr 1991 | A |
| 5031248 | Kemper | Jul 1991 | A |
| 5045077 | Blake | Sep 1991 | A |
| 5045283 | Patel | Sep 1991 | A |
| 5049144 | Payton | Sep 1991 | A |
| 5053339 | Patel | Oct 1991 | A |
| 5057092 | Webster | Oct 1991 | A |
| 5058088 | Haas et al. | Oct 1991 | A |
| 5071347 | McGuire | Dec 1991 | A |
| 5078707 | Peter | Jan 1992 | A |
| 5084037 | Barnett | Jan 1992 | A |
| 5100396 | Zamierowski | Mar 1992 | A |
| 5112324 | Wallace | May 1992 | A |
| 5147301 | Ruvio | Sep 1992 | A |
| 5176667 | Debring | Jan 1993 | A |
| 5195997 | Carns | Mar 1993 | A |
| 5196654 | Diflora et al. | Mar 1993 | A |
| 5203699 | McGuire | Apr 1993 | A |
| 5244458 | Takasu | Sep 1993 | A |
| 5246454 | Peterson | Sep 1993 | A |
| 5267988 | Farkas | Dec 1993 | A |
| 5275307 | Freese | Jan 1994 | A |
| 5282795 | Finney | Feb 1994 | A |
| 5294983 | Ersoz et al. | Mar 1994 | A |
| 5295983 | Kubo | Mar 1994 | A |
| 5300052 | Kubo | Apr 1994 | A |
| 5304749 | Crandell | Apr 1994 | A |
| 5312383 | Kubalak | May 1994 | A |
| 5318550 | Cermak et al. | Jun 1994 | A |
| 5330459 | Lavon et al. | Jul 1994 | A |
| 5340840 | Park et al. | Aug 1994 | A |
| 5382244 | Telang | Jan 1995 | A |
| 5409014 | Napoli et al. | Apr 1995 | A |
| 5411495 | Willingham | May 1995 | A |
| 5423784 | Metz | Jun 1995 | A |
| 5456246 | Schmieding et al. | Oct 1995 | A |
| 5466229 | Elson et al. | Nov 1995 | A |
| 5478334 | Bernstein | Dec 1995 | A |
| 5499977 | Marx | Mar 1996 | A |
| 5543042 | Filan et al. | Aug 1996 | A |
| D373928 | Green | Sep 1996 | S |
| 5582604 | Ahr et al. | Dec 1996 | A |
| 5592950 | Kopelowicz | Jan 1997 | A |
| 5605161 | Cross | Feb 1997 | A |
| 5618277 | Goulter | Apr 1997 | A |
| 5628735 | Skow | May 1997 | A |
| 5636643 | Argenta et al. | Jun 1997 | A |
| 5637104 | Ball et al. | Jun 1997 | A |
| 5674212 | Osborn et al. | Oct 1997 | A |
| 5678564 | Lawrence et al. | Oct 1997 | A |
| 5678654 | Uzawa | Oct 1997 | A |
| 5687429 | Rahlff | Nov 1997 | A |
| 5695485 | Duperret et al. | Dec 1997 | A |
| 5700254 | Mcdowall et al. | Dec 1997 | A |
| 5701612 | Daneshvar | Dec 1997 | A |
| 5705777 | Flanigan et al. | Jan 1998 | A |
| 5752944 | Dann et al. | May 1998 | A |
| 5763333 | Suzuki et al. | Jun 1998 | A |
| 5772644 | Bark et al. | Jun 1998 | A |
| 5792132 | Garcia | Aug 1998 | A |
| 5827243 | Palestrant | Oct 1998 | A |
| 5827247 | Kay | Oct 1998 | A |
| 5827250 | Fujioka et al. | Oct 1998 | A |
| 5827257 | Fujioka et al. | Oct 1998 | A |
| D401699 | Herchenbach et al. | Nov 1998 | S |
| 5859393 | Cummins et al. | Jan 1999 | A |
| 5865378 | Hollinshead et al. | Feb 1999 | A |
| 5876393 | Ahr et al. | Mar 1999 | A |
| 5887291 | Bellizzi | Mar 1999 | A |
| 5891125 | Plumley | Apr 1999 | A |
| 5894608 | Birbara | Apr 1999 | A |
| D409303 | Oepping | May 1999 | S |
| 5911222 | Lawrence et al. | Jun 1999 | A |
| 5957904 | Holland | Sep 1999 | A |
| 5968026 | Osborn et al. | Oct 1999 | A |
| 5972505 | Phillips et al. | Oct 1999 | A |
| 6007526 | Passalaqua et al. | Dec 1999 | A |
| 6039060 | Rower | Mar 2000 | A |
| 6050983 | Moore et al. | Apr 2000 | A |
| 6059762 | Boyer et al. | May 2000 | A |
| 6063064 | Tuckey et al. | May 2000 | A |
| 6098625 | Winkler | Aug 2000 | A |
| 6105174 | Karlsten et al. | Aug 2000 | A |
| 6113582 | Dwork | Sep 2000 | A |
| 6117163 | Bierman | Sep 2000 | A |
| 6123398 | Arai et al. | Sep 2000 | A |
| 6129718 | Wada et al. | Oct 2000 | A |
| 6131964 | Sareshwala | Oct 2000 | A |
| 6152902 | Christian et al. | Nov 2000 | A |
| 6164569 | Hollinshead et al. | Dec 2000 | A |
| 6177606 | Etheredge et al. | Jan 2001 | B1 |
| 6209142 | Mattsson et al. | Apr 2001 | B1 |
| 6220050 | Cooksey | Apr 2001 | B1 |
| 6244311 | Hand et al. | Jun 2001 | B1 |
| 6248096 | Dwork et al. | Jun 2001 | B1 |
| 6263887 | Dunn | Jul 2001 | B1 |
| 6283246 | Nishikawa | Sep 2001 | B1 |
| 6311339 | Kraus | Nov 2001 | B1 |
| 6336919 | Davis et al. | Jan 2002 | B1 |
| 6338729 | Wada et al. | Jan 2002 | B1 |
| 6352525 | Wakabayashi | Mar 2002 | B1 |
| 6394988 | Hashimoto | May 2002 | B1 |
| 6398742 | Kim | Jun 2002 | B1 |
| 6406463 | Brown | Jun 2002 | B1 |
| 6409712 | Dutari et al. | Jun 2002 | B1 |
| 6416500 | Wada et al. | Jul 2002 | B1 |
| 6423045 | Wise et al. | Jul 2002 | B1 |
| 6428521 | Droll | Aug 2002 | B1 |
| 6428522 | Dipalma et al. | Aug 2002 | B1 |
| 6446454 | Lee et al. | Sep 2002 | B1 |
| 6475198 | Lipman et al. | Nov 2002 | B1 |
| 6479726 | Cole et al. | Nov 2002 | B1 |
| 6491673 | Palumbo et al. | Dec 2002 | B1 |
| 6508794 | Palumbo et al. | Jan 2003 | B1 |
| 6524292 | Dipalma et al. | Feb 2003 | B1 |
| 6540729 | Wada et al. | Apr 2003 | B1 |
| 6547771 | Robertson et al. | Apr 2003 | B2 |
| 6569133 | Cheng et al. | May 2003 | B2 |
| D476518 | Doppelt | Jul 2003 | S |
| 6592560 | Snyder et al. | Jul 2003 | B2 |
| 6610038 | Dipalma et al. | Aug 2003 | B1 |
| 6618868 | Minnick | Sep 2003 | B2 |
| 6620142 | Flueckiger | Sep 2003 | B1 |
| 6629651 | Male et al. | Oct 2003 | B1 |
| 6635038 | Scovel | Oct 2003 | B2 |
| 6652495 | Walker | Nov 2003 | B1 |
| 6666850 | Ahr et al. | Dec 2003 | B1 |
| 6685684 | Falconer | Feb 2004 | B1 |
| 6695828 | Dipalma et al. | Feb 2004 | B1 |
| 6699174 | Bennett | Mar 2004 | B1 |
| 6700034 | Lindsay et al. | Mar 2004 | B1 |
| 6702793 | Sweetser et al. | Mar 2004 | B1 |
| 6706027 | Harvie et al. | Mar 2004 | B2 |
| 6732384 | Scott | May 2004 | B2 |
| 6736977 | Hall et al. | May 2004 | B1 |
| 6740066 | Wolff et al. | May 2004 | B2 |
| 6764477 | Chen et al. | Jul 2004 | B1 |
| 6783519 | Samuelsson | Aug 2004 | B2 |
| 6796974 | Palumbo et al. | Sep 2004 | B2 |
| 6814547 | Childers et al. | Nov 2004 | B2 |
| 6849065 | Schmidt et al. | Feb 2005 | B2 |
| 6857137 | Otto | Feb 2005 | B2 |
| 6885690 | Aggerstam et al. | Apr 2005 | B2 |
| 6888044 | Fell et al. | May 2005 | B2 |
| 6893425 | Dunn et al. | May 2005 | B2 |
| 6912737 | Ernest et al. | Jul 2005 | B2 |
| 6918899 | Harvie | Jul 2005 | B2 |
| 6979324 | Bybordi et al. | Dec 2005 | B2 |
| 7018366 | Easter | Mar 2006 | B2 |
| 7066411 | Male et al. | Jun 2006 | B2 |
| 7122023 | Hinoki | Oct 2006 | B1 |
| 7125399 | Miskie | Oct 2006 | B2 |
| 7131964 | Harvie | Nov 2006 | B2 |
| 7135012 | Harvie | Nov 2006 | B2 |
| 7141043 | Harvie | Nov 2006 | B2 |
| D533972 | La | Dec 2006 | S |
| 7160273 | Greter et al. | Jan 2007 | B2 |
| 7171699 | Ernest et al. | Feb 2007 | B2 |
| 7171871 | Kozak | Feb 2007 | B2 |
| 7179951 | Krishnaswamy-Mirle et al. | Feb 2007 | B2 |
| 7181781 | Trabold et al. | Feb 2007 | B1 |
| 7186245 | Cheng et al. | Mar 2007 | B1 |
| 7192424 | Cooper | Mar 2007 | B2 |
| 7219764 | Forbes | May 2007 | B1 |
| 7220250 | Suzuki et al. | May 2007 | B2 |
| D562975 | Otto | Feb 2008 | S |
| 7335189 | Harvie | Feb 2008 | B2 |
| 7358282 | Krueger et al. | Apr 2008 | B2 |
| 7390320 | Machida et al. | Jun 2008 | B2 |
| 7438706 | Koizumi et al. | Oct 2008 | B2 |
| 7488310 | Yang | Feb 2009 | B2 |
| 7491194 | Oliwa | Feb 2009 | B1 |
| D591106 | Dominique et al. | Apr 2009 | S |
| 7513381 | Heng et al. | Apr 2009 | B2 |
| 7520872 | Biggie et al. | Apr 2009 | B2 |
| D593801 | Wilson et al. | Jun 2009 | S |
| 7540364 | Sanderson | Jun 2009 | B2 |
| 7549511 | Marocco | Jun 2009 | B2 |
| 7549512 | Newberry | Jun 2009 | B2 |
| 7585293 | Vermaak | Sep 2009 | B2 |
| 7588560 | Dunlop | Sep 2009 | B1 |
| 7637905 | Saadat et al. | Dec 2009 | B2 |
| 7665359 | Barber | Feb 2010 | B2 |
| 7682347 | Parks et al. | Mar 2010 | B2 |
| 7687004 | Allen | Mar 2010 | B2 |
| 7695459 | Gilbert et al. | Apr 2010 | B2 |
| 7695460 | Wada et al. | Apr 2010 | B2 |
| 7699818 | Gilbert | Apr 2010 | B2 |
| 7699831 | Bengtson et al. | Apr 2010 | B2 |
| 7722584 | Tanaka et al. | May 2010 | B2 |
| 7727206 | Gorres | Jun 2010 | B2 |
| 7740620 | Gilbert et al. | Jun 2010 | B2 |
| 7749205 | Tazoe et al. | Jul 2010 | B2 |
| 7755497 | Wada et al. | Jul 2010 | B2 |
| 7766887 | Burns et al. | Aug 2010 | B2 |
| D625407 | Koizumi et al. | Oct 2010 | S |
| 7806879 | Brooks et al. | Oct 2010 | B2 |
| 7811272 | Lindsay et al. | Oct 2010 | B2 |
| 7815067 | Matsumoto et al. | Oct 2010 | B2 |
| 7833169 | Hannon | Nov 2010 | B2 |
| 7857806 | Karpowicz et al. | Dec 2010 | B2 |
| 7866942 | Harvie | Jan 2011 | B2 |
| 7871385 | Levinson et al. | Jan 2011 | B2 |
| 7875010 | Frazier et al. | Jan 2011 | B2 |
| 7901389 | Mombrinie | Mar 2011 | B2 |
| 7927320 | Goldwasser et al. | Apr 2011 | B2 |
| 7927321 | Marland | Apr 2011 | B2 |
| 7931634 | Swiecicki et al. | Apr 2011 | B2 |
| 7939706 | Okabe et al. | May 2011 | B2 |
| 7946443 | Stull et al. | May 2011 | B2 |
| 7947025 | Buglino et al. | May 2011 | B2 |
| 7963419 | Burney et al. | Jun 2011 | B2 |
| 7976519 | Bubb et al. | Jul 2011 | B2 |
| 7993318 | Olsson et al. | Aug 2011 | B2 |
| 8015627 | Baker et al. | Sep 2011 | B2 |
| 8016071 | Martinus et al. | Sep 2011 | B1 |
| 8028460 | Williams | Oct 2011 | B2 |
| 8047398 | DiMartino et al. | Nov 2011 | B2 |
| 8083094 | Caulfield et al. | Dec 2011 | B2 |
| 8128608 | Thevenin | Mar 2012 | B2 |
| 8181651 | Pinel | May 2012 | B2 |
| 8181819 | Burney et al. | May 2012 | B2 |
| 8211063 | Bierman et al. | Jul 2012 | B2 |
| 8221369 | Parks et al. | Jul 2012 | B2 |
| 8241262 | Mahnensmith | Aug 2012 | B2 |
| 8277426 | Wilcox et al. | Oct 2012 | B2 |
| 8287508 | Sanchez | Oct 2012 | B1 |
| 8303554 | Tsai et al. | Nov 2012 | B2 |
| 8322565 | Caulfield et al. | Dec 2012 | B2 |
| 8337477 | Parks et al. | Dec 2012 | B2 |
| D674241 | Bickert et al. | Jan 2013 | S |
| 8343122 | Gorres | Jan 2013 | B2 |
| 8343125 | Kawazoe et al. | Jan 2013 | B2 |
| 8353074 | Krebs | Jan 2013 | B2 |
| 8353886 | Bester et al. | Jan 2013 | B2 |
| D676241 | Merrill | Feb 2013 | S |
| 8388588 | Wada et al. | Mar 2013 | B2 |
| D679807 | Burgess et al. | Apr 2013 | S |
| 8425482 | Khoubnazar | Apr 2013 | B2 |
| 8434586 | Pawelski et al. | May 2013 | B2 |
| 8449510 | Martini et al. | May 2013 | B2 |
| D684260 | Lund et al. | Jun 2013 | S |
| 8470230 | Caulfield et al. | Jun 2013 | B2 |
| 8479941 | Matsumoto et al. | Jul 2013 | B2 |
| 8479949 | Henkel | Jul 2013 | B2 |
| 8500719 | Simpson et al. | Aug 2013 | B1 |
| 8512301 | Ma | Aug 2013 | B2 |
| 8529530 | Koch et al. | Sep 2013 | B2 |
| 8535284 | Joder et al. | Sep 2013 | B2 |
| 8546639 | Wada et al. | Oct 2013 | B2 |
| 8551075 | Bengtson | Oct 2013 | B2 |
| 8568376 | Delattre et al. | Oct 2013 | B2 |
| D694404 | Burgess et al. | Nov 2013 | S |
| 8585683 | Bengtson et al. | Nov 2013 | B2 |
| 8586583 | Hamblin et al. | Nov 2013 | B2 |
| 8652112 | Johannison et al. | Feb 2014 | B2 |
| 8669412 | Fernkvist et al. | Mar 2014 | B2 |
| D702973 | Norland et al. | Apr 2014 | S |
| 8703032 | Menon et al. | Apr 2014 | B2 |
| D704330 | Cicatelli | May 2014 | S |
| D704510 | Mason et al. | May 2014 | S |
| D705423 | Walsh Cutler | May 2014 | S |
| D705926 | Burgess et al. | May 2014 | S |
| 8714394 | Wulf | May 2014 | B2 |
| 8715267 | Bengtson et al. | May 2014 | B2 |
| 8757425 | Copeland | Jun 2014 | B2 |
| 8777032 | Biesecker et al. | Jul 2014 | B2 |
| 8808260 | Koch et al. | Aug 2014 | B2 |
| 8864730 | Conway et al. | Oct 2014 | B2 |
| 8881923 | Higginson | Nov 2014 | B2 |
| 8882731 | Suzuki et al. | Nov 2014 | B2 |
| 8936585 | Carson et al. | Jan 2015 | B2 |
| D729581 | Boroski | May 2015 | S |
| 9028460 | Medeiros | May 2015 | B2 |
| 9056698 | Noer | Jun 2015 | B2 |
| 9078792 | Ruiz | Jul 2015 | B2 |
| 9145879 | Pirovano et al. | Sep 2015 | B2 |
| 9173602 | Gilbert | Nov 2015 | B2 |
| 9173799 | Tanimoto et al. | Nov 2015 | B2 |
| 9187220 | Biesecker et al. | Nov 2015 | B2 |
| 9199772 | Krippendorf | Dec 2015 | B2 |
| 9233020 | Matsumiya | Jan 2016 | B2 |
| 9248058 | Conway et al. | Feb 2016 | B2 |
| 9308118 | Dupree et al. | Apr 2016 | B1 |
| 9309029 | Incorvia et al. | Apr 2016 | B2 |
| 9333281 | Giezendanner et al. | May 2016 | B2 |
| 9381108 | Longoni et al. | Jul 2016 | B2 |
| 9382047 | Schmidtner et al. | Jul 2016 | B2 |
| 9402424 | Roy | Aug 2016 | B2 |
| 9456937 | Ellis | Oct 2016 | B2 |
| 9480595 | Baham et al. | Nov 2016 | B2 |
| 9517865 | Albers et al. | Dec 2016 | B2 |
| D777941 | Piramoon | Jan 2017 | S |
| 9533806 | Ding et al. | Jan 2017 | B2 |
| 9550611 | Hodge | Jan 2017 | B2 |
| 9555930 | Campbell et al. | Jan 2017 | B2 |
| 9623159 | Locke | Apr 2017 | B2 |
| D789522 | Burgess et al. | Jun 2017 | S |
| 9687849 | Bruno et al. | Jun 2017 | B2 |
| 9694949 | Hendricks et al. | Jul 2017 | B2 |
| 9709048 | Kinjo | Jul 2017 | B2 |
| 9713547 | Lee et al. | Jul 2017 | B2 |
| 9732754 | Huang et al. | Aug 2017 | B2 |
| 9752564 | Arceno et al. | Sep 2017 | B2 |
| 9788992 | Harvie | Oct 2017 | B2 |
| D804907 | Sandoval | Dec 2017 | S |
| 9868564 | McGirr et al. | Jan 2018 | B2 |
| D814239 | Arora | Apr 2018 | S |
| D817484 | Lafond | May 2018 | S |
| 10037640 | Gordon | Jul 2018 | B2 |
| 10058470 | Phillips | Aug 2018 | B2 |
| 10098990 | Koch et al. | Oct 2018 | B2 |
| D835264 | Mozzicato et al. | Dec 2018 | S |
| D835779 | Mozzicato et al. | Dec 2018 | S |
| D840533 | Mozzicato et al. | Feb 2019 | S |
| D840534 | Mozzicato et al. | Feb 2019 | S |
| 10225376 | Perez Martinez | Mar 2019 | B2 |
| 10226376 | Sanchez et al. | Mar 2019 | B2 |
| 10258517 | Maschino et al. | Apr 2019 | B1 |
| D848612 | Mozzicato et al. | May 2019 | S |
| 10307305 | Hodges | Jun 2019 | B1 |
| 10335121 | Desai | Jul 2019 | B2 |
| D856512 | Cowart et al. | Aug 2019 | S |
| 10376406 | Newton | Aug 2019 | B2 |
| 10376407 | Newton | Aug 2019 | B2 |
| 10390989 | Sanchez et al. | Aug 2019 | B2 |
| D858144 | Fu | Sep 2019 | S |
| 10406039 | Mllarreal | Sep 2019 | B2 |
| 10407222 | Allen | Sep 2019 | B2 |
| 10478356 | Griffin | Nov 2019 | B2 |
| 10500108 | Maschino et al. | Dec 2019 | B1 |
| 10538366 | Pentelovitch et al. | Jan 2020 | B2 |
| 10569938 | Zhao et al. | Feb 2020 | B2 |
| 10577156 | Dagnelie et al. | Mar 2020 | B2 |
| RE47930 | Cho | Apr 2020 | E |
| 10618721 | Vazin | Apr 2020 | B2 |
| D884390 | Wang | May 2020 | S |
| 10669079 | Freedman et al. | Jun 2020 | B2 |
| D892315 | Airy | Aug 2020 | S |
| 10730672 | Bertram et al. | Aug 2020 | B2 |
| 10737848 | Philip et al. | Aug 2020 | B2 |
| 10765854 | Law et al. | Sep 2020 | B2 |
| 10766670 | Kittmann | Sep 2020 | B2 |
| 10799386 | Harrison | Oct 2020 | B1 |
| 10806642 | Tagomori et al. | Oct 2020 | B2 |
| D901214 | Hu | Nov 2020 | S |
| 10849799 | Nishikawa et al. | Dec 2020 | B2 |
| 10857025 | Davis et al. | Dec 2020 | B2 |
| 10865017 | Cowart et al. | Dec 2020 | B1 |
| 10889412 | West et al. | Jan 2021 | B2 |
| 10913581 | Stahlecker | Feb 2021 | B2 |
| D912244 | Rehm et al. | Mar 2021 | S |
| 10952889 | Newton et al. | Mar 2021 | B2 |
| 10973378 | Ryu et al. | Apr 2021 | B2 |
| 10973678 | Newton et al. | Apr 2021 | B2 |
| 10974874 | Ragias et al. | Apr 2021 | B2 |
| 11000401 | Ecklund et al. | May 2021 | B2 |
| D923365 | Wang | Jun 2021 | S |
| 11026829 | Harvie | Jun 2021 | B2 |
| 11027900 | Liu | Jun 2021 | B2 |
| 11045346 | Argent et al. | Jun 2021 | B2 |
| D928946 | Sanchez et al. | Aug 2021 | S |
| 11090183 | Sanchez et al. | Aug 2021 | B2 |
| 11160695 | Febo et al. | Nov 2021 | B2 |
| 11160697 | Maschino et al. | Nov 2021 | B2 |
| 11168420 | Kinugasa et al. | Nov 2021 | B2 |
| 11179506 | Barr et al. | Nov 2021 | B2 |
| 11207206 | Sharma et al. | Dec 2021 | B2 |
| 11226376 | Yamauchi et al. | Jan 2022 | B2 |
| 11253389 | Sharma et al. | Feb 2022 | B2 |
| 11253407 | Miao et al. | Feb 2022 | B2 |
| 11326586 | Milner et al. | May 2022 | B2 |
| 11369508 | Ecklund et al. | Jun 2022 | B2 |
| 11369524 | Hubbard et al. | Jun 2022 | B2 |
| 11376152 | Sanchez et al. | Jul 2022 | B2 |
| 11382786 | Sanchez et al. | Jul 2022 | B2 |
| 11382788 | Hjorth | Jul 2022 | B2 |
| 11389318 | Radl et al. | Jul 2022 | B2 |
| 11395871 | Radl et al. | Jul 2022 | B2 |
| 11399990 | Suyama | Aug 2022 | B2 |
| 11426303 | Davis et al. | Aug 2022 | B2 |
| 11504265 | Godinez et al. | Nov 2022 | B2 |
| 11529252 | Glithero et al. | Dec 2022 | B2 |
| 11547788 | Radl et al. | Jan 2023 | B2 |
| 11806266 | Sanchez et al. | Nov 2023 | B2 |
| 11839567 | Davis et al. | Dec 2023 | B2 |
| D1010109 | Ecklund et al. | Jan 2024 | S |
| 11857716 | Lee et al. | Jan 2024 | B2 |
| 11865030 | Davis et al. | Jan 2024 | B2 |
| 11890221 | Ulreich et al. | Feb 2024 | B2 |
| 11925575 | Newton | Mar 2024 | B2 |
| 11938053 | Austermann et al. | Mar 2024 | B2 |
| 11944740 | Hughett et al. | Apr 2024 | B2 |
| 12023457 | Mann et al. | Jul 2024 | B2 |
| 12042422 | Davis et al. | Jul 2024 | B2 |
| D1038385 | Ecklund et al. | Aug 2024 | S |
| 12090083 | Ecklund et al. | Sep 2024 | B2 |
| 20010037097 | Cheng et al. | Nov 2001 | A1 |
| 20010054426 | Knudson et al. | Dec 2001 | A1 |
| 20020019614 | Woon | Feb 2002 | A1 |
| 20020026161 | Grundke | Feb 2002 | A1 |
| 20020087131 | Wolff et al. | Jul 2002 | A1 |
| 20020091364 | Prabhakar | Jul 2002 | A1 |
| 20020189992 | Schmidt et al. | Dec 2002 | A1 |
| 20020193760 | Thompson | Dec 2002 | A1 |
| 20030004436 | Schmidt et al. | Jan 2003 | A1 |
| 20030032931 | Grundke et al. | Feb 2003 | A1 |
| 20030032944 | Cawood | Feb 2003 | A1 |
| 20030073964 | Palumbo et al. | Apr 2003 | A1 |
| 20030120178 | Heki | Jun 2003 | A1 |
| 20030157859 | Ishikawa | Aug 2003 | A1 |
| 20030181880 | Schwartz | Sep 2003 | A1 |
| 20030195484 | Harvie | Oct 2003 | A1 |
| 20030204173 | Burns et al. | Oct 2003 | A1 |
| 20030233079 | Parks et al. | Dec 2003 | A1 |
| 20040006321 | Cheng et al. | Jan 2004 | A1 |
| 20040015141 | Cheng et al. | Jan 2004 | A1 |
| 20040056122 | Male et al. | Mar 2004 | A1 |
| 20040084465 | Luburic | May 2004 | A1 |
| 20040127872 | Petryk et al. | Jul 2004 | A1 |
| 20040128749 | Scott | Jul 2004 | A1 |
| 20040143229 | Easter | Jul 2004 | A1 |
| 20040147863 | Diaz et al. | Jul 2004 | A1 |
| 20040147894 | Mizutani et al. | Jul 2004 | A1 |
| 20040158221 | Mizutani et al. | Aug 2004 | A1 |
| 20040176731 | Cheng et al. | Sep 2004 | A1 |
| 20040176746 | Forral | Sep 2004 | A1 |
| 20040191919 | Unger et al. | Sep 2004 | A1 |
| 20040200936 | Opperthauser | Oct 2004 | A1 |
| 20040207530 | Nielsen | Oct 2004 | A1 |
| 20040236292 | Tazoe et al. | Nov 2004 | A1 |
| 20040243075 | Harvie | Dec 2004 | A1 |
| 20040254547 | Okabe et al. | Dec 2004 | A1 |
| 20050010182 | Parks et al. | Jan 2005 | A1 |
| 20050033248 | Machida et al. | Feb 2005 | A1 |
| 20050065471 | Kuntz | Mar 2005 | A1 |
| 20050070861 | Okabe et al. | Mar 2005 | A1 |
| 20050070862 | Tazoe et al. | Mar 2005 | A1 |
| 20050082300 | Modrell et al. | Apr 2005 | A1 |
| 20050097662 | Leimkuhler et al. | May 2005 | A1 |
| 20050101924 | Elson et al. | May 2005 | A1 |
| 20050119630 | Harvie | Jun 2005 | A1 |
| 20050137557 | Swiecicki et al. | Jun 2005 | A1 |
| 20050154360 | Harvie | Jul 2005 | A1 |
| 20050177070 | Levinson et al. | Aug 2005 | A1 |
| 20050197639 | Mombrinie | Sep 2005 | A1 |
| 20050273920 | Marinas | Dec 2005 | A1 |
| 20050277904 | Chase et al. | Dec 2005 | A1 |
| 20050279359 | Leblanc et al. | Dec 2005 | A1 |
| 20060004332 | Marx | Jan 2006 | A1 |
| 20060015080 | Mahnensmith | Jan 2006 | A1 |
| 20060015081 | Suzuki et al. | Jan 2006 | A1 |
| 20060016778 | Park | Jan 2006 | A1 |
| 20060069359 | Dipalma et al. | Mar 2006 | A1 |
| 20060079854 | Kay et al. | Apr 2006 | A1 |
| 20060111648 | Vermaak | May 2006 | A1 |
| 20060155214 | Wightman | Jul 2006 | A1 |
| 20060171997 | Gruenbacher et al. | Aug 2006 | A1 |
| 20060200102 | Cooper | Sep 2006 | A1 |
| 20060229575 | Boiarski | Oct 2006 | A1 |
| 20060229576 | Conway et al. | Oct 2006 | A1 |
| 20060231648 | Male et al. | Oct 2006 | A1 |
| 20060235266 | Nan | Oct 2006 | A1 |
| 20060235359 | Marland | Oct 2006 | A1 |
| 20060241553 | Harvie | Oct 2006 | A1 |
| 20060269439 | White | Nov 2006 | A1 |
| 20060277670 | Baker et al. | Dec 2006 | A1 |
| 20070006368 | Key et al. | Jan 2007 | A1 |
| 20070010797 | Nishtala et al. | Jan 2007 | A1 |
| 20070016152 | Karpowicz et al. | Jan 2007 | A1 |
| 20070038194 | Wada et al. | Feb 2007 | A1 |
| 20070055209 | Patel et al. | Mar 2007 | A1 |
| 20070073252 | Forgrave | Mar 2007 | A1 |
| 20070117880 | Elson et al. | May 2007 | A1 |
| 20070118993 | Bates | May 2007 | A1 |
| 20070135786 | Schmidt et al. | Jun 2007 | A1 |
| 20070137718 | Rushlander et al. | Jun 2007 | A1 |
| 20070149935 | Dirico | Jun 2007 | A1 |
| 20070191804 | Coley | Aug 2007 | A1 |
| 20070203464 | Green et al. | Aug 2007 | A1 |
| 20070214553 | Carromba et al. | Sep 2007 | A1 |
| 20070225663 | Watt et al. | Sep 2007 | A1 |
| 20070225666 | Otto | Sep 2007 | A1 |
| 20070225668 | Otto | Sep 2007 | A1 |
| 20070266486 | Ramirez | Nov 2007 | A1 |
| 20070282309 | Bengtson et al. | Dec 2007 | A1 |
| 20080004576 | Tanaka et al. | Jan 2008 | A1 |
| 20080015526 | Reiner et al. | Jan 2008 | A1 |
| 20080015527 | House | Jan 2008 | A1 |
| 20080033386 | Okabe et al. | Feb 2008 | A1 |
| 20080041869 | Backaert | Feb 2008 | A1 |
| 20080091153 | Harvie | Apr 2008 | A1 |
| 20080091158 | Yang | Apr 2008 | A1 |
| 20080114327 | Barge | May 2008 | A1 |
| 20080167634 | Kouta et al. | Jul 2008 | A1 |
| 20080183157 | Walters | Jul 2008 | A1 |
| 20080215031 | Belfort et al. | Sep 2008 | A1 |
| 20080234642 | Patterson et al. | Sep 2008 | A1 |
| 20080269703 | Collins et al. | Oct 2008 | A1 |
| 20080281282 | Finger et al. | Nov 2008 | A1 |
| 20080287894 | Van Den Heuvel et al. | Nov 2008 | A1 |
| 20080312550 | Nishtala et al. | Dec 2008 | A1 |
| 20090025717 | Pinel | Jan 2009 | A1 |
| 20090048570 | Jensen | Feb 2009 | A1 |
| 20090056003 | Ivie et al. | Mar 2009 | A1 |
| 20090069761 | Vogel | Mar 2009 | A1 |
| 20090069765 | Wortham | Mar 2009 | A1 |
| 20090120179 | Nylander et al. | May 2009 | A1 |
| 20090192482 | Dodge et al. | Jul 2009 | A1 |
| 20090234312 | Otoole et al. | Sep 2009 | A1 |
| 20090251510 | Noro et al. | Oct 2009 | A1 |
| 20090264840 | Mrginio | Oct 2009 | A1 |
| 20090270822 | Medeiros | Oct 2009 | A1 |
| 20090281510 | Fisher | Nov 2009 | A1 |
| 20090283982 | Thomas | Nov 2009 | A1 |
| 20100004612 | Thevenin | Jan 2010 | A1 |
| 20100058660 | Williams | Mar 2010 | A1 |
| 20100121289 | Parks et al. | May 2010 | A1 |
| 20100158168 | Murthy et al. | Jun 2010 | A1 |
| 20100160882 | Lowe | Jun 2010 | A1 |
| 20100174250 | Hu et al. | Jul 2010 | A1 |
| 20100179493 | Heagle et al. | Jul 2010 | A1 |
| 20100185168 | Graauw et al. | Jul 2010 | A1 |
| 20100198172 | Wada et al. | Aug 2010 | A1 |
| 20100211032 | Tsai et al. | Aug 2010 | A1 |
| 20100234820 | Tsai et al. | Sep 2010 | A1 |
| 20100241104 | Gilbert | Sep 2010 | A1 |
| 20100263113 | Shelton et al. | Oct 2010 | A1 |
| 20100310845 | Bond et al. | Dec 2010 | A1 |
| 20110028920 | Johannison | Feb 2011 | A1 |
| 20110028922 | Kay et al. | Feb 2011 | A1 |
| 20110034889 | Smith | Feb 2011 | A1 |
| 20110036837 | Shang | Feb 2011 | A1 |
| 20110040267 | Wada et al. | Feb 2011 | A1 |
| 20110040271 | Rogers et al. | Feb 2011 | A1 |
| 20110054426 | Stewart et al. | Mar 2011 | A1 |
| 20110060299 | Wada et al. | Mar 2011 | A1 |
| 20110060300 | Weig et al. | Mar 2011 | A1 |
| 20110077495 | Gilbert | Mar 2011 | A1 |
| 20110077606 | Wilcox et al. | Mar 2011 | A1 |
| 20110087337 | Forsell | Apr 2011 | A1 |
| 20110137273 | Muellejans et al. | Jun 2011 | A1 |
| 20110145993 | Rader et al. | Jun 2011 | A1 |
| 20110152802 | Dicamillo et al. | Jun 2011 | A1 |
| 20110164147 | Takahashi et al. | Jul 2011 | A1 |
| 20110172620 | Khambatta | Jul 2011 | A1 |
| 20110172625 | Wada et al. | Jul 2011 | A1 |
| 20110202024 | Cozzens | Aug 2011 | A1 |
| 20110238023 | Slayton | Sep 2011 | A1 |
| 20110240648 | Tucker | Oct 2011 | A1 |
| 20110251572 | Nishtala et al. | Oct 2011 | A1 |
| 20110265889 | Tanaka et al. | Nov 2011 | A1 |
| 20110276020 | Mitsui | Nov 2011 | A1 |
| 20120029452 | Roedsten | Feb 2012 | A1 |
| 20120035577 | Tomes et al. | Feb 2012 | A1 |
| 20120041400 | Christensen | Feb 2012 | A1 |
| 20120059328 | Dikeman et al. | Mar 2012 | A1 |
| 20120066825 | Birbara et al. | Mar 2012 | A1 |
| 20120103347 | Wheaton et al. | May 2012 | A1 |
| 20120137420 | Gordon et al. | Jun 2012 | A1 |
| 20120165768 | Sekiyama et al. | Jun 2012 | A1 |
| 20120165786 | Chappa et al. | Jun 2012 | A1 |
| 20120210503 | Anzivino et al. | Aug 2012 | A1 |
| 20120233761 | Huang | Sep 2012 | A1 |
| 20120245541 | Suzuki et al. | Sep 2012 | A1 |
| 20120245542 | Suzuki et al. | Sep 2012 | A1 |
| 20120245547 | Wilcox et al. | Sep 2012 | A1 |
| 20120253303 | Suzuki et al. | Oct 2012 | A1 |
| 20120271259 | Ulert | Oct 2012 | A1 |
| 20120296305 | Barraza Khaled et al. | Nov 2012 | A1 |
| 20120316522 | Carter et al. | Dec 2012 | A1 |
| 20120330256 | Wilcox et al. | Dec 2012 | A1 |
| 20130006206 | Wada et al. | Jan 2013 | A1 |
| 20130045651 | Esteves et al. | Feb 2013 | A1 |
| 20130053804 | Soerensen et al. | Feb 2013 | A1 |
| 20130096523 | Chang et al. | Apr 2013 | A1 |
| 20130110059 | Kossow et al. | May 2013 | A1 |
| 20130138064 | Stroebech et al. | May 2013 | A1 |
| 20130150813 | Gordon et al. | Jun 2013 | A1 |
| 20130218112 | Thompson | Aug 2013 | A1 |
| 20130245496 | Wells et al. | Sep 2013 | A1 |
| 20130245586 | Jha | Sep 2013 | A1 |
| 20130292537 | Dirico | Nov 2013 | A1 |
| 20130330501 | Aizenberg et al. | Dec 2013 | A1 |
| 20140005647 | Shuffler et al. | Jan 2014 | A1 |
| 20140031774 | Bengtson | Jan 2014 | A1 |
| 20140039432 | Dunbar et al. | Feb 2014 | A1 |
| 20140107599 | Fink et al. | Apr 2014 | A1 |
| 20140157499 | Suzuki et al. | Jun 2014 | A1 |
| 20140171889 | Hopman et al. | Jun 2014 | A1 |
| 20140182051 | Tanimoto et al. | Jul 2014 | A1 |
| 20140196189 | Lee et al. | Jul 2014 | A1 |
| 20140276501 | Cisko | Sep 2014 | A1 |
| 20140303582 | Wright et al. | Oct 2014 | A1 |
| 20140316381 | Reglin | Oct 2014 | A1 |
| 20140325746 | Block | Nov 2014 | A1 |
| 20140348139 | Gomez Martinez | Nov 2014 | A1 |
| 20140352050 | Yao et al. | Dec 2014 | A1 |
| 20140371628 | Desai | Dec 2014 | A1 |
| 20150045757 | Lee et al. | Feb 2015 | A1 |
| 20150047114 | Ramirez | Feb 2015 | A1 |
| 20150048089 | Robertson | Feb 2015 | A1 |
| 20150135423 | Sharpe et al. | May 2015 | A1 |
| 20150157300 | Ealovega et al. | Jun 2015 | A1 |
| 20150209194 | Heyman | Jul 2015 | A1 |
| 20150290425 | Macy et al. | Oct 2015 | A1 |
| 20150320583 | Harvie | Nov 2015 | A1 |
| 20150329255 | Rzepecki | Nov 2015 | A1 |
| 20150342799 | Michiels et al. | Dec 2015 | A1 |
| 20150359660 | Harvie | Dec 2015 | A1 |
| 20150366699 | Nelson | Dec 2015 | A1 |
| 20160029998 | Brister et al. | Feb 2016 | A1 |
| 20160030228 | Jones | Feb 2016 | A1 |
| 20160038356 | Yao et al. | Feb 2016 | A1 |
| 20160058322 | Brister et al. | Mar 2016 | A1 |
| 20160060001 | Wada et al. | Mar 2016 | A1 |
| 20160100976 | Conway et al. | Apr 2016 | A1 |
| 20160106604 | Timm | Apr 2016 | A1 |
| 20160113809 | Kim | Apr 2016 | A1 |
| 20160183689 | Miner | Jun 2016 | A1 |
| 20160256022 | Le | Sep 2016 | A1 |
| 20160270982 | Raycheck et al. | Sep 2016 | A1 |
| 20160278662 | Brister et al. | Sep 2016 | A1 |
| 20160357400 | Penha et al. | Dec 2016 | A1 |
| 20160366699 | Zhang et al. | Dec 2016 | A1 |
| 20160367226 | Newton et al. | Dec 2016 | A1 |
| 20160367411 | Justiz et al. | Dec 2016 | A1 |
| 20160367726 | Gratzer | Dec 2016 | A1 |
| 20160374848 | Sanchez et al. | Dec 2016 | A1 |
| 20170007438 | Harvie | Jan 2017 | A1 |
| 20170014560 | Minskoff et al. | Jan 2017 | A1 |
| 20170100276 | Joh | Apr 2017 | A1 |
| 20170128638 | Giezendanner et al. | May 2017 | A1 |
| 20170136209 | Burnett et al. | May 2017 | A1 |
| 20170143534 | Sanchez | May 2017 | A1 |
| 20170165100 | Jackson et al. | Jun 2017 | A1 |
| 20170165405 | Muser et al. | Jun 2017 | A1 |
| 20170189225 | Voorhees et al. | Jul 2017 | A1 |
| 20170202692 | Laniado | Jul 2017 | A1 |
| 20170216081 | Accosta | Aug 2017 | A1 |
| 20170246026 | Laniado | Aug 2017 | A1 |
| 20170252014 | Siller Gonzalez et al. | Sep 2017 | A1 |
| 20170252202 | Sanchez et al. | Sep 2017 | A9 |
| 20170266031 | Sanchez et al. | Sep 2017 | A1 |
| 20170266658 | Bruno et al. | Sep 2017 | A1 |
| 20170281399 | Vanmiddendorp et al. | Oct 2017 | A1 |
| 20170312116 | Laniado | Nov 2017 | A1 |
| 20170325788 | Ealovega et al. | Nov 2017 | A1 |
| 20170333244 | Laniado | Nov 2017 | A1 |
| 20170042748 | Griffin | Dec 2017 | A1 |
| 20170348139 | Newton et al. | Dec 2017 | A1 |
| 20170354532 | Holt | Dec 2017 | A1 |
| 20170354551 | Gawley et al. | Dec 2017 | A1 |
| 20170367873 | Grannum | Dec 2017 | A1 |
| 20180002075 | Lee | Jan 2018 | A1 |
| 20180008451 | Stroebech | Jan 2018 | A1 |
| 20180008804 | Laniado | Jan 2018 | A1 |
| 20180021218 | Brosch et al. | Jan 2018 | A1 |
| 20180028349 | Newton et al. | Feb 2018 | A1 |
| 20180037384 | Archeny et al. | Feb 2018 | A1 |
| 20180049910 | Newton | Feb 2018 | A1 |
| 20180064572 | Wiltshire | Mar 2018 | A1 |
| 20180104131 | Killian | Apr 2018 | A1 |
| 20180127187 | Sewell | May 2018 | A1 |
| 20180193215 | Davies et al. | Jul 2018 | A1 |
| 20180200101 | Su | Jul 2018 | A1 |
| 20180228642 | Davis et al. | Aug 2018 | A1 |
| 20180256384 | Kasirye | Sep 2018 | A1 |
| 20180271694 | Fernandez et al. | Sep 2018 | A1 |
| 20180317892 | Catlin | Nov 2018 | A1 |
| 20180325748 | Sharma et al. | Nov 2018 | A1 |
| 20190001030 | Braga et al. | Jan 2019 | A1 |
| 20190021899 | Vlet | Jan 2019 | A1 |
| 20190038451 | Harvie | Feb 2019 | A1 |
| 20190046102 | Kushnir et al. | Feb 2019 | A1 |
| 20190059938 | Holsten | Feb 2019 | A1 |
| 20190091059 | Gabriel | Mar 2019 | A1 |
| 20190100362 | Meyers et al. | Apr 2019 | A1 |
| 20190133814 | Tammen et al. | May 2019 | A1 |
| 20190142624 | Sanchez et al. | May 2019 | A1 |
| 20190224036 | Sanchez et al. | Jul 2019 | A1 |
| 20190247222 | Ecklund et al. | Aug 2019 | A1 |
| 20190247223 | Brun | Aug 2019 | A1 |
| 20190282391 | Johannes et al. | Sep 2019 | A1 |
| 20190314189 | Acosta | Oct 2019 | A1 |
| 20190314190 | Sanchez et al. | Oct 2019 | A1 |
| 20190321587 | Mcmenamin et al. | Oct 2019 | A1 |
| 20190344934 | Faerber et al. | Nov 2019 | A1 |
| 20190365307 | Laing et al. | Dec 2019 | A1 |
| 20190365561 | Newton et al. | Dec 2019 | A1 |
| 20190374373 | Joh | Dec 2019 | A1 |
| 20200008985 | Nguyen et al. | Jan 2020 | A1 |
| 20200016012 | Dutkiewicz | Jan 2020 | A1 |
| 20200030595 | Boukidjian | Jan 2020 | A1 |
| 20200046544 | Godinez et al. | Feb 2020 | A1 |
| 20200055638 | Lau et al. | Feb 2020 | A1 |
| 20200070392 | Huber et al. | Mar 2020 | A1 |
| 20200085609 | Schelch et al. | Mar 2020 | A1 |
| 20200085610 | Cohn et al. | Mar 2020 | A1 |
| 20200086090 | Von Weymarn-schärli et al. | Mar 2020 | A1 |
| 20200107518 | Hiroshima et al. | Apr 2020 | A1 |
| 20200129322 | Leuckel | Apr 2020 | A1 |
| 20200171217 | Braga et al. | Jun 2020 | A9 |
| 20200206039 | Mclain | Jul 2020 | A1 |
| 20200214910 | Varona et al. | Jul 2020 | A1 |
| 20200216898 | Hubbell | Jul 2020 | A1 |
| 20200216989 | Kinugasa et al. | Jul 2020 | A1 |
| 20200229964 | Staali et al. | Jul 2020 | A1 |
| 20200231343 | Freedman et al. | Jul 2020 | A1 |
| 20200232841 | Satish et al. | Jul 2020 | A1 |
| 20200246172 | Ho | Aug 2020 | A1 |
| 20200246203 | Tulk et al. | Aug 2020 | A1 |
| 20200255189 | Liu | Aug 2020 | A1 |
| 20200261280 | Heyman | Aug 2020 | A1 |
| 20200276046 | Staali et al. | Sep 2020 | A1 |
| 20200306075 | Newton et al. | Oct 2020 | A1 |
| 20200315837 | Radl et al. | Oct 2020 | A1 |
| 20200315838 | Eckert | Oct 2020 | A1 |
| 20200315872 | Viens et al. | Oct 2020 | A1 |
| 20200315874 | Viens et al. | Oct 2020 | A1 |
| 20200331672 | Bertram et al. | Oct 2020 | A1 |
| 20200345332 | Duval | Nov 2020 | A1 |
| 20200353135 | Gregory et al. | Nov 2020 | A1 |
| 20200367677 | Silsby et al. | Nov 2020 | A1 |
| 20200369444 | Silsby et al. | Nov 2020 | A1 |
| 20200375781 | Staali et al. | Dec 2020 | A1 |
| 20200375810 | Carlin et al. | Dec 2020 | A1 |
| 20200385179 | McCourt | Dec 2020 | A1 |
| 20200390591 | Glithero et al. | Dec 2020 | A1 |
| 20200390592 | Merrill | Dec 2020 | A1 |
| 20200405521 | Glasroe | Dec 2020 | A1 |
| 20210008771 | Huber et al. | Jan 2021 | A1 |
| 20210009323 | Markarian et al. | Jan 2021 | A1 |
| 20210020072 | Moehring et al. | Jan 2021 | A1 |
| 20210023279 | Radl et al. | Jan 2021 | A1 |
| 20210059853 | Davis et al. | Mar 2021 | A1 |
| 20210061523 | Bytheway | Mar 2021 | A1 |
| 20210069005 | Sanchez et al. | Mar 2021 | A1 |
| 20210069008 | Blabas et al. | Mar 2021 | A1 |
| 20210069009 | Im | Mar 2021 | A1 |
| 20210069030 | Nishikawa et al. | Mar 2021 | A1 |
| 20210077993 | Nazareth et al. | Mar 2021 | A1 |
| 20210113749 | Radl et al. | Apr 2021 | A1 |
| 20210121318 | Pinlac | Apr 2021 | A1 |
| 20210137724 | Ecklund et al. | May 2021 | A1 |
| 20210138190 | Erbey et al. | May 2021 | A1 |
| 20210154055 | Villarreal | May 2021 | A1 |
| 20210170079 | Radl et al. | Jun 2021 | A1 |
| 20210178390 | Oueslati et al. | Jun 2021 | A1 |
| 20210186742 | Newton et al. | Jun 2021 | A1 |
| 20210212865 | Wallajapet et al. | Jul 2021 | A1 |
| 20210220162 | Jamison | Jul 2021 | A1 |
| 20210220163 | Mayrand | Jul 2021 | A1 |
| 20210228400 | Glithero | Jul 2021 | A1 |
| 20210228401 | Becker et al. | Jul 2021 | A1 |
| 20210228795 | Hughett et al. | Jul 2021 | A1 |
| 20210229877 | Ragias et al. | Jul 2021 | A1 |
| 20210236323 | Austermann et al. | Aug 2021 | A1 |
| 20210236324 | Sweeney | Aug 2021 | A1 |
| 20210251814 | Jönegren et al. | Aug 2021 | A1 |
| 20210267787 | Nazemi | Sep 2021 | A1 |
| 20210275343 | Sanchez et al. | Sep 2021 | A1 |
| 20210275344 | Wing | Sep 2021 | A1 |
| 20210290454 | Yamada | Sep 2021 | A1 |
| 20210315727 | Jiang | Oct 2021 | A1 |
| 20210353450 | Sharma et al. | Nov 2021 | A1 |
| 20210361469 | Liu et al. | Nov 2021 | A1 |
| 20210369495 | Cheng et al. | Dec 2021 | A1 |
| 20210386925 | Hartwell et al. | Dec 2021 | A1 |
| 20210393433 | Godinez et al. | Dec 2021 | A1 |
| 20220023091 | Ecklund et al. | Jan 2022 | A1 |
| 20220031523 | Pierpoint | Feb 2022 | A1 |
| 20220039995 | Johannes et al. | Feb 2022 | A1 |
| 20220047410 | Walthall | Feb 2022 | A1 |
| 20220062027 | Mitchell et al. | Mar 2022 | A1 |
| 20220062028 | Mitchell et al. | Mar 2022 | A1 |
| 20220062029 | Johannes et al. | Mar 2022 | A1 |
| 20220066825 | Saraf et al. | Mar 2022 | A1 |
| 20220071811 | Cheng et al. | Mar 2022 | A1 |
| 20220071826 | Kulkarni et al. | Mar 2022 | A1 |
| 20220104965 | Vaninetti et al. | Apr 2022 | A1 |
| 20220104976 | Hoeger et al. | Apr 2022 | A1 |
| 20220104981 | Jones | Apr 2022 | A1 |
| 20220117773 | Davis et al. | Apr 2022 | A1 |
| 20220117774 | Meyer et al. | Apr 2022 | A1 |
| 20220117775 | Jones et al. | Apr 2022 | A1 |
| 20220133524 | Davis | May 2022 | A1 |
| 20220151817 | Mann | May 2022 | A1 |
| 20220160949 | Simiele et al. | May 2022 | A1 |
| 20220168159 | Triado et al. | Jun 2022 | A1 |
| 20220193312 | Lee et al. | Jun 2022 | A1 |
| 20220211536 | Johannes et al. | Jul 2022 | A1 |
| 20220218510 | Metzger et al. | Jul 2022 | A1 |
| 20220229053 | Levin et al. | Jul 2022 | A1 |
| 20220241106 | Johannes et al. | Aug 2022 | A1 |
| 20220247407 | Yamamoto et al. | Aug 2022 | A1 |
| 20220248836 | Cagle et al. | Aug 2022 | A1 |
| 20220257407 | Johannes et al. | Aug 2022 | A1 |
| 20220265460 | Coker | Aug 2022 | A1 |
| 20220265462 | Alder et al. | Aug 2022 | A1 |
| 20220270711 | Feala et al. | Aug 2022 | A1 |
| 20220273482 | Johannes et al. | Sep 2022 | A1 |
| 20220280357 | Jagannathan et al. | Sep 2022 | A1 |
| 20220287689 | Johannes | Sep 2022 | A1 |
| 20220287867 | Jones et al. | Sep 2022 | A1 |
| 20220287868 | Garvey et al. | Sep 2022 | A1 |
| 20220296408 | Evans et al. | Sep 2022 | A1 |
| 20220305191 | Joseph et al. | Sep 2022 | A1 |
| 20220313222 | Austermann et al. | Oct 2022 | A1 |
| 20220313474 | Kriscovich et al. | Oct 2022 | A1 |
| 20220331170 | Erdem et al. | Oct 2022 | A1 |
| 20220339024 | Johannes et al. | Oct 2022 | A1 |
| 20220354685 | Davis et al. | Nov 2022 | A1 |
| 20220362049 | Austermann et al. | Nov 2022 | A1 |
| 20220370231 | Wang et al. | Nov 2022 | A1 |
| 20220370234 | Hughett et al. | Nov 2022 | A1 |
| 20220370235 | Johannes et al. | Nov 2022 | A1 |
| 20220370237 | Parmar et al. | Nov 2022 | A1 |
| 20220387001 | Askenazi et al. | Dec 2022 | A1 |
| 20220395390 | Brooks | Dec 2022 | A1 |
| 20220395391 | Saunders et al. | Dec 2022 | A1 |
| 20220409422 | Schneider et al. | Dec 2022 | A1 |
| 20230018845 | Lee | Jan 2023 | A1 |
| 20230020563 | Sharma et al. | Jan 2023 | A1 |
| 20230031640 | Hughett et al. | Feb 2023 | A1 |
| 20230037159 | Brennan et al. | Feb 2023 | A1 |
| 20230052238 | Oluwasogo | Feb 2023 | A1 |
| 20230062944 | Vollenberg et al. | Mar 2023 | A1 |
| 20230062994 | Ecklund et al. | Mar 2023 | A1 |
| 20230070347 | Watson et al. | Mar 2023 | A1 |
| 20230073708 | Xu et al. | Mar 2023 | A1 |
| 20230089032 | Hughett et al. | Mar 2023 | A1 |
| 20230099821 | Radl et al. | Mar 2023 | A1 |
| 20230099991 | Bianchi et al. | Mar 2023 | A1 |
| 20230105001 | Whittome et al. | Apr 2023 | A1 |
| 20230110577 | Choi | Apr 2023 | A1 |
| 20230138269 | Abdelal et al. | May 2023 | A1 |
| 20230145365 | Martin et al. | May 2023 | A1 |
| 20230155253 | Mn et al. | May 2023 | A1 |
| 20230210504 | Kuroda et al. | Jul 2023 | A1 |
| 20230210685 | Fallows et al. | Jul 2023 | A1 |
| 20230218426 | Hughett | Jul 2023 | A1 |
| 20230240884 | Davis et al. | Aug 2023 | A1 |
| 20230248562 | Sanchez et al. | Aug 2023 | A1 |
| 20230248564 | Mann et al. | Aug 2023 | A1 |
| 20230255812 | Sanchez et al. | Aug 2023 | A1 |
| 20230255813 | Sanchez et al. | Aug 2023 | A1 |
| 20230255815 | Newton | Aug 2023 | A1 |
| 20230263650 | Sanchez et al. | Aug 2023 | A1 |
| 20230263655 | Johannes et al. | Aug 2023 | A1 |
| 20230277362 | Davis et al. | Sep 2023 | A1 |
| 20230285178 | Sanchez et al. | Sep 2023 | A1 |
| 20230293339 | James | Sep 2023 | A1 |
| 20230301846 | Greenwood | Sep 2023 | A1 |
| 20230355423 | Stevenson et al. | Nov 2023 | A1 |
| 20230404791 | Ecklund et al. | Dec 2023 | A1 |
| 20240008444 | Su et al. | Jan 2024 | A1 |
| 20240009023 | Johannes et al. | Jan 2024 | A1 |
| 20240024170 | Scott | Jan 2024 | A1 |
| 20240041638 | Johannes et al. | Feb 2024 | A1 |
| 20240058161 | Ulreich et al. | Feb 2024 | A1 |
| 20240065881 | Kuroda et al. | Feb 2024 | A1 |
| 20240099874 | Sanchez et al. | Mar 2024 | A1 |
| 20240110318 | Bendt et al. | Apr 2024 | A1 |
| 20240123134 | Kharkar et al. | Apr 2024 | A1 |
| 20240261131 | Garvey et al. | Aug 2024 | A1 |
| Number | Date | Country |
|---|---|---|
| 2018216821 | Aug 2019 | AU |
| 2021299304 | Feb 2023 | AU |
| 2165286 | Sep 1999 | CA |
| 2354132 | Jun 2000 | CA |
| 2359091 | Sep 2003 | CA |
| 2488867 | Aug 2007 | CA |
| 3050918 | Aug 2018 | CA |
| 3098571 | Nov 2019 | CA |
| 2269203 | Dec 1997 | CN |
| 1332620 | Jan 2002 | CN |
| 1434693 | Aug 2003 | CN |
| 1533755 | Oct 2004 | CN |
| 1602825 | Apr 2005 | CN |
| 1720888 | Jan 2006 | CN |
| 2936204 | Aug 2007 | CN |
| 101262836 | Sep 2008 | CN |
| 101522148 | Sep 2009 | CN |
| 102159159 | Aug 2011 | CN |
| 202184840 | Apr 2012 | CN |
| 102481441 | May 2012 | CN |
| 202463712 | Oct 2012 | CN |
| 202950810 | May 2013 | CN |
| 103533968 | Jan 2014 | CN |
| 103717180 | Apr 2014 | CN |
| 204562697 | Aug 2015 | CN |
| 105411783 | Mar 2016 | CN |
| 105451693 | Mar 2016 | CN |
| 105534632 | May 2016 | CN |
| 205849719 | Jan 2017 | CN |
| 106726089 | May 2017 | CN |
| 107847384 | Mar 2018 | CN |
| 107920912 | Apr 2018 | CN |
| 108420590 | Aug 2018 | CN |
| 209285902 | Aug 2019 | CN |
| 110381883 | Oct 2019 | CN |
| 211198839 | Aug 2020 | CN |
| 112566550 | Mar 2021 | CN |
| 112603184 | Apr 2021 | CN |
| 114007493 | Feb 2022 | CN |
| 114375187 | Apr 2022 | CN |
| 116096332 | May 2023 | CN |
| 79818 | Oct 1893 | DE |
| 1516466 | Jun 1969 | DE |
| 2721330 | Nov 1977 | DE |
| 2742298 | Mar 1978 | DE |
| 9407554.9 | May 1995 | DE |
| 4443710 | Jun 1995 | DE |
| 4416094 | Nov 1995 | DE |
| 4236097 | Oct 1996 | DE |
| 19619597 | Nov 1997 | DE |
| 102005037762 | Sep 2006 | DE |
| 102011103783 | Dec 2012 | DE |
| 102012112818 | Jun 2014 | DE |
| 202015104597 | Jul 2016 | DE |
| 102020121462 | Jan 2022 | DE |
| 9600118 | Nov 1996 | DK |
| 0032138 | Jul 1981 | EP |
| 0066070 | Dec 1982 | EP |
| 0068712 | Jan 1983 | EP |
| 0140470 | May 1985 | EP |
| 0140471 | May 1988 | EP |
| 0274753 | Jul 1988 | EP |
| 0119143 | Nov 1988 | EP |
| 0483592 | May 1992 | EP |
| 0610638 | Aug 1994 | EP |
| 0613355 | Sep 1994 | EP |
| 0613355 | Jan 1997 | EP |
| 0787472 | Aug 1997 | EP |
| 0966936 | Dec 1999 | EP |
| 0987293 | Mar 2000 | EP |
| 1063953 | Jan 2001 | EP |
| 0653928 | Oct 2002 | EP |
| 1332738 | Aug 2003 | EP |
| 1382318 | Jan 2004 | EP |
| 1089684 | Oct 2004 | EP |
| 1616542 | Jan 2006 | EP |
| 1382318 | May 2006 | EP |
| 1063953 | Jan 2007 | EP |
| 1872752 | Jan 2008 | EP |
| 2180907 | May 2010 | EP |
| 2380532 | Oct 2011 | EP |
| 2389908 | Nov 2011 | EP |
| 2601916 | Jun 2013 | EP |
| 2676643 | Dec 2013 | EP |
| 2997950 | Mar 2016 | EP |
| 2879534 | Mar 2017 | EP |
| 3424471 | Jan 2019 | EP |
| 3169292 | Nov 2019 | EP |
| 3753492 | Dec 2020 | EP |
| 3788992 | Mar 2021 | EP |
| 3576689 | Mar 2022 | EP |
| 3752110 | Mar 2022 | EP |
| 3787570 | Mar 2022 | EP |
| 4025163 | Jul 2022 | EP |
| 3463180 | Mar 2023 | EP |
| 3569205 | Jun 2023 | EP |
| 4382082 | Jun 2024 | EP |
| 871820 | Jul 1961 | GB |
| 1011517 | Dec 1965 | GB |
| 1467144 | Mar 1977 | GB |
| 2106395 | Apr 1983 | GB |
| 2106784 | Apr 1983 | GB |
| 2148126 | May 1985 | GB |
| 2171315 | Aug 1986 | GB |
| 2181953 | May 1987 | GB |
| 2148126 | Jul 1987 | GB |
| 2191095 | Dec 1987 | GB |
| 2199750 | Jul 1988 | GB |
| 2260907 | May 1993 | GB |
| 2462267 | Feb 2010 | GB |
| 2469496 | Oct 2010 | GB |
| 2490327 | Oct 2012 | GB |
| 2507318 | Apr 2014 | GB |
| 2612752 | May 2023 | GB |
| 201800009129 | Apr 2020 | IT |
| S498638 | Jan 1974 | JP |
| S5410596 | Jan 1979 | JP |
| S5410596 | May 1979 | JP |
| S54155729 | Oct 1979 | JP |
| S55155618 | Dec 1980 | JP |
| S56152629 | Nov 1981 | JP |
| S57142534 | Sep 1982 | JP |
| S5888596 | Jun 1983 | JP |
| S58188016 | Dec 1983 | JP |
| S63107780 | Jul 1988 | JP |
| H0267530 | Mar 1990 | JP |
| H02103871 | Apr 1990 | JP |
| H02131422 | May 1990 | JP |
| H02131422 | Nov 1990 | JP |
| H0460220 | Feb 1992 | JP |
| H05123349 | May 1993 | JP |
| H05123350 | May 1993 | JP |
| H0626264 | Apr 1994 | JP |
| 3087938 | Oct 1995 | JP |
| H085630 | Jan 1996 | JP |
| H1040141 | Feb 1998 | JP |
| H10225430 | Aug 1998 | JP |
| H11113946 | Apr 1999 | JP |
| H11290365 | Oct 1999 | JP |
| 2000116690 | Apr 2000 | JP |
| 2000185068 | Jul 2000 | JP |
| 2001054531 | Feb 2001 | JP |
| 2001070331 | Mar 2001 | JP |
| 2001224616 | Aug 2001 | JP |
| 2001276107 | Oct 2001 | JP |
| 2001276108 | Oct 2001 | JP |
| 2002028173 | Jan 2002 | JP |
| 2003038563 | Feb 2003 | JP |
| 2003505152 | Feb 2003 | JP |
| 2003126242 | May 2003 | JP |
| 2003180722 | Jul 2003 | JP |
| 2003528691 | Sep 2003 | JP |
| 2004057578 | Feb 2004 | JP |
| 2004130056 | Apr 2004 | JP |
| 2004267530 | Sep 2004 | JP |
| 2005052219 | Mar 2005 | JP |
| 2005066011 | Mar 2005 | JP |
| 2005066325 | Mar 2005 | JP |
| 2005102978 | Apr 2005 | JP |
| 2005518237 | Jun 2005 | JP |
| 3749097 | Dec 2005 | JP |
| 2006026108 | Feb 2006 | JP |
| 3123547 | Jun 2006 | JP |
| 2006136492 | Jun 2006 | JP |
| 2006204868 | Aug 2006 | JP |
| 2007044494 | Feb 2007 | JP |
| 3132659 | May 2007 | JP |
| 2007209687 | Aug 2007 | JP |
| 4039641 | Nov 2007 | JP |
| 2008005975 | Jan 2008 | JP |
| 2009509570 | Mar 2009 | JP |
| 2009165887 | Jul 2009 | JP |
| 2009525776 | Jul 2009 | JP |
| 2010504150 | Feb 2010 | JP |
| 2010081981 | Apr 2010 | JP |
| 4640772 | Dec 2010 | JP |
| 2010536439 | Dec 2010 | JP |
| 2011500225 | Jan 2011 | JP |
| 2011030962 | Feb 2011 | JP |
| 4747166 | May 2011 | JP |
| 2011087823 | May 2011 | JP |
| 4801218 | Aug 2011 | JP |
| 2011218130 | Nov 2011 | JP |
| 2011224070 | Nov 2011 | JP |
| 3175719 | Apr 2012 | JP |
| 2012523869 | Oct 2012 | JP |
| 2013238608 | Nov 2013 | JP |
| 2014521960 | Aug 2014 | JP |
| 2015092945 | May 2015 | JP |
| 3198994 | Jul 2015 | JP |
| 2016521191 | Jul 2016 | JP |
| 2017014698 | Jan 2017 | JP |
| 2019076342 | May 2019 | JP |
| 2019525811 | Sep 2019 | JP |
| 2019170942 | Oct 2019 | JP |
| 2019533492 | Nov 2019 | JP |
| 2020520775 | Jul 2020 | JP |
| 2021120686 | Aug 2021 | JP |
| 2021522009 | Aug 2021 | JP |
| 2021522013 | Aug 2021 | JP |
| 7129493 | Aug 2022 | JP |
| 2023532132 | Jul 2023 | JP |
| 200290061 | Sep 2002 | KR |
| 20030047451 | Jun 2003 | KR |
| 20140039485 | Apr 2014 | KR |
| 101432639 | Aug 2014 | KR |
| 20180106659 | Oct 2018 | KR |
| 20180108774 | Oct 2018 | KR |
| 2068717 | Jun 2013 | PT |
| 505542 | Sep 1997 | SE |
| 8101957 | Jul 1981 | WO |
| 8804558 | Jun 1988 | WO |
| 9104714 | Apr 1991 | WO |
| 9104714 | Jun 1991 | WO |
| 9220299 | Feb 1993 | WO |
| 9303690 | Mar 1993 | WO |
| 9307839 | Apr 1993 | WO |
| 9309736 | May 1993 | WO |
| 9309736 | Jun 1993 | WO |
| 9514448 | Jun 1995 | WO |
| 9600096 | Jan 1996 | WO |
| 9634636 | Nov 1996 | WO |
| 9817211 | Apr 1998 | WO |
| 9830336 | Jul 1998 | WO |
| 0000112 | Jan 2000 | WO |
| 0000113 | Jan 2000 | WO |
| 0025651 | May 2000 | WO |
| 0033773 | Jun 2000 | WO |
| 0057784 | Oct 2000 | WO |
| 0069377 | Nov 2000 | WO |
| 0079497 | Dec 2000 | WO |
| 0145618 | Jun 2001 | WO |
| 0145621 | Jun 2001 | WO |
| 02094160 | Nov 2002 | WO |
| 03013967 | Feb 2003 | WO |
| 03024824 | Mar 2003 | WO |
| 03055423 | Jul 2003 | WO |
| 03071931 | Sep 2003 | WO |
| 03079942 | Oct 2003 | WO |
| 03071931 | Feb 2004 | WO |
| 2004019836 | Mar 2004 | WO |
| 2004024046 | Mar 2004 | WO |
| 2004026195 | Apr 2004 | WO |
| 2005051252 | Jun 2005 | WO |
| 2005074571 | Sep 2005 | WO |
| 2005089687 | Sep 2005 | WO |
| 2005107661 | Nov 2005 | WO |
| 2006021220 | Mar 2006 | WO |
| 2006037140 | Apr 2006 | WO |
| 2007005851 | Jan 2007 | WO |
| 2007007845 | Jan 2007 | WO |
| 2007042823 | Apr 2007 | WO |
| 2007055651 | May 2007 | WO |
| 2006098950 | Nov 2007 | WO |
| 2007134608 | Nov 2007 | WO |
| 2007128156 | Feb 2008 | WO |
| 2008026106 | Mar 2008 | WO |
| 2008078117 | Jul 2008 | WO |
| 2008104019 | Sep 2008 | WO |
| 2008141471 | Nov 2008 | WO |
| 2009004368 | Jan 2009 | WO |
| 2009004369 | Jan 2009 | WO |
| 2009052496 | Apr 2009 | WO |
| 2009052502 | Apr 2009 | WO |
| 2009007702 | Jul 2009 | WO |
| 2009101738 | Aug 2009 | WO |
| 2010058192 | May 2010 | WO |
| 2010030122 | Jul 2010 | WO |
| 2010101915 | Jan 2011 | WO |
| 2011018132 | Feb 2011 | WO |
| 2011018133 | Feb 2011 | WO |
| 2011024864 | Mar 2011 | WO |
| 2011054118 | May 2011 | WO |
| 2011079132 | Jun 2011 | WO |
| 2011107972 | Sep 2011 | WO |
| 2011108972 | Sep 2011 | WO |
| 2011117292 | Sep 2011 | WO |
| 2011123219 | Oct 2011 | WO |
| 2011132043 | Oct 2011 | WO |
| 2012012908 | Feb 2012 | WO |
| 2012065274 | May 2012 | WO |
| 2012097462 | Jul 2012 | WO |
| 2012098796 | Jul 2012 | WO |
| 2012101288 | Aug 2012 | WO |
| 2012175916 | Dec 2012 | WO |
| 2013018435 | Feb 2013 | WO |
| 2013033429 | Mar 2013 | WO |
| 2013055434 | Apr 2013 | WO |
| 2013082397 | Jun 2013 | WO |
| 2013103291 | Jul 2013 | WO |
| 2013131109 | Sep 2013 | WO |
| 2013167478 | Nov 2013 | WO |
| 2013177716 | Dec 2013 | WO |
| 2014041534 | Mar 2014 | WO |
| 2014046420 | Mar 2014 | WO |
| 2014118518 | Aug 2014 | WO |
| 2014160852 | Oct 2014 | WO |
| 2015023599 | Feb 2015 | WO |
| 2015052348 | Apr 2015 | WO |
| 2015068384 | May 2015 | WO |
| 2015169403 | Nov 2015 | WO |
| 2015170307 | Nov 2015 | WO |
| 2015197462 | Dec 2015 | WO |
| 2016051385 | Apr 2016 | WO |
| 2016055989 | Apr 2016 | WO |
| 2016071894 | May 2016 | WO |
| 2016103242 | Jun 2016 | WO |
| 2016116915 | Jul 2016 | WO |
| 2016124203 | Aug 2016 | WO |
| 2016139448 | Sep 2016 | WO |
| 2016166562 | Oct 2016 | WO |
| 2016167535 | Oct 2016 | WO |
| 2016191574 | Dec 2016 | WO |
| 2016200088 | Dec 2016 | WO |
| 2016200361 | Dec 2016 | WO |
| 2016204731 | Dec 2016 | WO |
| 2017001532 | Jan 2017 | WO |
| 2017001846 | Jan 2017 | WO |
| 2017075226 | May 2017 | WO |
| 2017152198 | Sep 2017 | WO |
| 2017153357 | Sep 2017 | WO |
| 2017162559 | Sep 2017 | WO |
| 2017205446 | Nov 2017 | WO |
| 2017209779 | Dec 2017 | WO |
| 2017210524 | Dec 2017 | WO |
| 2018022414 | Feb 2018 | WO |
| 2018044781 | Mar 2018 | WO |
| 2018056953 | Mar 2018 | WO |
| 2018090550 | May 2018 | WO |
| 2018138513 | Aug 2018 | WO |
| 2018144318 | Aug 2018 | WO |
| 2018144463 | Aug 2018 | WO |
| 2018150263 | Aug 2018 | WO |
| 2018150268 | Aug 2018 | WO |
| 2018152156 | Aug 2018 | WO |
| 2018183791 | Oct 2018 | WO |
| 2018150267 | Nov 2018 | WO |
| 2018235026 | Dec 2018 | WO |
| 2018235065 | Dec 2018 | WO |
| 2019004404 | Jan 2019 | WO |
| 2019041005 | Mar 2019 | WO |
| 2019044217 | Mar 2019 | WO |
| 2019044218 | Mar 2019 | WO |
| 2019044219 | Mar 2019 | WO |
| 2019050959 | Mar 2019 | WO |
| 2019065541 | Apr 2019 | WO |
| 2019096845 | May 2019 | WO |
| 2019150385 | Aug 2019 | WO |
| 2019161094 | Aug 2019 | WO |
| 2019188566 | Oct 2019 | WO |
| 2019190593 | Oct 2019 | WO |
| 2019212949 | Nov 2019 | WO |
| 2019212950 | Nov 2019 | WO |
| 2019212951 | Nov 2019 | WO |
| 2019212952 | Nov 2019 | WO |
| 2019212954 | Nov 2019 | WO |
| 2019212955 | Nov 2019 | WO |
| 2019212956 | Nov 2019 | WO |
| 2019214787 | Nov 2019 | WO |
| 2019214788 | Nov 2019 | WO |
| 2019226826 | Nov 2019 | WO |
| 2019239433 | Dec 2019 | WO |
| 2020000994 | Jan 2020 | WO |
| 2020020618 | Jan 2020 | WO |
| 2020038822 | Feb 2020 | WO |
| 2020088409 | May 2020 | WO |
| 2020049394 | Jun 2020 | WO |
| 2020120657 | Jun 2020 | WO |
| 2020152575 | Jul 2020 | WO |
| 2020182923 | Sep 2020 | WO |
| 2020204967 | Oct 2020 | WO |
| 2020205939 | Oct 2020 | WO |
| 2020209898 | Oct 2020 | WO |
| 2020242790 | Dec 2020 | WO |
| 2020251893 | Dec 2020 | WO |
| 2020256865 | Dec 2020 | WO |
| 2021007144 | Jan 2021 | WO |
| 2021007345 | Jan 2021 | WO |
| 2021010844 | Jan 2021 | WO |
| 2021016026 | Jan 2021 | WO |
| 2021016300 | Jan 2021 | WO |
| 2021025919 | Feb 2021 | WO |
| 2021034886 | Feb 2021 | WO |
| 2021041123 | Mar 2021 | WO |
| 2021046501 | Mar 2021 | WO |
| 2021086868 | May 2021 | WO |
| 2021094352 | May 2021 | WO |
| 2021094639 | May 2021 | WO |
| 2021097067 | May 2021 | WO |
| 2021102296 | May 2021 | WO |
| 2021107025 | Jun 2021 | WO |
| 2021138411 | Jul 2021 | WO |
| 2021138414 | Jul 2021 | WO |
| 2021154686 | Aug 2021 | WO |
| 2021155206 | Aug 2021 | WO |
| 2021170075 | Sep 2021 | WO |
| 2021173436 | Sep 2021 | WO |
| 2021188817 | Sep 2021 | WO |
| 2021195384 | Sep 2021 | WO |
| 2021205995 | Oct 2021 | WO |
| 2021207621 | Oct 2021 | WO |
| 2021211568 | Oct 2021 | WO |
| 2021211801 | Oct 2021 | WO |
| 2021211914 | Oct 2021 | WO |
| 2021216419 | Oct 2021 | WO |
| 2021216422 | Oct 2021 | WO |
| 2021231532 | Nov 2021 | WO |
| 2021247523 | Dec 2021 | WO |
| 2021257202 | Dec 2021 | WO |
| 2022006256 | Jan 2022 | WO |
| 2022031943 | Feb 2022 | WO |
| 2022035745 | Feb 2022 | WO |
| 2022051360 | Mar 2022 | WO |
| 2022054613 | Mar 2022 | WO |
| 2022066704 | Mar 2022 | WO |
| 2022067392 | Apr 2022 | WO |
| 2022069950 | Apr 2022 | WO |
| 2022071429 | Apr 2022 | WO |
| 2022076322 | Apr 2022 | WO |
| 2022076427 | Apr 2022 | WO |
| 2022086898 | Apr 2022 | WO |
| 2022090199 | May 2022 | WO |
| 2022098536 | May 2022 | WO |
| 2022099087 | May 2022 | WO |
| 2022101999 | May 2022 | WO |
| 2022115692 | Jun 2022 | WO |
| 2022125685 | Jun 2022 | WO |
| 2022140545 | Jun 2022 | WO |
| 2022145231 | Jul 2022 | WO |
| 2022150360 | Jul 2022 | WO |
| 2022150463 | Jul 2022 | WO |
| 2022159392 | Jul 2022 | WO |
| 2022170182 | Aug 2022 | WO |
| 2022182385 | Sep 2022 | WO |
| 2022187152 | Sep 2022 | WO |
| 2022192188 | Sep 2022 | WO |
| 2022192347 | Sep 2022 | WO |
| 2022204000 | Sep 2022 | WO |
| 2022216507 | Oct 2022 | WO |
| 2022216776 | Oct 2022 | WO |
| 2022222030 | Oct 2022 | WO |
| 2023286058 | Jan 2023 | WO |
| 2023014639 | Feb 2023 | WO |
| 2023014641 | Feb 2023 | WO |
| 2023018475 | Feb 2023 | WO |
| 2023023777 | Mar 2023 | WO |
| 2023034453 | Mar 2023 | WO |
| 2023038945 | Mar 2023 | WO |
| 2023038950 | Mar 2023 | WO |
| 2023049109 | Mar 2023 | WO |
| 2023049175 | Mar 2023 | WO |
| 2023086394 | May 2023 | WO |
| 2023149884 | Aug 2023 | WO |
| 2023149902 | Aug 2023 | WO |
| 2023149903 | Aug 2023 | WO |
| 2023154390 | Aug 2023 | WO |
| 2023191764 | Oct 2023 | WO |
| 2023244238 | Dec 2023 | WO |
| 2024058788 | Mar 2024 | WO |
| Entry |
|---|
| US 9,908,683 B2, 03/2018, Sandhausen et al. (withdrawn) |
| International Search Report and Written Opinion from International Application No. PCT/US2021/051456 mailed Jan. 19, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/012794 mailed May 3, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022015471 mailed May 16, 2022. |
| Notice of Allowance for U.S. Appl. No. 29/741,751 mailed Jun. 9, 2022. |
| U.S. Appl. No. 17/664,914 filed May 25, 222. |
| U.S. Appl. No. 17/749,340, filed May 20, 2022. |
| U.S. Appl. No. 17/756,201, filed May 19, 2022. |
| Advisory Action for U.S. Appl. No. 14/722,613 mailed Mar. 4, 2019. |
| Advisory Action for U.S. Appl. No. 14/952,591 mailed Jun. 1, 2018. |
| Advisory Action for U.S. Appl. No. 15/238,427 mailed Apr. 10, 2019. |
| Advisory Action for U.S. Appl. No. 16/899,956 mailed Jul. 9, 2021. |
| Advisory Action for U.S. Appl. No. 16/904,868 mailed Jul. 2, 2021. |
| Advisory Action for U.S. Appl. No. 16/905,400 mailed Feb. 16, 2022. |
| Advisory Action for U.S. Appl. No. 16/905,400 mailed Jun. 9, 2021. |
| Corrected International Search Report and Written Opinion for International Application No. PCT/US2017/043025 mailed Jan. 11, 2018. |
| Corrected Notice of Allowability for U.S. Appl. No. 15/221,106 mailed Jul. 2, 2019. |
| Corrected Notice of Allowability for U.S. Appl. No. 15/612,325 mailed Mar. 17, 2021. |
| Corrected Notice of Allowability for U.S. Appl. No. 17/330,657 mailed Dec. 9, 2021. |
| Final Office Action for U.S. Appl. No. 14/722,613 mailed on Nov. 29, 2018. |
| Final Office Action for U.S. Appl. No. 14/947,759 mailed Apr. 8, 2016. |
| Final Office Action for U.S. Appl. No. 14/952,591 mailed Feb. 23, 2018. |
| Final Office Action for U.S. Appl. No. 14/952,591 mailed Nov. 1, 2019. |
| Final Office Action for U.S. Appl. No. 14/952,591 mailed Nov. 27, 2020. |
| Final Office Action for U.S. Appl. No. 15/171,968 mailed Feb. 14, 2020. |
| Final Office Action for U.S. Appl. No. 15/171,968 mailed Mar. 19, 2019. |
| Final Office Action for U.S. Appl. No. 15/221,106 mailed Jan. 23, 2019. |
| Final Office Action for U.S. Appl. No. 15/238,427 mailed Jan. 2, 2019. |
| Final Office Action for U.S. Appl. No. 15/260,103 mailed Feb. 14, 2019. |
| Final Office Action for U.S. Appl. No. 15/612,325 mailed Sep. 17, 2020. |
| Final Office Action for U.S. Appl. No. 16/452,145 mailed Mar. 25, 2022. |
| Final Office Action for U.S. Appl. No. 16/899,956 mailed Apr. 19, 2021. |
| Final Office Action for U.S. Appl. No. 16/904,868 mailed Mar. 10, 2022. |
| Final Office Action for U.S. Appl. No. 16/904,868 mailed Mar. 26, 2021. |
| Final Office Action for U.S. Appl. No. 16/905,400 mailed Apr. 6, 2021. |
| Final Office Action for U.S. Appl. No. 16/905,400 mailed Dec. 9, 2021. |
| Final Office Action for U.S. Appl. No. 17/088,272 mailed May 25, 2021. |
| Final Office Action for U.S. Appl. No. 29/624,661 mailed Feb. 18, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2016/049274 mailed Dec. 1, 2016. |
| International Search Report and Written Opinion from International Application No. PCT/US2017/035625 mailed Aug. 15, 2017. |
| International Search Report and Written Opinion from International Application No. PCT/US2017/043025 mailed Oct. 18, 2017. |
| International Search Report and Written Opinion from International Application No. PCT/US2018/015968 mailed Apr. 6, 2018. |
| International Search Report and Written Opinion from International Application No. PCT/US2019/029608 mailed Sep. 3, 2019. |
| International Search Report and Written Opinion from International Application No. PCT/US2019/029609 mailed Sep. 3, 2019. |
| International Search Report and Written Opinion from International Application No. PCT/US2019/029610 mailed Sep. 3, 2019. |
| International Search Report and Written Opinion from International Application No. PCT/US2019/029611 mailed Jul. 3, 2019. |
| International Search Report and Written Opinion from International Application No. PCT/US2019/029613 mailed Jul. 3, 2019. |
| International Search Report and Written Opinion from International Application No. PCT/US2019/029614 mailed Sep. 26, 2019. |
| International Search Report and Written Opinion from International Application No. PCT/US2019/029616 mailed Aug. 30, 2019. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/023572 mailed Jul. 6, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/033064 mailed Aug. 31, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/033122 mailed Aug. 31, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/040860 mailed Oct. 2, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/041242 mailed Nov. 17, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/041249 mailed Oct. 2, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/042262 mailed Oct. 14, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/043059 mailed Oct. 6, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/044024 mailed Nov. 12, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/046914 mailed Dec. 1, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/055680 mailed Dec. 15, 2020. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/057562 mailed Jan. 27, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/061563 mailed Feb. 19, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/065234 mailed Apr. 12, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/067451 mailed Mar. 25, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/067454 mailed Mar. 29, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2020/067455 mailed Mar. 26, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/015024 mailed May 18, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/015787 mailed May 27, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/023001 mailed Jun. 21, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/024162 mailed Jul. 8, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/026607 mailed Jul. 29, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/027061 mailed Jul. 19, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/027104 mailed Jul. 6, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/027314 mailed Jul. 6, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/027422 mailed Aug. 12, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/027425 mailed Aug. 11, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/027913 mailed Jul. 12, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/027917 mailed Aug. 19, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/035181 mailed Sep. 16, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/043893 mailed Nov. 22, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/044699 mailed Nov. 22, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/045188 mailed Jan. 26, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/047536 mailed Dec. 23, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/048211 mailed Dec. 22, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/048661 mailed Feb. 14, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/049404 mailed Jan. 18, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/053593 mailed Apr. 11, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/056566 mailed Feb. 11, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/060993 mailed Mar. 18, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/062440 mailed Mar. 28, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/011108 mailed Apr. 22, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/011281 mailed Apr. 25, 2022. |
| Issue Notification for U.S. Appl. No. 14/952,591 mailed Jul. 28, 2021. |
| Issue Notification for U.S. Appl. No. 15/171,968 mailed Mar. 3, 2021. |
| Issue Notification for U.S. Appl. No. 15/221,106 mailed Jul. 24, 2019. |
| Issue Notification for U.S. Appl. No. 15/238,427 mailed Jul. 24, 2019. |
| Issue Notification for U.S. Appl. No. 15/260,103 mailed Aug. 7, 2019. |
| Issue Notification for U.S. Appl. No. 15/611,587 mailed Feb. 20, 2019. |
| Issue Notification for U.S. Appl. No. 15/612,325 mailed Mar. 24, 2021. |
| Issue Notification for U.S. Appl. No. 29/624,661 mailed Aug. 4, 2021. |
| Non-Final Office Action for U.S. Appl. No. 14/592,591 mailed Mar. 20, 2020. |
| Non-Final Office Action for U.S. Appl. No. 14/722,613 mailed Jun. 13, 2019. |
| Non-Final Office Action for U.S. Appl. No. 14/947,759 mailed Mar. 17, 2016. |
| Non-Final Office Action for U.S. Appl. No. 14/952,591 mailed Aug. 1, 2017. |
| Non-Final Office Action for U.S. Appl. No. 14/952,591 mailed Mar. 20, 2020. |
| Non-Final Office Action for U.S. Appl. No. 14/952,591 mailed Mar. 21, 2019. |
| Non-Final Office Action for U.S. Appl. No. 14/952,591 mailed Sep. 28, 2018. |
| Non-Final Office Action for U.S. Appl. No. 15/171,968 mailed May 11, 2020. |
| Non-Final Office Action for U.S. Appl. No. 15/171,968 mailed Aug. 20, 2019. |
| Non-Final Office Action for U.S. Appl. No. 15/171,968 mailed Jun. 12, 2018. |
| Non-Final Office Action for U.S. Application No. 15/221, 106 mailed Jun. 5, 2018. |
| Non-Final Office Action for U.S. Appl. No. 15/238,427 mailed Aug. 8, 2018. |
| Non-Final Office Action for U.S. Application No. 15/260, 103 mailed Sep. 26, 2018. |
| Non-Final Office Action for U.S. Appl. No. 15/611,587 mailed Dec. 29, 2017. |
| Non-Final Office Action for U.S. Appl. No. 15/611,587 mailed Jul. 13, 2018. |
| Non-Final Office Action for U.S. Appl. No. 15/612,325 mailed Mar. 19, 2020. |
| Non-Final Office Action for U.S. Appl. No. 16/245,726 mailed Jan. 21, 2022. |
| Non-Final Office Action for U.S. Appl. No. 16/369,676 mailed Mar. 31, 2022. |
| Non-Final Office Action for U.S. Appl. No. 16/433,773 mailed Apr. 21, 2022. |
| Non-Final Office Action for U.S. Appl. No. 16/449,039 mailed Dec. 8, 2021. |
| Non-Final Office Action for U.S. Appl. No. 16/452,145 mailed Sep. 28, 2021. |
| Non-Final Office Action for U.S. Appl. No. 16/452,258 mailed Sep. 28, 2021. |
| Non-Final Office Action for U.S. Appl. No. 16/478,180 mailed Oct. 22, 2021. |
| Non-Final Office Action for U.S. Appl. No. 16/899,956 mailed Oct. 16, 2020. |
| Non-Final Office Action for U.S. Appl. No. 16/899,956 mailed Sep. 2, 2021. |
| Non-Final Office Action for U.S. Appl. No. 16/904,868 mailed Nov. 25, 2020. |
| Non-Final Office Action for U.S. Appl. No. 16/904,868 mailed Oct. 5, 2021. |
| Non-Final Office Action for U.S. Appl. No. 16/905,400 mailed Apr. 27, 2022. |
| Non-Final Office Action for U.S. Appl. No. 16/905,400 mailed Dec. 2, 2020. |
| Non-Final Office Action for U.S. Appl. No. 16/905,400 mailed Jul. 22, 2021. |
| Non-Final Office Action for U.S. Appl. No. 17/088,272 mailed Jan. 25, 2021. |
| Non-Final Office Action for U.S. Appl. No. 17/330,657 mailed Aug. 11, 2021. |
| Non-Final Office Action for U.S. Appl. No. 29/624,661 mailed Jul. 18, 2019. |
| Non-Final Office Action for U.S. Appl. No. 29/694,002 mailed Jun. 24, 2020. |
| Non-Final Office Action for U.S. Appl. No. 29/741,751 mailed Jan. 18, 2022. |
| Notice of Allowance for U.S. Appl. No. 14/952,591 mailed Apr. 5, 2021. |
| Notice of Allowance for U.S. Appl. No. 14/952,591 mailed Jul. 8, 2021. |
| Notice of Allowance for U.S. Appl. No. 15/171,968 mailed Feb. 16, 2021. |
| Notice of Allowance for U.S. Appl. No. 15/171,968 mailed Nov. 6, 2020. |
| Notice of Allowance for U.S. Appl. No. 15/221,106 mailed May 1, 2019. |
| Notice of Allowance for U.S. Appl. No. 15/238,427 mailed May 23, 2019. |
| Notice of Allowance for U.S. Appl. No. 15/260,103 mailed Jun. 7, 2019. |
| Notice of Allowance for U.S. Appl. No. 15/611,587 mailed Dec. 21, 2018. |
| Notice of Allowance for U.S. Appl. No. 15/612,325 mailed Feb. 19, 2021. |
| Notice of Allowance for U.S. Appl. No. 15/612,325 mailed Jan. 21, 2021. |
| Notice of Allowance for U.S. Appl. No. 16/899,956 mailed Apr. 19, 2022. |
| Notice of Allowance for U.S. Appl. No. 16/899,956 mailed Dec. 29, 2021. |
| Notice of Allowance for U.S. Appl. No. 17/088,272 mailed Aug. 5, 2021. |
| Notice of Allowance for U.S. Appl. No. 17/088,272 mailed Mar. 4, 2022. |
| Notice of Allowance for U.S. Appl. No. 17/088,272 mailed Nov. 24, 2021. |
| Notice of Allowance for U.S. Appl. No. 17/330,657 mailed Mar. 16, 2022. |
| Notice of Allowance for U.S. Appl. No. 17/330,657 mailed Nov. 26, 2021. |
| Notice of Allowance for U.S. Appl. No. 29/624,661 mailed Apr. 28, 2021. |
| Notice of Allowance for U.S. Appl. No. 29/624,661 mailed Jul. 10, 2020. |
| Notice of Allowance for U.S. Appl. No. 29/624,661 mailed May 14, 2020. |
| Notice of Allowance for U.S. Appl. No. 29/624,661 mailed Sep. 29, 2020. |
| Notice of Allowance for U.S. Appl. No. 29/694,002 mailed Apr. 29, 2021. |
| Notice of Allowance for U.S. Appl. No. 29/694,002 mailed Jan. 29, 2021. |
| Notice of Allowance for U.S. Appl. No. 29/694,002 mailed Oct. 16, 2020. |
| Notice to File Missing Parts for U.S. Appl. No. 17/179,116 mailed Mar. 3, 2021. |
| Restriction Requirement for U.S. Appl. No. 16/433,773 mailed Dec. 7, 2021. |
| Restriction Requirement for U.S. Appl. No. 16/478,180 mailed May 25, 2021. |
| U.S. Appl. No. 14/625,469, filed Feb. 28, 2015. |
| U.S. Appl. No. 14/947,759, filed Nov. 20, 2015. |
| U.S. Appl. No. 14/952,591, filed Nov. 25, 2015. |
| U.S. Appl. No. 15/171,968, filed Jun. 2, 2016. |
| U.S. Appl. No. 15/221,106, filed Jul. 27, 2016. |
| U.S. Appl. No. 15/260,103, filed Sep. 8, 2016. |
| U.S. Appl. No. 15/384,196, filed Dec. 19, 2016. |
| U.S. Appl. No. 15/612,325, filed Jun. 2, 2017. |
| U.S. Appl. No. 16/245,726, filed Jan. 11, 2019. |
| U.S. Appl. No. 16/369,676, filed Mar. 29, 2019. |
| U.S. Appl. No. 16/433,773, filed Jun. 6, 2019. |
| U.S. Appl. No. 16/449,039, filed Jun. 21, 2019. |
| U.S. Appl. No. 16/452,145, filed Jun. 25, 2019. |
| U.S. Appl. No. 16/452,258, filed Jun. 25, 2019. |
| U.S. Appl. No. 16/478,180, filed Jul. 16, 2019. |
| U.S. Appl. No. 16/904,868, filed Jun. 18, 2020. |
| U.S. Appl. No. 16/905,400, filed Jun. 18, 2020. |
| U.S. Appl. No. 17/051,550, filed Oct. 29, 2020. |
| U.S. Appl. No. 17/051,554, filed Oct. 29, 2020. |
| U.S. Appl. No. 17/051,585, filed Oct. 29, 2020. |
| U.S. Appl. No. 17/051,600, filed Oct. 29, 2020. |
| U.S. Appl. No. 17/088,272, filed Nov. 3, 2020. |
| U.S. Appl. No. 17/179,116, filed Feb. 18, 2021. |
| U.S. Appl. No. 17/330,657, filed May 26, 2021. |
| U.S. Appl. No. 17/378,015, filed Jul. 16, 2021. |
| U.S. Appl. No. 17/394,055, filed Aug. 4, 2021. |
| U.S. Appl. No. 17/412,864, filed Aug. 26, 2021. |
| U.S. Appl. No. 17/444,825, filed Aug. 10, 2021. |
| U.S. Appl. No. 17/446,256, filed Aug. 27, 2021. |
| U.S. Appl. No. 17/446,654, filed Sep. 1, 2021. |
| U.S. Appl. No. 17/447,123, filed Sep. 8, 2021. |
| U.S. Appl. No. 17/450,864, filed Oct. 14, 2021. |
| U.S. Appl. No. 17/451,345, filed Oct. 19, 2021. |
| U.S. Appl. No. 17/451,354, filed Oct. 19, 2021. |
| U.S. Appl. No. 17/453,260, filed Nov. 2, 2021. |
| U.S. Appl. No. 17/453,560, filed Nov. 4, 2021. |
| U.S. Appl. No. 17/461,036 mailed Aug. 30, 2021. |
| U.S. Appl. No. 17/494,578, filed Oct. 5, 2021. |
| U.S. Appl. No. 17/501,591, filed Oct. 14, 2021. |
| U.S. Appl. No. 17/595,747, filed Nov. 23, 2021. |
| U.S. Appl. No. 17/597,408, filed Jan. 5, 2022. |
| U.S. Appl. No. 17/597,673, filed Jan. 18, 2022. |
| U.S. Appl. No. 17/614,173, filed Nov. 24, 2021. |
| U.S. Appl. No. 17/631,619, filed Jan. 31, 2022. |
| U.S. Appl. No. 17/645,821, filed Dec. 23, 2021. |
| U.S. Appl. No. 17/646,771, filed Jan. 3, 2022. |
| U.S. Appl. No. 17/653,314, filed Mar. 3, 2022. |
| U.S. Appl. No. 17/653,920, filed Mar. 8, 2022. |
| U.S. Appl. No. 17/654,156, filed Mar. 9, 2022. |
| U.S. Appl. No. 17/655,464, filed Mar. 18, 2022. |
| U.S. Appl. No. 17/657,474, filed Mar. 31, 2022. |
| U.S. Appl. No. 17/661,090, filed Apr. 28, 2022. |
| U.S. Appl. No. 17/662,700, filed May 10, 2022. |
| U.S. Appl. No. 17/663,046, filed May 12, 2022. |
| U.S. Appl. No. 17/754,736, filed Apr. 11, 2022. |
| U.S. Appl. No. 29/741,751, filed Jul. 15, 2020. |
| U.S. Appl. No. 61/955,537, filed Mar. 19, 2014. |
| U.S. Appl. No. 62/082,279, filed Nov. 20, 2014. |
| U.S. Appl. No. 62/084,078, filed Nov. 25, 2014. |
| U.S. Appl. No. 62/414,963, filed Oct. 31, 2016. |
| U.S. Appl. No. 62/452,437, filed Jan. 31, 2017. |
| U.S. Appl. No. 62/485,578, filed Apr. 14, 2017. |
| U.S. Appl. No. 62/665,297, filed May 1, 2018. |
| U.S. Appl. No. 62/665,302, filed May 1, 2018. |
| U.S. Appl. No. 62/665,317, filed May 1, 2018. |
| U.S. Appl. No. 62/665,321, filed May 1, 2018. |
| U.S. Appl. No. 62/665,331, filed May 1, 2018. |
| U.S. Appl. No. 62/665,335, filed May 1, 2018. |
| U.S. Appl. No. 62/853,279, filed May 28, 2019. |
| U.S. Appl. No. 62/853,889, filed May 29, 2019. |
| U.S. Appl. No. 62/864,656, filed Jun. 21, 2019. |
| U.S. Appl. No. 62/873,045, filed Jul. 11, 2019. |
| U.S. Appl. No. 62/873,048, filed Jul. 11, 2019. |
| U.S. Appl. No. 62/876,500, filed Jul. 19, 2019. |
| U.S. Appl. No. 62/877,558, filed Jul. 23, 2019. |
| U.S. Appl. No. 62/883,172, filed Aug. 6, 2019. |
| U.S. Appl. No. 62/889,149, filed Aug. 20, 2019. |
| U.S. Appl. No. 62/923,279, filed Oct. 18, 2019. |
| U.S. Appl. No. 62/926,767, filed Oct. 28, 2019. |
| U.S. Appl. No. 62/935,337, filed Nov. 14, 2019. |
| U.S. Appl. No. 62/938,447, filed Nov. 21, 2019. |
| U.S. Appl. No. 62/949,187, filed Dec. 17, 2019. |
| U.S. Appl. No. 62/956,756, filed Jan. 3, 2020. |
| U.S. Appl. No. 62/956,767, filed Jan. 3, 2020. |
| U.S. Appl. No. 62/956,770, filed Jan. 3, 2020. |
| U.S. Appl. No. 62/967,977, filed Jan. 30, 2020. |
| U.S. Appl. No. 62/994,912, filed Mar. 26, 2020. |
| U.S. Appl. No. 63/008,112, filed Apr. 10, 2020. |
| U.S. Appl. No. 63/011,445, filed Apr. 17, 2020. |
| U.S. Appl. No. 63/011,487, filed Apr. 17, 2020. |
| U.S. Appl. No. 63/011,571, filed Apr. 17, 2020. |
| U.S. Appl. No. 63/011,657, filed Apr. 17, 2020. |
| U.S. Appl. No. 63/011,760, filed Apr. 17, 2020. |
| U.S. Appl. No. 63/012,347, filed Apr. 20, 2020. |
| U.S. Appl. No. 63/012,384, filed Apr. 20, 2020. |
| U.S. Appl. No. 63/030,685, filed May 27, 2020. |
| U.S. Appl. No. 63/033,310, filed Jun. 2, 2020. |
| U.S. Appl. No. 63/047,374, filed Jul. 2, 2020. |
| U.S. Appl. No. 63/061,241, filed Aug. 5, 2020. |
| U.S. Appl. No. 63/061,244, filed Aug. 5, 2020. |
| U.S. Appl. No. 63/061,834, filed Aug. 6, 2020. |
| U.S. Appl. No. 63/064,017, filed Aug. 11, 2020. |
| U.S. Appl. No. 63/064,126, filed Aug. 11, 2020. |
| U.S. Appl. No. 63/067,542, filed Aug. 19, 2020. |
| U.S. Appl. No. 63/071,438, filed Aug. 28, 2020. |
| U.S. Appl. No. 63/071,821, filed Aug. 28, 2020. |
| U.S. Appl. No. 63/073,545, filed Sep. 2, 2020. |
| U.S. Appl. No. 63/073,553, filed Sep. 2, 2020. |
| U.S. Appl. No. 63/074,051, filed Sep. 3, 2020. |
| U.S. Appl. No. 63/074,066, filed Sep. 3, 2020. |
| U.S. Appl. No. 63/076,032, filed Sep. 9, 2020. |
| U.S. Appl. No. 63/076,474, filed Sep. 10, 2020. |
| U.S. Appl. No. 63/076,477, filed Sep. 10, 2020. |
| U.S. Appl. No. 63/082,261, filed Sep. 23, 2020. |
| U.S. Appl. No. 63/088,506, filed Oct. 7, 2020. |
| U.S. Appl. No. 63/088,511, filed Oct. 7, 2020. |
| U.S. Appl. No. 63/088,539, filed Oct. 7, 2020. |
| U.S. Appl. No. 63/094,464, filed Oct. 21, 2020. |
| U.S. Appl. No. 63/094,498, filed Oct. 21, 2020. |
| U.S. Appl. No. 63/094,594, filed Oct. 21, 2020. |
| U.S. Appl. No. 63/094,608, filed Oct. 21, 2020. |
| U.S. Appl. No. 63/094,626, filed Oct. 21, 2020. |
| U.S. Appl. No. 63/094,646, filed Oct. 21, 2020. |
| U.S. Appl. No. 63/109,066, filed Nov. 3, 2020. |
| U.S. Appl. No. 63/109,084, filed Nov. 3, 2020. |
| U.S. Appl. No. 63/112,417, filed Nov. 11, 2020. |
| U.S. Appl. No. 63/119,161, filed Nov. 30, 2020. |
| U.S. Appl. No. 63/124,271, filed Dec. 11, 2020. |
| U.S. Appl. No. 63/133,892, filed Jan. 5, 2021. |
| U.S. Appl. No. 63/134,287, filed Jan. 6, 2021. |
| U.S. Appl. No. 63/134,450, filed Jan. 6, 2021. |
| U.S. Appl. No. 63/134,631, filed Jan. 7, 2021. |
| U.S. Appl. No. 63/134,632, filed Jan. 7, 2021. |
| U.S. Appl. No. 63/134,754, filed Jan. 7, 2021. |
| U.S. Appl. No. 63/138,878, filed Jan. 19, 2021. |
| U.S. Appl. No. 63/146,946, filed Feb. 8, 2021. |
| U.S. Appl. No. 63/147,013, filed Feb. 8, 2021. |
| U.S. Appl. No. 63/147,299, filed Feb. 9, 2021. |
| U.S. Appl. No. 63/148,723, filed Feb. 12, 2021. |
| U.S. Appl. No. 63/154,248, filed Feb. 26, 2021. |
| U.S. Appl. No. 63/155,395, filed Mar. 2, 2021. |
| U.S. Appl. No. 63/157,007, filed Mar. 5, 2021. |
| U.S. Appl. No. 63/157,014, filed Mar. 5, 2021. |
| U.S. Appl. No. 63/159,142, filed Mar. 10, 2021. |
| U.S. Appl. No. 63/159,186, filed Mar. 10, 2021. |
| U.S. Appl. No. 63/159,210, filed Mar. 10, 2021. |
| U.S. Appl. No. 63/159,280, filed Mar. 10, 2021. |
| U.S. Appl. No. 63/165,273, filed Mar. 24, 2021. |
| U.S. Appl. No. 63/165,384, filed Mar. 24, 2021. |
| U.S. Appl. No. 63/171,165, filed Apr. 6, 2021. |
| U.S. Appl. No. 63/172,975, filed Apr. 9, 2021. |
| U.S. Appl. No. 63/181,695, filed Apr. 29, 2021. |
| U.S. Appl. No. 63/191,558, filed May 21, 2021. |
| U.S. Appl. No. 63/192,274, filed May 24, 2021. |
| U.S. Appl. No. 63/192,289, filed May 24, 2021. |
| U.S. Appl. No. 63/193,235, filed May 26, 2021. |
| U.S. Appl. No. 63/193,406, filed May 26, 2021. |
| U.S. Appl. No. 63/193,891, filed May 27, 2021. |
| U.S. Appl. No. 63/208,262, filed Jun. 8, 2021. |
| U.S. Appl. No. 63/214,551, filed Jun. 24, 2021. |
| U.S. Appl. No. 63/214,570, filed Jun. 24, 2021. |
| U.S. Appl. No. 63/215,017, filed Jun. 25, 2021. |
| U.S. Appl. No. 63/228,244, filed Aug. 2, 2021. |
| U.S. Appl. No. 63/228,252, filed Aug. 2, 2021. |
| U.S. Appl. No. 63/228,258, filed Aug. 2, 2021. |
| U.S. Appl. No. 63/230,894, filed Aug. 9, 2021. |
| U.S. Appl. No. 63/230,897, filed Aug. 9, 2021. |
| U.S. Appl. No. 63/238,457, filed Aug. 30, 2021. |
| U.S. Appl. No. 63/238,477, filed Aug. 30, 2021. |
| U.S. Appl. No. 63/241,562, filed Sep. 8, 2021. |
| U.S. Appl. No. 63/241,564, filed Sep. 8, 2021. |
| U.S. Appl. No. 63/241,575, filed Sep. 8, 2021. |
| U.S. Appl. No. 63/246,972, filed Sep. 22, 2021. |
| U.S. Appl. No. 63/247,375, filed Sep. 23, 2021. |
| U.S. Appl. No. 63/247,478, filed Sep. 23, 2021. |
| U.S. Appl. No. 63/247,491, filed Sep. 23, 2021. |
| U.S. Appl. No. 63/299,208, filed Jan. 13, 2022. |
| Sage's Second Supplemental Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508, 10,226,375, 10,390,989, and 10,376,407, 292 pages. |
| Plaintiff's Identification of Claim Terms and Proposed Constructions, 3 pages. |
| Sage's Preliminary Identification of Claim Elements and Proposed Constructions for U.S. Pat. Nos. 8,287,508, 10,226,376, 10,390,989 and 10,376,407, 7 pages. |
| Corrected Certificate of Service, 2020, 2 pages. |
| Excerpts from the 508 (Patent No. 8,278,508) Patent's Prosecution History, 2020, 99 pages. |
| Declaration of Diane K. Newman Curriculum Vitae, 2020, pp. 1-199. |
| Sage's Supplemental and Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; 10,226,375; 10,390,989 and Initial Invalidity Contentions Regarding U.S. Pat. No. 10,376,407, Aug. 21, 2020, 277 pages. |
| Decision Granting Institution of Inter Partes Review for U.S. Pat. No. 8,287,508, Feb. 17, 2021, 39 pages. |
| Memorandum Order, Feb. 2021, 14 pgs. |
| BOEHRINGER CareDry System—Second Generation for Non-Invasive Urinary Management for Females, Mar. 2021, 3 pgs. |
| PureWick's Response to Interrogatory No. 9 in PureWick, LLC v. Sage Products, LLC, Mar. 23, 2020, 6 pages. |
| Sage's Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; 10,226,375; and 10,390,989, May 29, 2020, 193 pages. |
| Defendant and Counterclaim Plaintiff Sage Products, LLC's Answer, Defenses, and Counterclaims to Plaintiff's Amended Complaint, Nov. 1, 2019. |
| Plaintiff's Opening Claim Construction Brief, Oct. 16, 2020, 26 pages. |
| “3 Devices Take Top Honors in Dare-To-Dream Medtech Design Contest”, R+D Digest, Nov. 2013, 1 page. |
| “Advanced Mission Extender Device (AMDX) Products”, Omni Medical Systems, Inc., 15 pages. |
| “AMXD Control Starter Kit Brochure”, https://www.omnimedicalsys.com/index.php?page=products, 8 pages. |
| “AMXDmax In-Flight Bladder Relief”, Omni Medical; Omni Medical Systems, Inc., 2015. |
| “AMXDX—Advanced Mission Extender Device Brochure”, Omni Medical, 2 pages. |
| “External Urine Management for Female Anatomy”, https://www.stryker.com/us/en/sage/products/sage-primafit.html, Jul. 2020, 4 pages. |
| “High Absorbancy Cellulose Acetate Electrospun Nanofibers for Feminine Hygiene Application”, https://www.sciencedirect.com/science/article/abs/pii/S2352940716300701?via%3Dihub, Jul. 2016, 3 pages. |
| “How Period Panties Work”, www.shethinx.com/pages/thinx-itworks, 2020, 10 pages. |
| “Hydrogel properties of electrospun polyvinylpyrrolidone and polyvinylpyrrolidone/poly(acrylic acid) blend nanofibers”, https://pubs.rsc.org/en/content/articlelanding/2015/ra/c5ra07514a#!divAbstract, 2015, 5 pages. |
| “In Flight Bladder Relief”, Omni Medical, 14 pages. |
| “Making Women's Sanitary Products Safer and Cheaper”, https://www.elsevier.com/connect/making-womens-sanitary-products-safer-and-cheaper, Sep. 2016, 10 pages. |
| “Novel Nanofibers Make Safe and Effective Absorbent for Sanitary Products”, https://www.materialstoday.com/nanomaterials/news/nanofibers-make-safe-and-effective-absorbent/, Oct. 2016, 3 pages. |
| “Research and Development Work Relating to Assistive Technology Jun. 2005”, British Department of Health, Nov. 2006, 40 pages. |
| “Rising Warrior Insulated Gallon Jug Cover”, https://www.amazon.com/Rising-Warrior-Insulated-Sleeve, 2021, 2 pages. |
| “Step by Step How Ur24 WorksHome”, http://medicalpatentur24.com, Aug. 30, 2017, 4 pages. |
| “Underwear that absorbs your period”, Thinx!, 7 pages. |
| “Urine Bag Cover-Catheter Bag Cover 2000 ml Volume-Medline Style-Multiple Sclerosis-Spine Injury-Suprapublic Catheter-Bladder Incontinence”, https://www.etsy.com/listing/1142934658/urine-bag-cover-caatheter-bag-cover-2000, 2022, 1 page. |
| “User & Maintenance Guide”, Omni Medical, 2007, 16 pages. |
| “Vinyl Dust Cover, Janome #741811000, Janome, Sewing Parts Online”, https://www.sewingpartsonline.com/vinyl-dust-cover-janome-74181000, 2020, 2 pages. |
| “Winners Announced for Dare-to-Dream Medtech Design Challenge”, https://www.mddionline.com/design-engineering/winners-announced-dare-dream-medtech-design-challenge, 2014, 4 pages. |
| Ali , “Sustainability Assessment: Seventh Generation Diapers versus gDiapers”, The University of Vermont, Dec. 6, 2011, pp. 1-31. |
| Autumn, et al., “Frictional adhesion: a new angle on gecko attachment”, The Journal of Experimental Biology, 2006, pp. 3569-3579. |
| Cañas, et al., “Effect of nano- and micro-roughness on adhesion of bioinspired micropatterned surfaces”, Acta Biomaterialia 8, 2012, pp. 282-288. |
| Chaudhary, et al., “Bioinspired dry adhesive: Poly(dimethylsiloxane) grafted with poly(2-ethylhexyl acrylate) brushes”, European Polymer Journal, 2015, pp. 432-440. |
| Dai, et al., “Non-sticky and Non-slippery Biomimetic Patterned Surfaces”, Journal of Bionic Engineering, Mar. 2020, pp. 326-334. |
| Espinoza-Ramirez, “Nanobiodiversity and Biomimetic Adhesives Development: From Nature to Production and Application”, Journal of Biomaterials and Nanobiotechnology, pp. 78-101, 2019. |
| Hollister, “Female Urinary and Pouch and Male Urinary Pouch Brochure”, 2011, 1 page. |
| Hollister, “Male Urinary Pouch External Collection Device”, http://www.hollister.com/en/products/Continence-Care-Products/Urine-Collectors/Urine-Collection-Accessories/Male-Urinary-Pouch-External-Collection-Device. |
| Hollister, “Retracted Penis Pouch by Hollister”, Vitality Medical.com, 6 pages. |
| Hwang, et al., “Multifunctional Smart Skin Adhesive Patches for Advanced Health Care”, Adv. Healthcare Mater, 2018, pp. 1-20. |
| Jagota, et al., “Adhesion, friction, and compliance of bio-mimetic and bio-inspired structured interfaces”, Materials Science and Engineering, 2011, pp. 253-292. |
| Jeong, et al., “A nontransferring dry adhesive with hierarchical polymer nanohairs”, PNAS, Apr. 7, 2009, pp. 5639-5644. |
| Jeong, et al., “Nanohairs and nanotubes: Efficient structural elements for gecko-inspired artificial dry adhesives”, Science Direct, 2009, pp. 335-346. |
| Karp, et al., “Dry solution to a sticky problem”, Nature., 2011, pp. 42-43. |
| Lee, et al., “Continuous Fabrication of Wide-Tip Microstructures for Bio-Inspired Dry Adhesives via Tip Inking Process”, Journal of Chemistry, Jan. 2, 2019, pp. 1-5. |
| Macaulay, et al., “A Noninvasive Continence Management System: Development and Evaluation of a Novel Toileting Device for Women”, The Wound, Ostomy and Continence Nurses Society, 2007, pp. 641-648. |
| Newman, et al., “The Urinary Incontinence Sourcebook”, Petition for Interparties Review, 1997, 23 pages. |
| Newton, et al., “Measuring Safety, Effectiveness and Ease of Use of PureWick in the Management of Urinary Incontinence in Bedbound Women: Case Studies”, Jan. 8, 2016, 11 pages. |
| Parmar , “10 Finalists Chosen for Dare-to-Dream Medtech Design Challenge (PureWick)”, Design Services, Nov. 10, 2014, 3 pages. |
| Parness, et al., “A microfabricated wedge-shaped adhesive array displaying gecko-like dynamic adhesion, directionality”, J.R. Soc. Interface, 2009, pp. 1223-1232. |
| Purewick “Incontinence Relief for Women”, Presentation, Sep. 23, 2015, 7 pages. |
| Pytlik, “Super Absorbent Polymers”, University of Buffalo. |
| Sachtman, “New Relief for Pilots? It Depends”, Wired, 2008, 2 pages. |
| Tsipenyuk, et al., “Use of biomimetic hexagonal surface texture in friction against lubricated skin”, Journal of The Royal Society—Interface, 2014, pp. 1-6. |
| Advisory Action for U.S. Appl. No. 16/245,726 mailed Apr. 19, 2023. |
| Advisory Action for U.S. Appl. No. 16/369,676 mailed Mar. 24, 2023. |
| Advisory Action for U.S. Appl. No. 16/433,773 mailed Feb. 15, 2023. |
| Advisory Action for U.S. Appl. No. 16/452,258 mailed Oct. 26, 2022. |
| Advisory Action for U.S. Appl. No. 16/478,180 mailed Sep. 21, 2022. |
| Advisory Action for U.S. Appl. No. 16/478,180 mailed Sep. 7, 2023. |
| Advisory Action for U.S. Appl. No. 16/904,868 mailed Jun. 15, 2022. |
| Advisory Action for U.S. Appl. No. 17/051,550 mailed Sep. 8, 2023. |
| Advisory Action for U.S. Appl. No. 17/444,792 mailed Aug. 25, 2023. |
| Advisory Action for U.S. Appl. No. 17/662,700 mailed Jan. 30, 2023. |
| Final Office Action for U.S. Appl. No. 16/245,726 mailed Nov. 25, 2022. |
| Final Office Action for U.S. Appl. No. 16/369,676 mailed Aug. 31, 2023. |
| Final Office Action for U.S. Appl. No. 16/369,676 mailed Dec. 5, 2022. |
| Final Office Action for U.S. Appl. No. 16/433,773 mailed Oct. 25, 2022. |
| Final Office Action for U.S. Appl. No. 16/449,039 mailed Aug. 1, 2022. |
| Final Office Action for U.S. Appl. No. 16/452,258 mailed Jun. 14, 2022. |
| Final Office Action for U.S. Appl. No. 16/478,180 mailed Jun. 22, 2022. |
| Final Office Action for U.S. Appl. No. 16/478,180 mailed May 31, 2023. |
| Final Office Action for U.S. Appl. No. 17/051,399 mailed Mar. 9, 2023. |
| Final Office Action for U.S. Appl. No. 17/051,550 mailed May 23, 2023. |
| Final Office Action for U.S. Appl. No. 17/051,585 mailed Jul. 27, 2023. |
| Final Office Action for U.S. Appl. No. 17/444,792 mailed Jun. 15, 2023. |
| Final Office Action for U.S. Appl. No. 17/446,256 mailed Sep. 19, 2023. |
| Final Office Action for U.S. Appl. No. 17/448,811 mailed Aug. 3, 2023. |
| Final Office Action for U.S. Appl. No. 17/451,345 mailed May 3, 2023. |
| Final Office Action for U.S. Appl. No. 17/653,137 mailed Sep. 21, 2023. |
| Final Office Action for U.S. Appl. No. 17/655,464 mailed Sep. 1, 2023. |
| Final Office Action for U.S. Appl. No. 17/662,700 mailed Sep. 30, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/IB2021/057173 mailed Nov. 5, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/039866 mailed Oct. 7, 2021. |
| International Search Report and Written Opinion from International Application No. PCT/US2021/055515 mailed Jan. 28, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/011419 mailed Jun. 7, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/011421 mailed Jun. 13, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/014285 mailed Sep. 28, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/014749 mailed Sep. 28, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/015026 mailed Oct. 31, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/015045 mailed Sep. 9, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/015073 mailed Sep. 8, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/015418 mailed Nov. 11, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/015420 mailed Nov. 18, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/015492 mailed Apr. 26, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/015781 mailed May 6, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/016942 mailed Jun. 8, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/018159 mailed Dec. 12, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/018170 mailed May 31, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/019254 mailed Jun. 7, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/019480 mailed Jun. 13, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/021103 mailed Jun. 23, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/022111 mailed Oct. 26, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/023594 mailed Jul. 12, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/026667 mailed Aug. 22, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/030685 mailed Oct. 31, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/031032 mailed Sep. 9, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/032424 mailed Oct. 11, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/034457 mailed Oct. 12, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/034744 mailed Dec. 9, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/039018 mailed Jan. 10, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/039022 mailed Jan. 10, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/039711 mailed Jan. 12, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/039714 mailed Nov. 22, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/041085 mailed Mar. 16, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/041688 mailed Nov. 21, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/042719 mailed Dec. 5, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/042725 mailed Dec. 19, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/043818 mailed Mar. 24, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/044107 mailed Dec. 23, 2022. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/044208 mailed May 8, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/044212 mailed Jan. 20, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/044243 mailed Feb. 24, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/049300 mailed Jun. 6, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2022/050909 mailed Jul. 24, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/012696 mailed Jul. 6, 2023. |
| Issue Notification for U.S. Appl. No. 16/899,956 mailed Mar. 29, 2023. |
| Issue Notification for U.S. Appl. No. 16/905,400 mailed Nov. 30, 2022. |
| Issue Notification for U.S. Appl. No. 17/088,272 mailed Jun. 15, 2022. |
| Issue Notification for U.S. Appl. No. 17/330,657 mailed Jun. 22, 2022. |
| Non-Final Office Action for U.S. Appl. No. 16/433,773 mailed Apr. 11, 2023. |
| Non-Final Office Action for U.S. Appl. No. 16/449,039 mailed Apr. 27, 2023. |
| Non-Final Office Action for U.S. Appl. No. 16/452,145 mailed Mar. 28, 2023. |
| Non-Final Office Action for U.S. Appl. No. 16/452,258 mailed Apr. 26, 2023. |
| Non-Final Office Action for U.S. Appl. No. 16/478,180 mailed Dec. 20, 2022. |
| Non-Final Office Action for U.S. Appl. No. 16/904,868 mailed Mar. 15, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/051,399 mailed Aug. 18, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/051,550 mailed Dec. 15, 2022. |
| Non-Final Office Action for U.S. Appl. No. 17/051,585 mailed Mar. 29, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/179,116 mailed Mar. 24, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/326,980 mailed Jul. 11, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/444,792 mailed Feb. 10, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/446,256 mailed Apr. 13, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/446,654 mailed Sep. 8, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/448,811 mailed Mar. 1, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/450,864 mailed May 10, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/451,345 mailed Dec. 7, 2022. |
| Non-Final Office Action for U.S. Appl. No. 17/451,354 mailed May 3, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/453,260 mailed Mar. 14, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/501,591 mailed Apr. 25, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/646,771 mailed Jul. 5, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/653,137 mailed Apr. 7, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/655,464 mailed Mar. 14, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/657,474 mailed Sep. 12, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/661,090 mailed Jul. 6, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/662,700 mailed Jul. 22, 2022. |
| Non-Final Office Action for U.S. Appl. No. 17/664,487 mailed Jun. 8, 2023. |
| Non-Final Office Action for U.S. Appl. No. 18/139,523 mailed Aug. 17, 2023. |
| Non-Final Office Action for U.S. Appl. No. 18/140,751 mailed Sep. 14, 2023. |
| Notice of Allowance for U.S. Appl. No. 16/245,726 mailed Jul. 6, 2023. |
| Notice of Allowance for U.S. Appl. No. 16/449,039 mailed Dec. 15, 2022. |
| Notice of Allowance for U.S. Appl. No. 16/899,956 mailed Aug. 10, 2022. |
| Notice of Allowance for U.S. Appl. No. 16/899,956 mailed Dec. 1, 2022. |
| Notice of Allowance for U.S. Appl. No. 16/905,400 mailed Aug. 17, 2022. |
| Notice of Allowance for U.S. Appl. No. 17/051,554 mailed Jul. 6, 2023. |
| Notice of Allowance for U.S. Appl. No. 17/461,036 mailed Feb. 22, 2023. |
| Notice of Allowance for U.S. Appl. No. 17/461,036 mailed Jun. 30, 2023. |
| Notice of Allowance for U.S. Appl. No. 17/461,036 mailed Oct. 6, 2022. |
| Notice of Allowance for U.S. Appl. No. 17/662,700 mailed Jul. 28, 2023. |
| Notice of Allowance for U.S. Appl. No. 17/662,700 mailed Mar. 28, 2023. |
| Notice of Allowance for U.S. Appl. No. 17/663,046 mailed Jan. 30, 2023. |
| Notice of Allowance for U.S. Appl. No. 18/299,788 mailed Jul. 24, 2023. |
| Restriction Requirement for U.S. Appl. No. 17/051,600 mailed Sep. 21, 2023. |
| Restriction Requirement for U.S. Appl. No. 17/326,980 mailed Mar. 20, 2023. |
| Restriction Requirement for U.S. Appl. No. 17/446,256 mailed Jan. 23, 2023. |
| Restriction Requirement for U.S. Appl. No. 17/645,821 mailed Jul. 12, 2023. |
| Restriction Requirement for U.S. Appl. No. 17/646,771 mailed Apr. 6, 2023. |
| Restriction Requirement for U.S. Appl. No. 17/657,474 mailed Jun. 30, 2023. |
| Text Messages to Lorena Eckert Re Prototype PureWick Holder dated Apr. 16, 2022. |
| U.S. Appl. No. 15/611,587, filed Jun. 1, 2017. |
| U.S. Appl. No. 17/664,487, filed May 23, 2022. |
| U.S. Appl. No. 17/758,152, filed Jun. 29, 2022. |
| U.S. Appl. No. 17/758,316, filed Jul. 1, 2022. |
| U.S. Appl. No. 17/759,697, filed Jul. 28, 2022. |
| U.S. Appl. No. 17/878,268, filed Aug. 1, 2022. |
| U.S. Appl. No. 17/907,125, filed Sep. 23, 2022. |
| U.S. Appl. No. 17/912,147, filed Sep. 16, 2022. |
| U.S. Appl. No. 17/929,887, filed Sep. 6, 2022. |
| U.S. Appl. No. 17/930,238, filed Sep. 7, 2022. |
| U.S. Appl. No. 17/933,590, filed Sep. 20, 2022. |
| U.S. Appl. No. 17/996,064, filed Oct. 12, 2022. |
| U.S. Appl. No. 17/996,155, filed Oct. 13, 2022. |
| U.S. Appl. No. 17/996,253, filed Oct. 14, 2022. |
| U.S. Appl. No. 17/996,468, filed Oct. 18, 2022. |
| U.S. Appl. No. 17/996,556, filed Oct. 19, 2022. |
| U.S. Appl. No. 18/003,029, filed Dec. 22, 2022. |
| U.S. Appl. No. 18/006,807, filed Jan. 25, 2023. |
| U.S. Appl. No. 18/007,105, filed Jan. 27, 2023. |
| U.S. Appl. No. 18/041,109, filed Feb. 9, 2023. |
| U.S. Appl. No. 18/042,842, filed Feb. 24, 2023. |
| U.S. Appl. No. 18/043,618, filed Mar. 1, 2023. |
| U.S. Appl. No. 18/115,444, filed Feb. 28, 2023. |
| U.S. Appl. No. 18/134,857, filed Apr. 14, 2023. |
| U.S. Appl. No. 18/140,163, filed Apr. 27, 2023. |
| U.S. Appl. No. 18/140,751, filed Apr. 28, 2023. |
| U.S. Appl. No. 18/164,800, filed Feb. 6, 2023. |
| U.S. Appl. No. 18/198,464, filed May 17, 2023. |
| U.S. Appl. No. 18/246,121, filed Mar. 21, 2023. |
| U.S. Appl. No. 18/247,986, filed Apr. 5, 2023. |
| U.S. Appl. No. 18/259,626, filed Jun. 28, 2023. |
| U.S. Appl. No. 18/260,122, filed Jun. 30, 2023. |
| U.S. Appl. No. 18/260,391, filed Jul. 5, 2023. |
| U.S. Appl. No. 18/260,394, filed Jul. 5, 2023. |
| U.S. Appl. No. 18/263,800, filed Aug. 1, 2023. |
| U.S. Appl. No. 18/264,004, filed Aug. 2, 2023. |
| U.S. Appl. No. 18/265,736, filed Jun. 7, 2023. |
| U.S. Appl. No. 18/299,788, filed Apr. 13, 2023. |
| U.S. Appl. No. 18/335,579, filed Jun. 15, 2023. |
| U.S. Appl. No. 18/548,152, filed Aug. 28, 2023. |
| U.S. Appl. No. 18/549,387, filed Sep. 7, 2023. |
| U.S. Appl. No. 18/549,658, filed Sep. 8, 2023. |
| U.S. Appl. No. 62/967,158, filed Jan. 26, 2020. |
| U.S. Appl. No. 62/991,754, filed Mar. 19, 2020. |
| U.S. Appl. No. 63/150,640, filed Feb. 18, 2021. |
| U.S. Appl. No. 63/241,328, filed Sep. 7, 2021. |
| U.S. Appl. No. 63/308,190, filed Feb. 9, 2022. |
| PureWick Corporation v. Sage Products, LLC Transcripts vol. 2, Mar. 29, 2022. |
| PureWick Corporation v. Sage Products, LLC Transcripts vol. 3, Mar. 30, 2022. |
| PureWick Corporation v. Sage Products, LLC Transcripts vol. 4, Mar. 31, 2022. |
| PureWick Corporation v. Sage Products, LLC Transcripts vol. 5, Apr. 1, 2022. |
| PureWick Corporation v. Sage Products, LLC Transcripts vol. 1, Mar. 28, 2022. |
| “AMXD Control Starter Kit”, Omni Medical Systems, Inc., 1 page. |
| “AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical, Jan. 11, 2010, 10 pages. |
| “AMXDmax Development History 2002-2014”, Omni Medical Systems, Inc., 2 pages. |
| “Combat Force Multiplier in Flight Bladder Relief Cockpit Essential Equipment Brochure”, Omni Medical, 20 pages. |
| “GSA Price List”, Omni Medical, Apr. 2011, 2 pages. |
| “How is Polypropylene Fiber Made”, https:www.yarnsandfibers.com/textile-resources/synthetic-fibers/polypropylene-fiber/polypropylene-fiber-production-raw-materials/how-is-polypropylene- fiber-made/ last accessed 2020, Oct. 7, 2020, 3 pages. |
| “Letter to Mark Harvie of Omni Measurement Systems”, Department of Veterans Affairs, Nov. 1, 2007, 11 pages. |
| “Revised AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical Systems, Oct. 8, 2019, 52 pages. |
| Merriam-Webster Dictionary, “Embed Definition & Meaning”, https://www.merriam-webster.com/dictionary/embed last accessed Aug. 3, 2023, 2003. |
| Pieper, et al., “An external urine-collection device for women: A clinical trial”, Journal of ER Nursing, vol. 20, No. 2, Mar./Apr. 1993, pp. 51-55. |
| Mnas, “A Solution for an Awkward—But Serious—Subject”, http://www.aero-news.net/index.cfm?do=main.textpost&id=69ae2bb1-838b-4098-a7b5-7flbb2505688 last accessed Feb. 8, 2021. |
| Advisory Action for U.S. Appl. No. 16/433,773 mailed Dec. 29, 2023. |
| Advisory Action for U.S. Appl. No. 16/449,039 mailed Jan. 25, 2024. |
| Advisory Action for U.S. Appl. No. 16/904,868 mailed Jan. 2, 2024. |
| Advisory Action for U.S. Appl. No. 17/051,585 mailed Oct. 17, 2023. |
| Advisory Action for U.S. Appl. No. 17/179,116 mailed Jan. 8, 2024. |
| Advisory Action for U.S. Appl. No. 17/446,256 mailed Dec. 8, 2023. |
| Advisory Action for U.S. Appl. No. 17/448,811 mailed Nov. 15, 2023. |
| Advisory Action for U.S. Appl. No. 17/451,345 mailed Oct. 20, 2023. |
| Advisory Action for U.S. Appl. No. 17/451,354 mailed Jan. 30, 2024. |
| Advisory Action for U.S. Appl. No. 17/453,260 mailed Dec. 22, 2023. |
| Advisory Action for U.S. Appl. No. 17/501,591 mailed Feb. 22, 2024. |
| Advisory Action for U.S. Appl. No. 17/646,771 mailed Feb. 29, 2024. |
| Advisory Action for U.S. Appl. No. 17/653,137 mailed Dec. 1, 2023. |
| Advisory Action for U.S. Appl. No. 17/655,464 mailed Dec. 13, 2023. |
| Advisory Action for U.S. Appl. No. 17/661,090 mailed Feb. 26, 2024. |
| Advisory Action for U.S. Appl. No. 17/663,330 mailed Feb. 27, 2024. |
| Advisory Action for U.S. Appl. No. 18/164,800 mailed Feb. 12, 2024. |
| Communication of Notice of Opposition of European Application No. 17807547.9 mailed Jan. 5, 2024. |
| Corrected Notice of Allowability for U.S. Appl. No. 16/369,676 mailed Dec. 7, 2023. |
| Corrected Notice of Allowability for U.S. Appl. No. 17/326,980 mailed Feb. 8, 2024. |
| Final Office Action for U.S. Appl. No. 16/433,773 mailed Oct. 10, 2023. |
| Final Office Action for U.S. Appl. No. 16/449,039 mailed Nov. 21, 2023. |
| Final Office Action for U.S. Appl. No. 16/452,258 mailed Dec. 21, 2023. |
| Final Office Action for U.S. Appl. No. 16/478,180 mailed Feb. 28, 2024. |
| Final Office Action for U.S. Appl. No. 16/904,868 mailed Nov. 2, 2023. |
| Final Office Action for U.S. Appl. No. 17/051,399 mailed Jan. 8, 2024. |
| Final Office Action for U.S. Appl. No. 17/179,116 mailed Oct. 31, 2023. |
| Final Office Action for U.S. Appl. No. 17/446,654 mailed Jan. 31, 2024. |
| Final Office Action for U.S. Appl. No. 17/450,864 mailed Dec. 28, 2023. |
| Final Office Action for U.S. Appl. No. 17/451,354 mailed Oct. 30, 2023. |
| Final Office Action for U.S. Appl. No. 17/453,260 mailed Oct. 5, 2023. |
| Final Office Action for U.S. Appl. No. 17/501,591 mailed Nov. 14, 2023. |
| Final Office Action for U.S. Appl. No. 17/646,771 mailed Dec. 21, 2023. |
| Final Office Action for U.S. Appl. No. 17/661,090 mailed Dec. 11, 2023. |
| Final Office Action for U.S. Appl. No. 17/664,487 mailed Jan. 4, 2024. |
| Final Office Action for U.S. Appl. No. 18/139,523 mailed Dec. 22, 2023. |
| Final Office Action for U.S. Appl. No. 18/140,751 mailed Jan. 17, 2024. |
| Final Office Action for U.S. Appl. No. 18/164,800 mailed Dec. 6, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/018474 mailed Sep. 11, 2023. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/024805 mailed Dec. 14, 2023. |
| Issue Notification for U.S. Appl. No. 16/245,726 mailed Oct. 18, 2023. |
| Issue Notification for U.S. Appl. No. 17/461,036 mailed Oct. 11, 2023. |
| Issue Notification for U.S. Appl. No. 17/663,046 mailed Dec. 20, 2023. |
| Issue Notification for U.S. Appl. No. 18/299,788 mailed Feb. 21, 2024. |
| Non-Final Office Action for U.S. Appl. No. 16/369,676 mailed Feb. 29, 2024. |
| Non-Final Office Action for U.S. Appl. No. 16/433,773 mailed Feb. 26, 2024. |
| Non-Final Office Action for U.S. Appl. No. 16/452,145 mailed Nov. 2, 2023. |
| Non-Final Office Action for U.S. Appl. No. 16/478,180 mailed Nov. 7, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/051,550 mailed Oct. 24, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/051,585 mailed Jan. 8, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/051,600 mailed Jan. 17, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/179,116 mailed Feb. 26, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/444,792 mailed Nov. 17, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/446,256 mailed Feb. 13, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/447,123 mailed Jan. 24, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/448,811 mailed Jan. 17, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/451,345 mailed Jan. 17, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/453,560 mailed Oct. 16, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/645,821 mailed Oct. 25, 2023. |
| Non-Final Office Action for U.S. Appl. No. 17/653,137 mailed Jan. 18, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/664,914 mailed Jan. 31, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/808,354 mailed Nov. 28, 2023. |
| Non-Final Office Action for U.S. Appl. No. 18/134,857 mailed Jan. 25, 2024. |
| Non-Final Office Action for U.S. Appl. No. 18/140,163 mailed Nov. 9, 2023. |
| Non-Final Office Action for U.S. Appl. No. 18/198,464 mailed Dec. 7, 2023. |
| Notice of Allowance for U.S. Appl. No. 16/369,676 mailed Nov. 14, 2023. |
| Notice of Allowance for U.S. Appl. No. 17/051,550 mailed Feb. 7, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/051,554 mailed Oct. 18, 2023. |
| Notice of Allowance for U.S. Appl. No. 17/326,980 mailed Jan. 29, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/453,560 mailed Jan. 31, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/662,700 mailed Nov. 15, 2023. |
| Notice of Allowance for U.S. Appl. No. 18/299,788 mailed Nov. 6, 2023. |
| Restriction Requirement for U.S. Appl. No. 18/134,857 mailed Oct. 23, 2023. |
| Submission in Opposition Proceedings for European Application No. 17807547.9 filed Jan. 10, 2024. |
| Supplemental Notice of Allowance for U.S. Appl. No. 17/051,550 mailed Feb. 21, 2024. |
| Supplemental Notice of Allowance for U.S. Appl. No. 17/051,554 mailed Feb. 14, 2024. |
| U.S. Appl. No. 17/451,719, filed Oct. 19, 2021. |
| U.S. Appl. No. 18/294,370, filed Feb. 1, 2024. |
| U.S. Appl. No. 18/294,403, filed Feb. 1, 2024. |
| U.S. Appl. No. 18/373,424, filed Sep. 27, 2023. |
| U.S. Appl. No. 18/376,274, filed Oct. 3, 2023. |
| U.S. Appl. No. 18/389,009, filed Nov. 13, 2023. |
| U.S. Appl. No. 18/415,080, filed Jan. 17, 2024. |
| U.S. Appl. No. 18/426,795, filed Jan. 30, 2024. |
| U.S. Appl. No. 18/553,625, filed Oct. 2, 2023. |
| U.S. Appl. No. 18/556,945, filed Oct. 24, 2023. |
| U.S. Appl. No. 18/558,502, filed Nov. 1, 2023. |
| U.S. Appl. No. 18/562,626, filed Nov. 20, 2023. |
| U.S. Appl. No. 18/563,672, filed Nov. 22, 2023. |
| U.S. Appl. No. 18/569,711, filed Dec. 13, 2023. |
| U.S. Appl. No. 18/569,778, filed Dec. 13, 2023. |
| U.S. Appl. No. 18/584,002, filed Feb. 22, 2024. |
| U.S. Appl. No. 18/681,987, filed Feb. 7, 2024. |
| U.S. Appl. No. 18/682,006, filed Feb. 7, 2024. |
| U.S. Appl. No. 18/687,117, filed Feb. 27, 2024. |
| U.S. Appl. No. 18/688,023, filed Feb. 29, 2024. |
| U.S. Appl. No. 63/596,012, filed Nov. 3, 2023. |
| U.S. Appl. No. 63/608,553, filed Dec. 11, 2023. |
| Wikipedia Article, “Zylinder (Geometrie)” , https://de.wikipedia.org/w/index.php?title=Zylinder (Geometrie)&oldid=154862081, version of Jun. 1, 2016, 7 pages. |
| Advisory Action for U.S. Appl. No. 16/452,258 mailed Apr. 8, 2024. |
| Advisory Action for U.S. Appl. No. 16/478,180 mailed Jun. 7, 2024. |
| Advisory Action for U.S. Appl. No. 17/051,585 mailed Oct. 8, 2024. |
| Advisory Action for U.S. Appl. No. 17/444,792 mailed Jul. 8, 2024. |
| Advisory Action for U.S. Appl. No. 17/446,654 mailed Apr. 15, 2024. |
| Advisory Action for U.S. Appl. No. 17/450,864 mailed Mar. 21, 2024. |
| Advisory Action for U.S. Appl. No. 17/451,345 mailed Jul. 3, 2024. |
| Advisory Action for U.S. Appl. No. 17/645,821 mailed Jul. 2, 2024. |
| Advisory Action for U.S. Appl. No. 17/664,487 mailed Mar. 13, 2024. |
| Advisory Action for U.S. Appl. No. 17/808,354 mailed Jun. 12, 2024. |
| Advisory Action for U.S. Appl. No. 18/134,857 mailed Oct. 23, 2024. |
| Advisory Action for U.S. Appl. No. 18/139,523 mailed Apr. 24, 2024. |
| Advisory Action for U.S. Appl. No. 18/140,163 mailed Jun. 3, 2024. |
| Advisory Action for U.S. Appl. No. 18/140,751 mailed Apr. 24, 2024. |
| Corrected Notice of Allowability for U.S. Appl. No. 17/450,864 mailed Oct. 24, 2024. |
| Corrected Notice of Allowability for U.S. Appl. No. 17/501,591 mailed Aug. 9, 2024. |
| Corrected Notice of Allowability for U.S. Appl. No. 17/657,474 mailed Mar. 13, 2024. |
| Corrected Notice of Allowability for U.S. Appl. No. 17/657,474 mailed May 14, 2024. |
| Corrected Notice of Allowability for U.S. Appl. No. 17/664,914 mailed Aug. 9, 2024. |
| Final Office Action for U.S. Appl. No. 16/433,773 mailed Sep. 9, 2024. |
| Final Office Action for U.S. Appl. No. 17/051,585 mailed Jul. 5, 2024. |
| Final Office Action for U.S. Appl. No. 17/051,600 mailed Jun. 27, 2024. |
| Final Office Action for U.S. Appl. No. 17/444,792 mailed Apr. 3, 2024. |
| Final Office Action for U.S. Appl. No. 17/446,256 mailed Aug. 7, 2024. |
| Final Office Action for U.S. Appl. No. 17/447,123 mailed May 14, 2024. |
| Final Office Action for U.S. Appl. No. 17/451,345 mailed Apr. 18, 2024. |
| Final Office Action for U.S. Appl. No. 17/597,673 mailed Oct. 22, 2024. |
| Final Office Action for U.S. Appl. No. 17/645,821 mailed Apr. 3, 2024. |
| Final Office Action for U.S. Appl. No. 17/653,137 mailed Aug. 7, 2024. |
| Final Office Action for U.S. Appl. No. 17/653,920 mailed Aug. 14, 2024. |
| Final Office Action for U.S. Appl. No. 17/808,354 mailed Apr. 10, 2024. |
| Final Office Action for U.S. Appl. No. 18/003,029 mailed Oct. 22, 2024. |
| Final Office Action for U.S. Appl. No. 18/134,857 mailed Jul. 25, 2024. |
| Final Office Action for U.S. Appl. No. 18/140,163 mailed Mar. 27, 2024. |
| Final Office Action for U.S. Appl. No. 18/164,800 mailed Oct. 22, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/025192 mailed Feb. 7, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/025939 mailed Feb. 7, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/030365 mailed Mar. 13, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/030373 mailed Mar. 13, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/031433 mailed Mar. 4, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/031740 mailed Mar. 4, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/036238 mailed Jul. 22, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/036868 mailed Jun. 5, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/075507 mailed Jun. 13, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/077168 mailed Jun. 24, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/077208 mailed May 10, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/080680 mailed Jul. 22, 2024. |
| International Search Report and Written Opinion from International Application No. PCT/US2023/085516 mailed Aug. 26, 2024. |
| Issue Notification for U.S. Appl. No. 16/369,676 mailed Oct. 2, 2024. |
| Issue Notification for U.S. Appl. No. 16/449,039 mailed Jun. 19, 2024. |
| Issue Notification for U.S. Appl. No. 16/452,145 mailed Oct. 23, 2024. |
| Issue Notification for U.S. Appl. No. 17/051,550 mailed Mar. 13, 2024. |
| Issue Notification for U.S. Appl. No. 17/051,554 mailed Mar. 6, 2024. |
| Issue Notification for U.S. Appl. No. 17/326,980 mailed Jul. 10, 2024. |
| Issue Notification for U.S. Appl. No. 17/448,811 mailed Jul. 3, 2024. |
| Issue Notification for U.S. Appl. No. 17/453,260 mailed Jul. 10, 2024. |
| Issue Notification for U.S. Appl. No. 17/453,560 mailed Aug. 7, 2024. |
| Issue Notification for U.S. Appl. No. 17/657,474 mailed Jun. 19, 2024. |
| Issue Notification for U.S. Appl. No. 17/662,700 mailed Oct. 23, 2024. |
| Non-Final Office Action for U.S. Appl. No. 16/452,258 mailed Jun. 20, 2024. |
| Non-Final Office Action for U.S. Appl. No. 16/478,180 mailed Aug. 7, 2024. |
| Non-Final Office Action for U.S. Appl. No. 16/904,868 mailed Mar. 12, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/378,015 mailed Jul. 5, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/446,654 mailed Jun. 25, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/450,864 mailed May 29, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/451,345 mailed Jul. 25, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/451,354 mailed Apr. 4, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/595,747 mailed Jun. 7, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/597,408 mailed Aug. 15, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/597,673 mailed Mar. 20, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/614,173 mailed Sep. 24, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/628,411 mailed Sep. 23, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/645,821 mailed Sep. 6, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/646,771 mailed Apr. 24, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/653,314 mailed Aug. 29, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/653,920 mailed Mar. 15, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/655,464 mailed Mar. 26, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/661,090 mailed May 22, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/664,487 mailed Jun. 17, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/749,340 mailed Aug. 14, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/757,311 mailed Oct. 22, 2024. |
| Non-Final Office Action for U.S. Appl. No. 17/758,316 mailed Aug. 28, 2024. |
| Non-Final Office Action for U.S. Appl. No. 18/003,029 mailed Mar. 26, 2024. |
| Non-Final Office Action for U.S. Appl. No. 18/139,523 mailed Aug. 26, 2024. |
| Non-Final Office Action for U.S. Appl. No. 18/140,751 mailed Jun. 21, 2024. |
| Non-Final Office Action for U.S. Appl. No. 18/164,800 mailed Mar. 22, 2024. |
| Non-Final Office Action for U.S. Appl. No. 18/389,009 mailed May 24, 2024. |
| Non-Final Office Action for U.S. Appl. No. 18/426,795 mailed Aug. 9, 2024. |
| Non-Final Office Action for U.S. Appl. No. 18/451,080 mailed Jul. 30, 2024. |
| Non-Final Office Action for U.S. Appl. No. 18/584,002 mailed Sep. 19, 2024. |
| Notice of Allowance for U.S. Appl. No. 16/369,676 mailed Jun. 17, 2024. |
| Notice of Allowance for U.S. Appl. No. 16/449,039 mailed Mar. 28, 2024. |
| Notice of Allowance for U.S. Appl. No. 16/452,145 mailed Jul. 11, 2024. |
| Notice of Allowance for U.S. Appl. No. 16/904,868 mailed Sep. 29, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/179,116 mailed Sep. 13, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/326,980 mailed Apr. 5, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/447,123 mailed Jul. 26, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/448,811 mailed Jun. 14, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/450,864 mailed Sep. 18, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/453,260 mailed Apr. 8, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/501,591 mailed Jul. 31, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/657,474 mailed Mar. 5, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/657,474 mailed May 2, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/662,700 mailed Jun. 12, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/662,700 mailed Mar. 6, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/664,914 mailed Jul. 26, 2024. |
| Notice of Allowance for U.S. Appl. No. 17/667,097 mailed Aug. 28, 2024. |
| Notice of Allowance for U.S. Appl. No. 18/140,163 mailed Aug. 21, 2024. |
| Notice of Allowance for U.S. Appl. No. 18/198,464 mailed Apr. 17, 2024. |
| Notice of Allowance for U.S. Appl. No. 18/198,464 mailed Jul. 30, 2024. |
| Notice of Allowance for U.S. Appl. No. 18/389,009 mailed Aug. 28, 2024. |
| Restriction Requirement for U.S. Appl. No. 17/527,769 mailed Jun. 17, 2024. |
| Restriction Requirement for U.S. Appl. No. 17/596,629 mailed Sep. 19, 2024. |
| Restriction Requirement for U.S. Appl. No. 17/625,941 mailed Aug. 7, 2024. |
| Restriction Requirement for U.S. Appl. No. 17/667,097 mailed Mar. 20, 2024. |
| Restriction Requirement for U.S. Appl. No. 17/756,201 mailed Oct. 4, 2024. |
| Restriction Requirement for U.S. Appl. No. 17/878,268 mailed Sep. 20, 2024. |
| U.S. Appl. No. 17/013,822, filed Sep. 7, 2020. |
| U.S. Appl. No. 17/444,792, filed Aug. 10, 2021. |
| U.S. Appl. No. 18/249,577, filed Oct. 19, 2021. |
| U.S. Appl. No. 18/610,523, filed Mar. 20, 2024. |
| U.S. Appl. No. 18/662,216, filed May 13, 2024. |
| U.S. Appl. No. 18/693,638, filed Mar. 20, 2024. |
| U.S. Appl. No. 18/694,090, filed Mar. 21, 2024. |
| U.S. Appl. No. 18/728,604, filed Jul. 12, 2024. |
| U.S. Appl. No. 18/757,964, filed Jun. 28, 2024. |
| U.S. Appl. No. 18/758,025, filed Jun. 28, 2024. |
| U.S. Appl. No. 18/828,559, filed Sep. 9, 2024. |
| U.S. Appl. No. 18/834,115, filed Jul. 29, 2024. |
| U.S. Appl. No. 18/834,176, filed Jul. 29, 2024. |
| U.S. Appl. No. 18/834,340, filed Jul. 30, 2024. |
| U.S. Appl. No. 18/835,068, filed Aug. 1, 2024. |
| U.S. Appl. No. 18/835,444, filed Aug. 2, 2024. |
| U.S. Appl. No. 18/836,204, filed Aug. 6, 2024. |
| U.S. Appl. No. 18/841,630, filed Aug. 26, 2024. |
| U.S. Appl. No. 18/851,197, filed Sep. 26, 2024. |
| U.S. Appl. No. 18/886,306, filed Sep. 16, 2024. |
| U.S. Appl. No. 18/903,592, filed Oct. 1, 2024. |
| U.S. Appl. No. 18/925,921, filed Oct. 24, 2024. |
| U.S. Appl. No. 63/564,696, filed Mar. 13, 2024. |
| U.S. Appl. No. 63/561,893, filed Dec. 11, 2023. |
| U.S. Appl. No. 63/568,615, filed Mar. 22, 2024. |
| U.S. Appl. No. 63/683,428, filed Aug. 15, 2024. |
| U.S. Appl. No. 63/711,438, filed Oct. 24, 2024. |
| U.S. Appl. No. 63/711,445, filed Oct. 24, 2024. |
| “Dictionary.com, Abut Definition and Meaning”, Dictionary.com, https://www.dictionary.com/browse/abut, 2024, 1 page. |
| “Oblong”, Cambridge Dictionary, https://dictionary.cambridge.org/dictionary/english/oblong, 2024, 1 page. |
| Britannica, “Polyolefin”, Britannica Online Encyclopedia, T. Editors of Encyclopaedia, https://www.britannica.com/science/polyolefin, Jul. 26, 2012. |
| Martin, et al., “Chapter 5 Applications of Polyethylene Oxide (POLYOX) in Hydrophilic Matrices”, Hydrophilic Matrix Tablets for Oral Controlled Release, AAPS Advances in the Pharmaceutical Sciences vol. 16, 2014, pp. 123-141. |
| Wikipedia Article, “Decibel”, https://web.archive.org/web/2020041521917/https://en.wikipedia/org/wiki/Decibel last accessed Mar. 11, 2024, 21 pages. |
| Wikipedia Article, “Fiberglass”, https://web.archive.org.web/20200309194847/https://en.wikipedia.org/wiki/Fiberglass last accessed Mar. 11, 2024. |
| Number | Date | Country | |
|---|---|---|---|
| 20220370236 A1 | Nov 2022 | US |
| Number | Date | Country | |
|---|---|---|---|
| 63191558 | May 2021 | US |
